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reviewed is well described. It's easy to read, except some technical details wich could be difficult to 
understand for readers not used to take up this topic.  
There are some changes to do. 
 
1-First of all, the references in all the tables are wrong as none of them correspond to the authors 
listed. This must be corrected.  
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removes any inter-individual variability in the speed at which the blue-green ratio is adjusted, 
therefore improving the accuracy of the MPOD value.’  
 
All referencing has been updated accordingly. 
 
Note 2 
Some of our figure legends didn’t explain exactly what technique was being used. Therefore we have 
updated these too (highlighted in revised manuscript). 
 
 
1 
 
Measuring Macular Pigment Optical Density In Vivo: A Review Of Techniques 
 
Olivia Howells, Frank Eperjesi, Hannah Bartlett 
 
Ophthalmic Research Group, School of Life and Health Sciences, Aston University, 
Birmingham, B4 7ET, UK 
 
Corresponding author:  Olivia Howells; o.howells@aston.ac.uk; Tel. 0121 204 4135;  
 Fax. 0121 204 4048 
 
ABSTRACT 
 
Background: Macular pigment has been the focus of much attention in recent years, as a 
potential modifiable risk factor for age-related macular degeneration. This interest has been 
heightened by the ability to measure macular pigment optical density (MPOD) in vivo. 
Method: A systematic literature search was undertaken to identify all available papers that 
have used in vivo MPOD techniques. The papers were reviewed and all relevant information 
was incorporated into this article. Results: Measurement of MPOD is achievable with a wide 
range of techniques, which are typically categorized into one of two groups: psychophysical 
(requiring a response from the subject) or objective (requiring minimal input from the 
subject). The psychophysical methods include heterochromatic flicker photometry and 
minimum motion photometry. The objective methods include fundus reflectometry, fundus 
autofluorescence, resonance Raman spectroscopy and visual evoked potentials. Even 
within the individual techniques, there is often much variation in how data is obtained and 
processed. Conclusion: This review comprehensively details the procedure, instrumentation, 
assumptions, validity and reliability of each MPOD measurement technique currently 
available, along with their respective advantages and disadvantages. This leads us to 
conclude that development of a commercial instrument, based on fundus reflectometry or 
fundus autofluorescence, would be beneficial to macular pigment research and would 
support MPOD screening in a clinical setting. 
 
Keywords: fundus autofluorescence; fundus reflectometry; heterochromatic flicker 
photometry; macular pigment; macular pigment optical density; motion photometry; Raman 
spectroscopy.
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INTRODUCTION 
 
Macular pigment is the collective name for three carotenoids, lutein, zeaxanthin and meso-
zeaxanthin, which are found at higher concentrations in the retina than anywhere else in the 
body, and to the exclusion of all other carotenoids [1]. They are only accessible to the body 
by dietary intake of foodstuffs or supplements containing them [2, 3], with high levels being 
found in certain fruits and vegetables, such as kiwi fruit, corn and spinach, as well as egg 
yolks [4]. 
 
Analysis of donor maculae is possibly the most unequivocal approach for assessing the 
distribution of macular pigment in the retina, and pioneering work by Snodderly and 
colleagues in the 1980s achieved this [5, 6]. Using primate monkeys and the technique of 
microdensitometry, it was confirmed, as expected, that macular pigment reaches its peak in 
the centre of the retina. There was then a sharp decline to negligible levels at approximately 
1 mm (4°) from the central fovea. In 1988, Bone et al., using high-performance liquid 
chromatography (HPLC), investigated the spatial distribution of macular pigment in human 
donors; in this case, it was found to reach negligible levels at 7° eccentricity [7]. Within the 
retinal layers, macular pigment is primarily located in the photoreceptor axons and to a 
lesser extent in the inner plexiform layer [6, 8].  
 
The macular carotenoids have an absorption spectrum of 400 – 540 nm, peaking at 
approximately 460 nm [9]. This spectral peak, along with the spatial distribution and retinal 
layer localization of macular pigment contribute to its proposed function as a blue light filter. 
Short-wavelength (blue) light is more damaging to the retina than longer-wavelength light 
[10] so by attenuating the amount of blue light reaching the photoreceptors, macular pigment 
may protect the macula from this photo-damage; the higher the density of macular pigment 
(macular pigment optical density, or MPOD), the greater the amount of blue light filtering that 
will occur [11, 12]. A second proposed function of macular pigment is that it protects the 
macula against oxidative stress by acting as an antioxidant [e.g. 13]. These blue light filter 
and antioxidant functions have led to the school of thought that having a high MPOD could 
help to protect against the eye disease age-related macular degeneration (AMD), the most 
prevalent cause of severe visual impairment in Western society [14-16]. As a result, there 
have been a multitude of studies investigating possible links between MPOD and AMD, 
using a variety of measurement techniques. Some of these studies have supported an 
MPOD-AMD association [e.g. 17, 18, 19] and some have not [e.g. 20, 21]. This inconsistent 
evidence is not too surprising, given the apparent multifactorial nature of AMD. What’s more, 
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it is highly likely that an individual’s MPOD is equally multifactorial, but as one of the few 
potentially modifiable risk factors for AMD, its continued investigation is extremely important. 
 
Macular pigment optical density may be measured in vitro or in vivo. In vitro measurement 
involves the techniques of HPLC [e.g. 22, 23] or microdensitometry [e.g. 24]. However, they 
can only be performed on excised retinas and so are clearly not suitable for widespread use. 
This review therefore details the most common techniques currently used to measure MPOD 
in vivo. These in vivo techniques are noninvasive and are normally categorized under one of 
two headings: psychophysical (requiring a response from the subject) or objective (requiring 
minimal input from the subject). Together they have established that MPOD varies widely 
between individuals, from virtually no macular pigment to greater than 1 log unit optical 
density, with average levels ranging from 0.16 [25] to 0.50 [26], depending on the method 
and/or the study population. 
  
METHOD 
 
A systematic literature search was conducted using ISI Web of Knowledge and PubMed. 
Key words and their combinations used for the search included ‘macular pigment’, ‘macular 
pigment optical density’, ‘lutein’, ‘zeaxanthin’, ‘heterochromatic flicker photometry’, ‘motion 
photometry’, reflectometry’, ‘autofluorescence’, ‘Raman’, ‘electrophysiology’, and ‘macular 
degeneration’. Further searches were undertaken for key researchers in the field such as 
Beatty, Berendschot, Bernstein, Bone, Delori, Gellermann, Hammond, Landrum, Moreland, 
Nolan, Robson, Snodderly, Stringham, Trieschmann, van de Kraats, and Wenzel. Further 
papers were obtained from the references of the retrieved articles. All the articles were 
reviewed and relevant information was incorporated into the manuscript. 
 
RESULTS OF REVIEW 
 
Psychophysical techniques 
 
Psychophysical techniques of measuring macular pigment optical density (MPOD) include 
the following: 
 
Threshold spectral sensitivity [e.g. 27, 28-31]. 
Colour matching [e.g. 32, 33-35]. 
Dichroism-based measurements [e.g. 9, 36]. 
Minimum motion photometry and apparent motion photometry [e.g. 37, 38-41]. 
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Heterochromatic flicker photometry [e.g. 42, 43-53]. 
 
The first three of the psychophysical methods have now been largely superseded by 
heterochromatic flicker photometry (HFP) and, to some extent, minimum motion photometry. 
This is in part due to their increased level of difficulty and/or the longer time needed to 
perform them [54]. This review will therefore focus on the latter two methods. For information 
regarding the threshold sensitivity, colour matching and dichroism techniques, the reader is 
directed to the referenced studies, along with a validity review by Hammond et al. [54]. 
  
Heterochromatic flicker photometry 
 
Developed by Ives in the early 1900s [55], HFP has so far been the most commonly used of 
all the techniques for measuring MPOD. As such, it is often used as a standard against 
which other techniques are validated [e.g. 56, 57-60], although at present there is no true 
‘gold-standard’ in vivo measure of MPOD. 
 
The use of HFP to measure macular pigment levels was first described over 30 years ago by 
Werner and Wooten [61] but the technique wasn’t elaborated on until 1987, in a key paper 
by Werner, Donnelly and Kliegl [42]. Since then, HFP has been developed and used by 
numerous research groups investigating macular pigment. Key papers incorporating detailed 
descriptions and variations of the technique include Hammond and Fuld [43], Hammond et 
al. [44], Landrum et al. [45], Wooten et al. [46], Beatty et al. [47], Mellerio et al. [48], Bone 
and Landrum [49], Snodderly et al. [50], Tang et al. [62], Iannaccone et al. [51], Stringham et 
al. [52], and van der Veen et al. [53]. All other studies using HFP to measure MPOD tend to 
use the instruments originally designed or developed by these investigators. 
 
Procedure 
 
In conjunction with many of the MPOD techniques, HFP exploits the spectral absorption 
properties and retinal location of macular pigment. Essentially, HFP determines MPOD by 
presenting a light stimulus of two alternating wavelengths at the fovea and at a parafoveal 
area. The wavelengths are chosen such that one is a short wavelength blue light that is 
maximally absorbed by macular pigment and the other is a longer wavelength green to 
yellow light that is not absorbed by macular pigment [6]. If the colours are alternated at an 
appropriate frequency and the luminance of the two colours is not perceived to be equal by 
the subject, the stimulus will appear as a flickering light; the perceived colour of this light will 
be an amalgamation of the two source colours [47, 49, 50, 63]. Typically, the radiance (often 
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also termed intensity) of the blue light is adjusted by the subject until the observed flicker is 
minimized [e.g. 44, 45, 46, 48, 50, 52, 62]. This occurs when there is an equiluminance 
match between the blue and green lights [63, 64]. The procedure is then repeated at a 
parafoveal locus where macular pigment is negligible [65]. Since more blue light will be 
absorbed by macular pigment at the fovea than the parafovea, a greater radiance of blue 
light will be required at the fovea to appreciate minimal flicker. The log ratio of the radiance 
of blue light needed at the fovea compared with that needed at the parafovea gives a 
measure of peak MPOD (Formula 1), although whether this is truly the peak value is subject 
to discussion (see ‘the edge hypothesis of heterochromatic flicker photometry’). 
 
MPOD = log (Rfs / R
p
s
) − log (Rfγ / R
p
γ
) 
 
Formula 1. Example calculation for macular pigment optical density, from Stringham et al. 
[52]. Rfs = radiance of a peak macular pigment absorption wavelength, e.g. 460 nm, 
measured at a foveal location. Rps = radiance of a peak macular pigment absorption 
wavelength, measured at a parafoveal location, e.g. 7°. Rf γ = radiance of a negligible 
macular pigment absorption wavelength, e.g. 570 nm, measured at a foveal location. Rp γ = 
radiance of a negligible macular pigment absorption wavelength, measured at a parafoveal 
location. 
 
Instrumentation 
 
Several variations on MPOD measurement by HFP have been developed since its first use 
in the 1970s. Traditionally, Maxwellian view devices have been used [e.g. 42, 43, 45]. These 
are complex optical systems that are not easily portable and which require the use of a 
dental bite bar. The bite bar keeps the subject’s head stable so that their eye is correctly 
aligned with the incoming light beam [46, 65]. Given the complexity of these devices, 
operators need a significant amount of training [46]. As a result, several research groups 
have simplified the optics and allowed the use of a free view, or Newtonian view, setup [e.g. 
46, 47, 48, 62]. This negates the need for a bite bar, making the procedure more 
comfortable for the subject. Free view optical systems are also cheaper, easier to operate, 
and more portable (if not completely portable) than their Maxwellian counterparts [46, 47, 
62]. Wooten et al. [46] demonstrated a strong correlation for mean and individual MPOD 
calculated between their free view system and an established Maxwellian view system (r = 
0.95, no p-value provided). This showed that using the free viewing technique does not 
affect the accuracy of the derived result. Figures 1 and 2 depict a typical Maxwellian view 
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optical system and free view optical system, respectively, whilst Table 1 summarizes their 
differences. It should be noted that slight variations in these differences do occur. For 
instance, the instrument developed by Beatty and co-workers [47] uses both a quartz 
halogen and light-emitting diode (LED) light source. 
 
INSERT FIGURES 1 AND 2 ABOUT HERE 
INSERT TABLE 1 ABOUT HERE (AFTER FIGURES 1 AND 2) 
 
TEST FIELDS 
The test fields are viewed at a near working distance, e.g. 33 cm [48]. Most devices use a 
central stimulus that corresponds to a visual angle of 1° as standard, although there are 
exceptions; Landrum’s 1.5° [45] and Werner’s 0.70° [66], for instance. Moreover, many 
studies have used smaller test stimuli such as 12′ or 30′ when mapping the spatial profile of 
macular pigment [42, 44, 49, 50, 52, 60, 64, 67-79].  
 
The wavelength chosen for the blue light has varied between researchers from 458 nm [e.g. 
11, 46, 52, 75, 80, 81] to 476 nm [17], and from 530 nm [e.g. 43, 82-85] to 575 nm [62] for 
the green light. Where the blue wavelength does not coincide exactly with the peak of 
macular pigment absorption, this should be accounted for in the final calculation of MPOD. 
This is of greater importance in the objective techniques where wavelengths are often further 
from the peak than those used in HFP. MPOD should also be adjusted according to the 
bandwidth of the light source; the narrower the bandwidth, the more accurately the 
measurement reflects MPOD at the particular wavelength [54]. For the HFP device first 
described by Wooten et al. [46], the LED with peak energy at 458 nm has a half-bandwidth 
of 20 nm. As a result, MPOD must be increased by a 15% constant to correct for this [20, 
50, 54, 77]. 
  
The peripheral reference measurement is usually made using the same test stimulus as 
used for the central measure, but the subject’s gaze is directed to an eccentric fixation point. 
An exception to this is the Maculometer (developed by Mellerio et al. [48]) which instead 
turns the central 1° field into a fixation point and presents an annular test field at 5.5° from 
fixation. The subject therefore fixates centrally throughout the procedure. The authors 
reported that many subjects found this easier than maintaining an eccentric fixation. The 
parafoveal location used in different HFP apparatus varies from 4° from the central fovea 
[e.g. 11, 43, 46, 62, 71, 80, 81, 86] to 10° [72, 76] or 12° [66]. Similarly, the location of the 
peripheral point on the retina varies from temporal, nasal or superior retina, depending on 
instrument type. 
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FLICKER RATES 
The rate at which the blue and green lights are alternated is a difficult decision for 
researchers to make, since flicker sensitivity can vary between observers [65]. Ideally the 
flicker rate should allow for a suitable amount of null or minimal flicker to be achieved when 
adjusting the radiance of the test stimulus. If the flicker frequency is too low for an individual, 
they will have difficulty obtaining a point of null flicker. Conversely, if the flicker frequency is 
too high for an individual, they will have a wide range of null flicker, leading to variation in 
measurements [50, 52, 63, 75]. There is also the need for rod and short-wavelength cone 
suppression to consider (see ‘assumptions’). Until recently, most investigators have used set 
flicker frequencies that have varied from 11 Hz [e.g. 11, 57, 80, 81, 87, 88] to 30 Hz [e.g. 49, 
68, 89, 90] in the fovea and from 6 Hz [e.g. 11, 46, 57, 80, 81, 87, 88] to 25 Hz [e.g. 17, 47, 
91] in the parafovea. 
 
BACKGROUND FIELDS 
Like test fields, the backgrounds upon which they are presented can also vary in size and 
wavelength between equipment. Sizes have ranged from 4° in diameter [e.g. 43, 82] to 30° 
[53]. The colour of the background is invariably a blue wavelength or white. The purpose of 
these colours is discussed in the ‘assumptions’ section. 
 
RECENT DEVELOPMENTS 
In 2001, Moreland et al. described a novel method of measuring MPOD by HFP. They used 
the blue and green phosphor emissions of a colour computer monitor as stimuli for flicker 
minimization. Although perceptually distinct as blue and green, the broadband emission 
spectra of the phosphors resulted in a 50% underestimation of MPOD. This was correctable 
with a model that incorporated these emission spectra and therefore allowed a way of 
calibrating the monitor. Bone and Landrum [49] questioned whether the retinal illuminance 
provided by the instrument was high enough to avoid rod intrusion. Apart from further use by 
Robson et al. [92] and Robson and Parry [41] this method of MPOD determination does not 
appear to have been widely used. 
 
Snodderly et al. [50] paved the way for a new customized approach to HFP when they 
established a standardized protocol for measuring MPOD. The device used was a modified 
version of the one described by Wooten and colleagues in 1999, and included the addition of 
optimizing the flicker frequency for each individual. This was achieved by working out each 
subject’s critical flicker frequency at the fovea and parafovea, then using an algorithm to 
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determine the appropriate flicker rate to use when measuring MPOD. This procedure has 
since been adopted in other MPOD research [e.g. 51, 52, 64, 71, 72, 75, 76, 78, 79, 86, 93]. 
  
A new HFP technique called the macular assessment profile (MAP) test has been described 
by Rodriguez-Carmona et al. [94] and Kvansakul et al. [95]. The principle appears similar to 
the method detailed by Moreland et al. [38] and described above, in so far as the broadband 
phosphors of a visual display are employed and again require a correction model for this. 
The authors state that the test is a ‘rapid and convenient’ way of measuring a subject’s 
macular pigment profile up to 8° from the fovea, taking advantage of the ability of visual 
displays to produce stimuli of different sizes at randomized locations [94]. Although the test 
is said to have been validated, there does not appear to be any formally published data on 
this. 
 
A further development for customized HFP was briefly described by Engles et al. [93] and 
elaborated upon by Nolan et al. [75] and Stringham et al. [52]. This involves the inverse-
yoking of the radiances of the blue and green stimuli so that the overall luminance of the test 
field remains constant, i.e. when the radiance of the blue stimulus is increased, the radiance 
of the green stimulus is proportionately decreased. As a result, potential distractions by 
changes in perceived brightness for the subject are avoided. 
 
An entirely different approach to measurement of MPOD by HFP has been adopted in a new 
commercially available device which is described in detail by van der Veen et al. [53]. 
Instead of the subject responding to minimal or no flicker, they respond to the appearance of 
flicker as the alternation rate is decreased at 6 Hz per sec from a starting level of 60 Hz. This 
is above the critical flicker fusion frequency for the test conditions and therefore subjects do 
not perceive any flicker initially. Rather than the radiance of one wavelength being adjusted 
by the observer, a sequence of blue-green ratios is used. These are inverse-yoked to ensure 
that overall luminance stays the same. With similarities to Snodderly et al. [50], the 
instrument determines each observer’s sensitivity to flicker prior to the main part of the test. 
The technique also offers the possibility of estimating MPOD from a central measure alone, 
the peripheral measure being estimated from the age of the subject and their expected level 
of lens yellowing. A comparison between central and peripheral derived MPOD and 
estimated (central only) MPOD in 5616 eyes revealed a very close correlation (r = 0.92, no 
p-value provided) [96]. 
 
Most recently, a further development on customized HFP and inverse yoking has been 
described by Connolly et al. [78] and Nolan et al. [97]. Whilst sticking with the traditional 
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method of HFP MPOD determination, i.e. the radiance of blue light being 
increased/decreased until the point of minimal flicker, it takes on a more automated 
approach, as per the device of van der Veen et al. [53]. The instrument’s electronics 
increase/decrease the amount of blue in the stimulus at a set rate. This removes any inter-
individual variability in the speed at which the blue-green ratio is adjusted, therefore 
improving the accuracy of the MPOD value. 
 
Assumptions 
 
The HFP measurement of MPOD relies on several assumptions. Many of these assumptions 
are largely accepted because of the close relationship between HFP-derived macular 
pigment spectral absorption curves and spectral curves derived in vitro. Nevertheless, some 
of the main assumptions are described: 
 
1. Absorption or scattering properties of the ocular media being accounted for through use of 
a parafoveal locus [47, 49, 56, 98]. Essentially, this means that the amount of yellowing in 
the media (e.g. the crystalline lens) would influence the measured MPOD value but the 
reference measure outside of the fovea cancels this effect [96]. This is demonstrated by 
Formula 2, below. Evidence that this assumption is correct comes from real and simulated 
data. For instance, Ciulla et al. [81] measured MPOD in 24 patients before and after cataract 
surgery. No significant difference in MPOD pre or post surgery was found, indicating that 
varying degrees of crystalline lens absorption does not affect macular pigment measurement 
when the HFP method is used. Wooten et al. [46] simulated clear and dense lenses by 
incrementally altering the background field radiance of their free view device. No significant 
differences in MPOD were found. Most recently, Makridaki et al. [96] demonstrated on a new 
HFP instrument [53] that lens yellowing, whether simulated or real, had no effect on the 
measured MPOD. 
 
B fov x Tlens x TMP = B ref x Tlens  (i) 
 
TMP = B ref / B fov    (ii) 
 
MPOD = log 1/TMP = log (B fov / B ref) (iii) 
 
Formula 2: Macular pigment optical density derivation, from Snodderly and Hammond [65]. 
In addition to the transmission of blue light through the macular pigment (TMP), the 
transmission through the lens (Tlens) is taken into account. B fov and B ref are the radiances 
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of blue light needed to minimize flicker at the fovea and reference point, respectively. Since 
Tlens is assumed to be the same at both the fovea and reference, it is removed from equation 
(i). The final equation (iii) is a simplified version of Formula 1. 
 
2. Accurate subject fixation and response. This is partly checked through assessment of 
instrument reliability. Werner et al. [42] also checked fixation accuracy on four of their 
subjects (age range 15 to 71) with an additional test; all subjects were able to accurately 
fixate to within ±1.00° of the foveal and parafoveal stimuli, or better, providing further 
evidence for this particular assumption. 
 
3. Equal spectral sensitivity and distribution of photoreceptors across the retina, such that 
the difference ratio between the foveal and parafoveal locations is dependent solely on the 
macular pigment [12, 42, 65]. This assumption is not correct but is accounted for with the 
design of HFP instrumentation. Rods and short-wavelength sensitive cones (S-cones) are 
absent at the fovea, whilst being abundant in the peripheral retina and parafovea, 
respectively [99, 100]. Conversely, medium-wavelength cones (M-cones) and long-
wavelength cones (L-cones) are present in much higher concentration in the fovea than 
elsewhere [101]. However, unlike rods and S-cones, the ratio of M to L cones has been 
shown to remain fairly constant, at least in the central retina [102-104] and, as a result, 
should not affect the measured MPOD. It is therefore generally accepted that removing the 
rod and S-cone contributions is of greater importance. To do this, investigators have 
designed their HFP apparatus accordingly. The background field is often blue to suppress 
the S-cone population [e.g. 42, 43, 44, 46, 48, 50-52, 62, 105] or bright white to provide 
photopic conditions and hence suppress the rod population [e.g. 45, 49, 53]. The flicker 
frequency is chosen so that it is high enough to further exclude rods and S-cones. This is 
achieved because the flicker rate is above the critical flicker fusion frequency (the alternation 
rate at which a flickering light is no longer resolvable by the visual system and thus appears 
steady to an observer) of rods and S-cones, but is still lower than the critical flicker fusion 
frequency of M- and L-cones [65, 106, 107]. 
 
4. The peripheral reference locus having a negligible level of macular pigment. Some studies 
have questioned this assumption [39, 94, 108-112], particularly when eccentricities as little 
as 4° from the fovea have been used [11, 20, 43, 46, 62, 71, 80, 81, 86-88, 113]. HFP 
spatial distribution plots of macular pigment (see ‘validity and reliability’) have gone some 
way to disproving any concerns, such that for most individuals, the assumption holds. 
 
Validity and reliability 
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The validity and reliability of a technique are two important but quite different issues. 
Reliability, as described by Gallaher et al. [114], refers to the ‘ascertainment of the 
reproducibility of a given measurement on the same subject at two distinct points in time’. 
Although this is a very important aspect of any instrument, it does not automatically imply 
that the instrument is valid. This was well illustrated by Snodderly et al. [50], where it was 
pointed out that one observer had a repeatable negative value of MPOD. The measure was 
therefore reliable but was nevertheless of questionable validity. For in vivo measurement of 
MPOD, validity is demonstrated by showing a matching comparison with the known spectral 
and spatial properties of macular pigment in vitro. Some studies have done this indirectly by 
comparing the measurements from a new device with those of an older, more established 
device [46, 56-59]. 
 
VALIDITY 
As mentioned above, the validity of MPOD measurement by HFP can be assessed in two 
main ways [52, 71]. Either by deriving the spatial profile of macular pigment across the fovea 
[e.g. 42, 44, 50, 52, 53, 67, 70, 71, 75] and comparing that to in vitro knowledge of macular 
pigment distribution [e.g. 5, 7, 24, 115], or by deriving the spectral absorption profile of 
macular pigment [17, 42, 43, 47, 49, 52, 71] and comparing that to the shape of a known in 
vitro absorption curve of macular pigment. The latter method is considered to be more 
robust than the former, since spatial profile can vary between individuals [44, 50, 59, 64, 71, 
75, 78, 116, 117].  
 
Spatial profiles of MPOD are achieved by altering the size and/or the eccentric position of 
the test stimulus, thus producing a curve that can be used to describe the change in MPOD 
with increasing eccentricity from the central fovea. An example is shown in Figure 3. 
 
INSERT FIGURE 3 ABOUT HERE 
 
Spectral absorption profiles of MPOD are obtained by systematically altering the wavelength 
of the test stimulus. The procedure is the same as that used to determine peak MPOD, 
except that a number of light wavelengths must be alternated with the reference stimulus 
until minimum flicker is accomplished, instead of the blue light alone. The extra 
measurements increase the duration of the test but permit a curve of spectral absorption to 
be plotted, see Figure 4. The in vivo HFP-generated curve is simultaneously compared with 
the shape of an in vitro spectral curve of lutein and zeaxanthin. The choice of which in vitro 
curve to use is not an easy one, since the ideal comparison of in situ spectral data from 
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human retinas does not currently exist [54]. Consequently, different researchers have used 
different data. These include: Wyszecki and Stiles’ composite data curve1 [118], used by 
Werner et al. [42], Hammond and Fuld [43], Beatty et al. [47], and Beatty et al. [17]; 
Snodderly and colleagues’ microspectrophotometry-derived data from primate monkeys [6], 
used by Hammond and Fuld [43]; and spectral measures of lutein and zeaxanthin dissolved 
in olive oil [24] or incorporated in liposomes [9]. These last two in vitro spectrums have more 
recently been used in combination when assessing validity [52, 54, 71].  
 
The outcomes of these validity tests have shown a good correlation with in vitro MPOD 
distribution and absorption [e.g. 71] and therefore attest to the validity of HFP as a 
measurement method for MPOD. 
 
INSERT FIGURE 4 ABOUT HERE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1The data from Wyszecki and Stiles [118] is actually a weighted composite curve of six 
psychophysical methods that had been used up to that time, rather than in vitro data.
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RELIABILITY 
Numerous researchers, through test-retest checks, have assessed the reliability of HFP 
measurement of macular pigment. The statistical descriptors used to evaluate reliability vary 
between studies. Table 2 is a summary of all available information on HFP test-retest 
reliability indicators. It shows that for most subjects, HFP provides repeatable measures of 
MPOD and is therefore a reliable technique. Interestingly, the two most recent evaluations of 
HFP appear to give the weakest indication of its reliability [119, 120]. These studies were 
independent of each other but used the same HFP device, one of the first that has been 
designed for use in a clinical setting rather than a research setting. The results suggest that 
further developments may be required for this particular HFP instrument in order to verify its 
suitability to accurately assess MPOD. 
 
INSERT TABLE 2 ABOUT HERE 
 
The edge hypothesis of heterochromatic flicker photometry 
 
As mentioned previously, most instruments use a stimulus size of 1° to measure MPOD. 
One might reasonably assume that this measures the total amount of macular pigment 
across the whole 1° area or the peak level of macular pigment. However, many investigators 
disagree with both these assumptions and instead believe that the level of calculated MPOD 
is mediated by the edge of the stimulus [e.g. 11, 42, 44, 48, 50, 52, 121], so that for a 1° 
stimulus, the recorded MPOD corresponds to the macular pigment level at 0.5° from the 
centre of the fovea. Werner et al. [42] were the first to suggest this theory and it gained 
momentum when Hammond et al. [44] found a very high correlation (r = 0.91, p < 0.00001) 
between MPOD measured with a 1° test stimulus and a point test stimulus of 12′ placed at 
0.5° (see Figure 5). Their data also indicated that MPOD at 0.5° (as measured with a 1° 
stimulus) is an estimated 69% of the true peak MPOD. For example, an MPOD value of 0.4 
measured with a 1° test would indicate a peak macular pigment density of 0.58. The ‘edge 
hypothesis’ has been questioned, however, most notably by Bone et al. [68]. In contrast to 
Hammond et al. [44], they found that the measured MPOD corresponds to the level of 
macular pigment at approximately 50% of the stimulus radius (Figure 6). Further evaluation 
indicated that this equated closely to the average amount of macular pigment over the whole 
stimulus area [68]. Nevertheless, in spite of this conflicting evidence, most researchers have 
continued to assume the edge hypothesis in their HFP work [e.g. 60, 63, 64, 73-75, 78, 122] 
and this would appear to be a reasonable decision, with further evidence for it coming most 
recently from van der Veen et al.[121]. 
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INSERT FIGURES 5 AND 6 ABOUT HERE 
 
Advantages and disadvantages of HFP 
 
Advantages include: 1) no pupil dilation required 2) inexpensive equipment relative to 
objective techniques 3) independence from absorption and scattering properties of the 
ocular media 4) good test-retest reliability on many subject populations 5) proven validity. 
Disadvantages include: 1) some subjects finding HFP difficult to carry out, especially the 
peripheral task, which is subject to Troxler’s effect – a perceptual fading of peripheral stimuli 
[123]; Troxler’s effect also becomes more distracting the more eccentric the peripheral target 
is, making the use of eccentricities certain to have no macular pigment difficult to record 
accurately 2) a long testing time if complete spectral and/or spatial distribution is required 3) 
unsuitability for some individuals, such as young children, people with learning difficulties or 
people with insufficient visual acuity or visual fields. 
 
Motion photometry 
 
The minimum motion paradigm was initially described by Stumpf [124], although this went 
largely unnoticed until its translation into English by Todorović in 1996 [40, 125]. With 
parallels to HFP, it refers to the perceived reduction in motion of a moving square or sine 
wave grating as equiluminance of the colours involved is reached. The concept was taken 
up for use in photometry by both Moreland [126, 127] and Anstis and Cavanagh [128], but in 
subtly different ways. This then led to the use of minimum motion photometry for in vivo 
measurement of macular pigment [e.g. 33, 37]. 
 
Procedure 
 
Many of the principles described for HFP also apply for motion photometry measurement of 
MPOD, i.e. a wavelength of light at the peak of macular pigment absorption is compared 
with a wavelength of light not absorbed by macular pigment, at central and parafoveal 
locations. Moving square wave gratings are used, with the bars being alternately illuminated 
by the two light wavelengths. The radiance of the longer wavelength stimulus is adjusted 
until the motion appears to slow down or change direction, depending on the method being 
employed [126-128]. The slowing down of the grating is minimum motion photometry, 
whereas the reversal of grating movement is known as apparent motion photometry [40]. As 
with HFP, different radiances of the test wavelength will be required for equiluminance at the 
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foveal and parafoveal positions, on account of the higher levels of macular pigment at the 
fovea. A log ratio of these radiances provides a measure of MPOD [37-41, 92, 129]. 
  
Instrumentation 
 
The motion photometry technique for measurement of MPOD has not been as widely used 
as HFP. Apart from the fundamental differences between classic minimum motion 
photometry and apparent motion photometry (explained below), there is little variation in the 
instrumentation that has been adopted. 
 
MINIMUM MOTION PHOTOMETRY 
Minimum motion photometry for MPOD, as described and used by Moreland, Robson and 
colleagues [e.g. 37, 38-41, 92, 129], employs a Moreland anomaloscope (traditionally used 
for colour vision assessment) that is adapted to produce a moving square wave grating with 
a spatial frequency of 0.38 cycles per degree. A rotating spiral mirror generates the grating 
which, when viewed through a circular or annular stop, appears to move horizontally across 
the visual field. The bars of the grating are alternately illuminated with two narrow-band 
interference filters from a single tungsten-halogen lamp. The interference filters typically 
provide wavelengths of 460 nm (blue – maximal absorption by macular pigment) and 580 
nm (yellow – negligible absorption by macular pigment). Luminance matched filters of 450 
nm are added to the grating bars to create a background pedestal that saturates S-cones 
(see ‘assumptions’). The grating moves at a constant velocity of 14 Hz; this also rules out 
any rod or S-cone contribution. 
 
Unlike HFP, it is the norm with motion photometry for the spatial profile of macular pigment 
to be plotted, rather than peak MPOD alone. Consequently, the test fields comprise up to 
two central, circular stops of 0.8-0.9 (visual angle) and 2.2, and 11 annular stops placed 
eccentrically from 0.8-7.5 in the superior visual field. The setup is illustrated in Figure 7. 
The minimum motion technique described here uses a Maxwellian view system but does not 
require a bite bar; rather, an adjustable chin rest (vertically and horizontally) is used for pupil 
centration [40]. 
 
INSERT FIGURE 7 ABOUT HERE 
  
APPARENT MOTION PHOTOMETRY 
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Apparent motion photometry, based on the phenomenon detailed by Anstis and Cavanagh 
[128], has been developed into a commercially available device for MPOD assessment by 
West and Mellerio [130]. However, there do not appear to be any peer-reviewed studies on 
the instrument. The instrumentation details given below are therefore based on information 
from the Cambridge Research Systems’ (CRS) website 
(http://www.crsltd.com/catalog/metropsis/MP.html).  
 
Instead of a Moreland anomaloscope, a cathode ray tube (CRT) monitor is used. Four 
square wave gratings on a blue background are presented sequentially, 90 degrees out of 
phase with each other. The first and third gratings are made up of blue and red bars, 
produced by the blue and red phosphors of the CRT; blue for maximal macular pigment and 
red for negligible macular pigment absorption. The second and fourth gratings are 
achromatic, being composed of light and dark grey bars, i.e. luminance gratings. The 
apparent motion paradigm dictates that when the luminance of the red bars is greater than 
the blue, the red bars appear to jump rightwards to the light grey bars in the luminance 
grating, and when the luminance of the blue bars is greater than the red, the blue bars 
appear to jump leftwards to the light grey bars in the luminance grating (Figure 8, left). The 
subject therefore sees movement in one of two directions. The setup of West and Mellerio’s 
device results in these directions being up or down (Figure 8, right). The red luminance is 
adjustable, and at the point of red-blue equiluminance, the direction of motion becomes 
‘ambiguous’. A two-alternative forced choice procedure is used to determine equiluminance 
(and subsequent MPOD) at central and eccentric locations. The system crosses over the 
threshold several times and can provide the standard deviation of each MPOD 
measurement. The grating alternation frequency must be optimized, usually between 8 and 
20 Hz, for each subject for reliable results. 
 
INSERT FIGURE 8 ABOUT HERE 
  
Like minimum motion, the apparent motion photometer for MPOD routinely plots the spatial 
distribution of macular pigment. Two central vertical strips (0.3° x 1.25°) are located at 0° 
and 1°, whilst six 45° annular test fields are located from 2°-7° from fixation. A shorter three-
location test is also available.  
 
With a CRT monitor comes the problem of spectral overlap of the red, green and blue 
phosphors, similar to the problems of the colour monitor for HFP discussed in HFP ‘recent 
developments’ [38, 41, 92]. The apparent motion photometer overcomes this with the use of 
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an optical filter that blocks light between 460 and 640 nm, thus avoiding a significant 
underestimate of MPOD. 
 
Assumptions 
 
The same assumptions apply to minimum motion photometry as for HFP, namely absorption 
or scattering properties of the ocular media being accounted for through use of a parafoveal 
locus; accurate subject fixation and response; equal spectral sensitivity and distribution of L- 
and M-cones across the retina; and the peripheral reference locus having a negligible level 
of macular pigment.  
 
The apparent motion device offers an interesting solution to accurate fixation by using a 
video gaze tracking system that inhibits stimulus presentation whenever fixation is not 
maintained to a sufficient level (within  0.5° of target). This offers an improvement over 
unmonitored free view techniques whilst avoiding the need for a Maxwellian view system. 
With respect to L- and M-cone distribution, Robson et al. [129] used a 460/550 nm 
combination as well as the customary 460/580 nm to see if there was any variation in MPOD 
measurements. The correlation was extremely strong (slope = 1.00, r = 0.99), indicating that 
even if the distribution does vary with eccentricity, the effect is likely to be very small [129]. 
Like HFP, motion photometry also uses a blue background and a suitable temporal 
frequency to ensure rod and S-cone suppression. The assumption of the peripheral 
reference eccentricity having negligible macular pigment should hold for most individuals 
because spatial distribution is always plotted out as far as 7 or 8 degrees with motion 
photometry. 
 
Validity 
 
We could find no evidence of motion photometry being used to derive spectral profiles of 
macular pigment. As a result, it is difficult to know the true validity of the technique, although 
average MPOD values and spatial profiles are in line with HFP, and consistent correlations 
with the autofluorescence method of macular pigment measurement [39, 129] and two HFP 
devices [38, 48] have been found. Nevertheless, questions regarding the validity of motion 
photometry for measurement of macular pigment have been raised [54]. 
 
Reliability 
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The reliability of minimum and apparent motion photometry has not been as vigorously 
assessed as it has been with HFP. The average of five readings is taken at each location 
[37, 39, 41, 92, 129] and repeated measurements have been incorporated in averaged 
results [39]. However, there does not appear to be any published statistical data on test-
retest reliability. 
 
The non-edge hypothesis of motion photometry 
 
It was explained earlier that most researchers using HFP assume an edge hypothesis with 
MPOD. In minimum motion photometry, data analysis has led to the support of a non-edge 
hypothesis [34, 39, 40]. To reiterate, this would mean that when a circular, foveal stimulus is 
used, the measured MPOD would not represent the amount of macular pigment at the 
stimulus radius. In the case of motion photometry, researchers believe that the measured 
MPOD actually represents the amount of macular pigment at approximately 70% of the 
stimulus radius [34, 40]. Subsequently, the ‘peak’ MPOD value using the smaller 0.8-0.9° 
central stimulus has been plotted at 0.3° eccentricity from the fovea [e.g. 39, 41, 129]. 
 
Advantages and disadvantages of motion photometry 
 
As a psychophysical technique, motion photometry has much in common with HFP in terms 
of pros and cons. There is no need for pupil dilation, any interference from the ocular media 
is accounted for and it is a relatively straightforward test for subjects to partake in. On the 
down side, Troxler’s effect remains a problem for some individuals, and good 
comprehension of the task is required, so it is not suitable for everyone. No information is 
provided in any motion photometry studies regarding the level of visual acuity of subjects; 
therefore it is unknown whether reliable MPOD measurements are achievable on subjects 
with lower than normal acuity. 
 
Objective techniques 
 
The objective techniques for measuring MPOD are: 
 
Fundus reflectometry 
Fundus autofluorescence 
Resonance Raman spectroscopy 
Electrophysiology using visual evoked potentials 
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Fundus reflectometry 
 
Quantitative measurement of light reflected from the fundus is known as fundus 
reflectometry (FR), and the researchers Brindley and Willmer [131] were the first to adopt 
this technique. Their aim was to estimate MPOD in vivo by comparing light reflected at the 
macula with light reflected from a peripheral area of retina. Since then, FR has gone on to 
become the most widely used of the objective methods for MPOD measurement, although 
many improvements and variations have been developed along the way. 
 
Procedure 
 
When light enters the eye it has many structures to pass through, including the cornea, the 
crystalline lens, the retina and the choroid. Some of these structures (and their components) 
will reflect a small part of the light, whilst others will absorb part of it. Through measurement 
of reflected light from the retina and choroid, FR is able to assess several ocular features, 
including macular pigment [109]. A thorough history of FR is provided by Berendschot, 
DeLint and van Norren [132]; this review will be limited to the use of FR in measuring 
MPOD. 
 
Although there are several variations on the reflectometry procedure, there are two methods 
that predominate. The first is a comparison technique, similar to that used in HFP. Light 
reflected from the fovea is compared with light reflected from an eccentric retinal area, using 
two wavelengths (one absorbed by macular pigment and one not) or using a spectrum of 
wavelengths. Since macular pigment absorbs rather than reflects certain wavelengths there 
will be a difference in the observed reflectances at the fovea and periphery, owing to the 
assumed lack of macular pigment at the eccentric site. Researchers who have used this 
method include Brindley and Willmer [131], van Norren and Tiemeijer [133], Delori and 
Pflibsen [134], Elsner et al. [135], Berendschot et al. [136], Delori et al. [56], Bour et al. [137], 
Wüstemeyer et al. [98], and Cardinault et al. [138]. 
 
The second core technique is known as a spectral analysis [109]. As the name suggests, 
this involves the analysis of a spectrum of reflected light from a spot of light on the retina. To 
achieve this, a detailed optical model of the pathways of light in the eye is required. A 
number of optical models of increasing complexity have been proposed over the years, from 
van Norren and Tiemeijer [133] through to van de Kraats and van Norren [139]. Probably the 
most familiar optical model is that derived by van de Kraats, Berendschot and van Norren 
[140], which has been used to work out MPOD in several studies [e.g. 58, 136, 141-144]. In 
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essence, the density of macular pigment is determined using its known spectral 
characteristics and by taking into account the amount of light reflected at the internal limiting 
membrane, the photoreceptor discs and the sclera [58, 136, 140, 141, 143]. The densities of 
the lens, melanin and blood are likewise calculated. 
 
Even with these two quite separate forms of FR, there is often an overlap between the two, 
as demonstrated in the following section. 
 
Instrumentation 
 
Many instruments have been used for FR and it is beyond the scope of this review to explain 
them all. Consequently, only the more recent fundus reflectometers will be described in any 
detail. However, common to most methods of FR is the need for pupil dilation, a bleaching of 
the visual pigments prior to measurement, and some form of head stabilization, either with a 
bite bar or with a chin rest and temple pads.  
 
Equipment for reflectometry can be broadly categorised into modified fundus cameras, 
purpose-built reflectometers and modified scanning laser ophthalmoscopes. 
 
FUNDUS CAMERAS 
Many investigators have used modified fundus cameras to measure MPOD, including van 
Norren and Tiemeijer [133], Delori and Pflibsen [134], Chen, Chang and Wu [108], Bour et 
al. [137], Chang et al. [145], Neuringer et al. [3], and Bone, Brener and Gibert [59]. Of these, 
some have used the comparison technique, some spectral analysis and others a mixture of 
the two. Chen et al. [108], for example, used an optical model as per the spectral analysis 
technique but only two wavelengths (460 nm and 560 nm) rather than a full spectrum of 
wavelengths. In brief, their setup, like several others, consisted of a fundus camera 
connected to a cooled CCD (charge-coupled device). The filter normally used to take red-
free photographs was replaced with narrow band interference filters of 460 and 560 nm, i.e. 
maximal and minimal macular pigment absorption. Following pupil dilation, the subjects were 
instructed to fixate a dim red dot with the eye not being tested whilst the measured eye was 
slowly light adapted in order to bleach nearly all the photoreceptor pigments [56, 108, 146]. 
Two fundus pictures, one taken at each of the two wavelengths, were manually aligned 
using retinal landmarks. Using a chosen optical model, MPOD at each pixel point in the 
retina was calculated. In this way, Chen et al. were also able to plot the spatial distribution of 
macular pigment across the central retina. 
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Recently, Bone et al. [59] described a modified fundus camera that does not require pupil 
dilation or bleaching of the photoreceptor pigments. 
 
PURPOSE-BUILT REFLECTOMETERS 
The most recent ‘purpose-built reflectometers’ are the Foveal Reflection Analyzer (FRA), 
originally developed by Zagers et al. [146] and the Macular Pigment Reflectometer (MPR), 
originally developed by van de Kraats et al. [117]. 
  
The diagrammatic setup of the FRA is shown in Figure 9. After dilation, subjects fixate a 
central cross hair (Figure 9b). In the original instrument (FRA 1), light from a halogen lamp is 
directed into the eye as a Maxwellian view system with an entrance pupil of 0.8 x 1.2 mm. 
This illuminates a 2.8° spot on the central fovea, of which the middle 1.9° is used for 
analysis. A video observation channel of the pupil and retina helps alignment as well as 
allowing monitoring of subject fixation. An imaging spectrograph collects the reflected light 
from the 1.9° area and focuses it onto a cooled CCD camera. The spectrograph has a slit 
that creates a 0.8 x 12 mm exit pupil above the smaller entrance pupil, and its spectral range 
is 420 to 790 nm, thus allowing a spectral analysis of the reflected light using one of the 
optical models referred to earlier. The FRA 1 has been used to investigate MPOD in studies 
by Zagers and van Norren [147] and Berendschot and van Norren [141]. Berendschot and 
van Norren [141] also used a newer version of the device, the FRA 2, which has a number of 
differences from the first version, including being smaller, which makes it desktop 
mountable. Kanis et al. [143, 148] and van de Kraats and van Norren [139] have also used 
the FRA 2 in their studies. 
 
INSERT FIGURE 9 ABOUT HERE 
 
The diagrammatic setup of the MPR is shown in Figure 10. Like the FRA, the MPR, as 
described by van de Kraats et al. [58], involves a 30W halogen lamp directed into the pupil, 
a separated exit pupil and a spectrometer, i.e. spectrograph. The spectrometer has a 
spectral range of 400 to 800 nm. The subject is asked to fixate the centre of a 1° incoming 
light beam. This incoming illumination forms a 1° spot on the central fovea; the reflected light 
is also collected over the same 1° area and analyzed using an optical model. The MPR is 
the first reflectometry device that has a proven ability to measure MPOD through an 
undilated pupil, provided the pupil is 3 mm or larger; van de Kraats et al. [58] found no 
significant difference between their MPOD measurements for dilated and undilated pupils in 
20 subjects. A further development of the MPR, recently reported by van de Kraats et al. 
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[139], is the means to measure the individual optical densities of lutein and zeaxanthin, the 
components of macular pigment. 
 
INSERT FIGURE 10 ABOUT HERE 
 
SCANNING LASER OPHTHALMOSCOPES 
Elsner et al. [149] were the first to use a scanning laser ophthalmoscope (SLO) for the 
purpose of measuring MPOD. Since then it has become a popular FR method for measuring 
macular pigment [e.g. 25, 98, 116, 136, 141, 150]. Some SLOs have been custom-built for 
MPOD measurement and as such are not accessible to most clinicians [135, 136]. However, 
Wüstemeyer et al. [98] modified a commercially available SLO, allowing reflectance images 
to be recorded with an argon laser at wavelengths 488 nm and 514 nm, with a fast switch 
between the two. They used the comparison technique, with an eccentric reference point of 
14° from the fovea. MPOD in a 2° central fovea test field was calculated as follows (Formula 
3): 
 
MPOD = Cλ * [ log (Ref514,foveal / Ref488,foveal) – log (Ref514,parafoveal / Ref488,parafoveal) ] 
 
Formula 3. Calculation of macular pigment optical density, from Wüstemeyer et al. [98]. Cλ = 
constant, dependent on the absorption coefficients of macular pigment. Ref514 and Ref488 = 
reflectances measured at 514 and 488 nm. 
 
Using a foveal and parafoveal comparison is not common to all SLOs when measuring 
MPOD. Berendschot and van Norren [116, 141], for instance, used the same two 
wavelengths as Wüstemeyer et al. [98] but did not use any specific eccentric reference point 
and therefore produced density maps of the sum of both the lens and macular pigment. 
 
One of the main advantages of using a SLO over other FR techniques is its confocal optics, 
which help minimize stray light scatter, the biggest hindrance in FR. This will be elaborated 
on in the ‘assumptions’ section. 
 
TEST FIELD VARIATIONS 
The size of the detection field chosen to measure peak MPOD varies not only between the 
three categories of reflectometer but also within the categories, from 0.5° [116, 141] to 2° 
[25, 56, 98, 138] and 2.5° [133]. Likewise, when two wavelengths corresponding to high and 
low macular pigment absorption are used, as is often the case for modified fundus cameras, 
the chosen wavelengths differ slightly between equipment, as they do in HFP devices. In 
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SLOs, the two wavelengths are always 488 and 514 nm because these are the two most 
appropriate argon laser lines. The deviation of these laser lines from the true maximum and 
minimum of macular pigment absorption (460 and >530 nm, respectively [54]) requires that a 
correction is made to account for this in the final MPOD estimation [116, 136, 141, 151], 
although it is not clear whether all research groups actually do this. For the comparison 
technique when a peripheral reference point is used, the chosen eccentricity has ranged 
from as little as 4° from the central fovea [137] up to 14° [98, 136]. 
 
Assumptions 
 
The assumptions for FR are not as openly explained in the literature as for HFP. 
Nonetheless, several of the more commonly noted assumptions are highlighted below: 
 
1. Homogeneity of fundus tissues. The spectral characteristics, absorption, reflection and 
scattering properties of the various retinal tissues (e.g. melanin) are assumed to be 
homogenous across the areas being assessed. Gellermann and Bernstein [111], among 
others, point out that this is a simplification. However, most researchers [e.g. 58] do not 
consider this to be a problem, and with good reason it would seem. For instance, the effect 
of irregular RPE melanin distribution on measured MPOD was investigated by Delori et al. 
[56]. They concluded that it had no strong effect on MPOD as measured with their 
reflectometry technique. 
 
2. Bleaching of photoreceptor pigments. It has been established that 93-99% of cone 
photopigment and 59-85% of rod photopigment is bleached as a result of the level of 
illumination used prior to measurement, depending on the particular reflectometry method 
used [56, 58, 108, 137]. Bleaching is important to avoid light absorption by the pigments and 
their subsequent interference with MPOD. It is assumed that any remaining unbleached 
photopigment, particularly rhodopsin (the pigment in rods), has a minimal effect. This has 
been investigated by Chen et al. [108], Delori et al. [56] and Bour et al. [137] and proven to 
be the case. 
 
3. Light scatter accounted for. If reflectance from pre-retinal and intra-retinal structures are 
not controlled for, the measured MPOD can be artificially low [56, 109, 141]. This is because 
the reflectance method works on the principle that all the incident light is reflected after 
passing through the macular pigment. If some light is reflected before it reaches the macular 
pigment, e.g. by the crystalline lens, then this will be collected as reflected light but it won’t 
actually have been affected by macular pigment absorption, thus leading to an erroneously 
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low MPOD [25]. Most reflectometry devices do aim to eliminate this problem, although it 
would appear that some are more successful than others, judging by the lower than 
‘average’ MPOD estimates found in some studies [e.g. 25, 56, 98, 137]. Methods used to 
allow this assumption to hold as far as possible include separating the entrance and exit 
pupils, using confocal optics as found in SLOs, and the incorporation of stray light into 
optical models. In addition, for the comparison technique of FR, the use of a peripheral 
reference should account for crystalline lens scatter [56].  
 
4. Negligible macular pigment at a peripheral reference site. If the comparison method is 
used, the same rules apply as per HFP; provided the peripheral locus is eccentric enough to 
exclude any macular pigment contribution, the assumption will hold. Choosing a point far 
enough away from the fovea is easier with FR, since there is little participation required by 
the subject. Delori et al. [56] commented that the use of a peripheral reference in FR is 
enough to reduce the influence of the ocular media on the MPOD measurement. Hammond 
et al. [54], however, argue that regardless of this, as an objective technique FR will suffer 
from a loss of signal as a result of increased lens scatter and density in some subjects. 
 
5. MPOD measured over the entire stimulus area. Whereas with the psychophysical 
methods there is some disagreement regarding which part of the macular pigment 
distribution is actually being measured with the test stimulus, with FR there is a general 
consensus that the MPOD is the mean amount over the chosen detection field [56, 98, 136, 
141]. However, this assumption has not been verified [54].  
 
Validity 
 
Like HFP, the validity of FR for measurement of MPOD can be assessed by plotting spectral 
and spatial profiles of macular pigment and comparing these with in vitro data. Van de 
Kraats et al. [58] argue that any technique demonstrating an increase in MPOD following 
increased lutein intake is also an indication of its validity. Several reflectometry studies have 
shown such an increase [3, 136, 152]. 
 
Spectral profiles of macular pigment have not been generated to the extent that they have in 
HFP studies. In fact, there appears to be only one study that has comprehensively 
investigated this aspect of validity. Delori et al. [56], used the comparison technique and 
measured reflectance at wavelengths of 430, 450, 470, 490, 520 and 550 nm. Their results 
from 147 subjects accurately matched the spectral curve of macular pigment in vitro, albeit 
with some small systematic deviations such as lower values at 430 nm (see Figure 12). The 
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investigators point out, however, that the deviations altered depending on which in vitro 
curve they chose for comparison, highlighting the point that the true macular pigment 
absorption spectrum is not known with enough certainty to assume that the reflectometry 
deviations are an inaccuracy. It is also interesting to note that lower values at the short 
wavelength end of the spectrum are also a common finding in HFP spectral profiles (see 
Figure 4), perhaps lending further support to there being a genuine difference between the in 
vivo and in vitro macular pigment spectral profile. 
 
The plotting of ‘macular pigment maps’ to assess macular pigment spatial profiles has 
become reasonably commonplace in FR studies [e.g. 59, 108, 116, 135, 136, 137]. For 
SLOs, this generally involves a digital subtraction of the images obtained at two wavelengths 
(maximal and minimal macular pigment absorption). Chen et al. [108], used a modified 
fundus camera (the method is described above) and obtained spatial distributions for 54 
subjects of various ages. These distributions, divided into three age groups, are shown in 
Figure 11. The decline in macular pigment from the fovea is rapid and symmetrical, very 
similar to the decline in macular pigment expected from in vitro knowledge and also from 
HFP-derived plots of MPOD (see Figure 3). 
 
INSERT FIGURE 11 ABOUT HERE 
 
Chen et al. [108] looked at the half width of macular pigment distribution (HWMPD) for each 
of the age groups, and found a significant increase (i.e. widening) with age. With further 
analyses they also noted that ‘shoulders’ of varying type were present in the MPOD profile of 
all subjects. Small irregularities in the otherwise undisturbed decline of macular pigment with 
eccentricity have been reported in other studies [5, 44, 59, 64, 71, 75, 115-117, 153, 154], 
both in vivo and in vitro, and are the subject of much ongoing discussion [e.g. 155]. 
 
Recently, the MPR [58] has been used to investigate MPOD distribution, or more 
specifically, to plot the individual distributions of lutein and zeaxanthin [152]. Rather than 
macular pigment maps, reflection spectra were taken at a variety of eccentricities up to 8° 
from the fovea, in a similar manner to HFP. 
 
An indirect way of demonstrating validity is to compare results with those of a technique with 
established validity, i.e. HFP. This has been done in several FR studies with fairly good 
results [56, 58, 59, 141]. 
 
Reliability 
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With so many different instruments being used to measure MPOD by FR, there ought to be 
an abundance of reliability data available. However, few studies have assessed the inter-
session reliability of their devices, although more have assessed within-session reliability. 
This is perhaps because, unlike HFP, the actual measurement time in FR is short and does 
not demand too much effort from the subject; hence it’s more convenient to take repeat 
measurements within the same session. That said, Zagers et al. [146] believed the variability 
in their intra-session MPOD results was the result of fixation errors, with the less 
experienced subjects showing greater variability. Nonetheless, as Snodderly and colleagues 
point out, inter-session reliability is really more valuable than intra-session reliability [50]. 
Since results generally show higher variability between sessions, this is a more robust test 
for an instrument. Table 3 outlines the reliability indicators provided in FR studies regarding 
instrument reliability. It shows that for the studies with published data on reliability, the 
results are good and comparable with HFP. 
 
INSERT TABLE 3 ABOUT HERE 
 
Advantages and disadvantages of FR 
 
Advantages include: 1) as an objective method it requires minimal effort from the subject 2) 
quick measurement time 3) density maps of macular pigment distribution can be plotted 
quickly 4) reliability appears to be good in several instruments 5) suitability for many subject 
populations including children. Disadvantages include: 1) pupil dilation normally required 2) 
the need for precise alignment before measurements 3) unpleasant light levels because of 
the requirement for photopigment bleaching 4) the need to control for light scatter, which can 
include considerable modeling 5) costly and complicated instruments, although attempts are 
being made to produce less expensive reflectometers using commonly available equipment 
[59, 98, 137].  
 
Fundus autofluorescence 
 
One of the newer ways for measuring MPOD in vivo relies on the intrinsic fluorescence, or 
autofluorescence (AF), of lipofuscin in the retinal pigment epithelium (RPE). Lipofuscin in the 
RPE is a waste product of photoreceptor outer segment phagocytosis and it accumulates 
with age [156-158]. When excited with light wavelengths of 400 to 590 nm, lipofuscin 
fluoresces, emitting light in the wavelength range 520 – 800 nm [159]. 
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Delori [156] was the first to develop a technique for fundus AF with the primary aim of 
measuring lipofuscin. Further studies by Delori et al. [157] and von Rückmann et al. [158] 
provided evidence for lipofuscin being the main fluorophore in AF. It was their observations 
of a decrease in AF at the macula that lead to the use of AF as a means for measuring 
MPOD. For an in-depth look at fundus AF and its application, see Schmitz-Valckenberg et 
al. [160]. The current review will concentrate on the use of AF in macular pigment 
measurement. 
 
Procedure 
 
To recall, the absorption spectrum of macular pigment is in the range 400 – 540 nm [6] and 
the absorption spectrum of lipofuscin is in the range 400 – 590 nm [159]. Since macular 
pigment is located anterior to lipofuscin, incoming light directed at the fovea will be absorbed 
by the macular pigment before it reaches the lipofuscin, provided the wavelength of the light 
is within the absorption range of macular pigment. As a result, there will be an attenuation of 
lipofuscin fluorescence at the macula; the more macular pigment present, the higher the 
level of attenuation. By comparing the emitted AF at the fovea and parafovea of two 
excitation wavelengths, one that is well absorbed by macular pigment and one that is not, 
MPOD can be calculated [56].  
 
Two AF procedures exist for measurement of macular pigment. The first is a comparison 
method as used in HFP and some forms of FR. The emitted fluorescence is collected from a 
foveal and parafoveal sampling area, and then compared to give a measure of MPOD [e.g. 
56]. The second and more common procedure is an imaging method whereby up to 32 
images [39, 129] are taken in succession with one or two wavelengths. The images are 
aligned (manually or using dedicated software) and averaged, then a greyscale index of 
intensity is used to generate density maps of macular pigment, which includes a measure of 
peak MPOD. Key studies using the AF imaging technique include those of Wüstemeyer et 
al. [25], Berendschot and van Norren [141], Delori et al. [117], Liew et al. [161], Trieschmann 
et al. [162] and Wolf-Schnurrbusch et al. [154]. 
 
Instrumentation 
 
By far the most commonly used instrument for AF acquisition of MPOD is the confocal SLO, 
purpose-built [e.g. 116, 141] or a modified version of a commercially available SLO [e.g. 25, 
161, 163]. All SLOs use the imaging method of fundus AF. The subject fixes a target whilst 
multiple AF fundus images, usually taken over a 20° field, are obtained at wavelengths of 
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488 nm and 514 nm. A barrier filter above or close to the threshold of MP absorption (e.g. 
530 nm) is used to ensure that the emitted AF is only collected outside the absorption range 
of macular pigment, thereby avoiding any further absorption and allowing a single-pass 
measurement rather than a double-pass as used in reflectometry. All the AF images are 
aligned and averaged for each wavelength. A computer program (see Trieschmann et al. 
[162] for details) digitally subtracts the averaged images at the two wavelengths and uses a 
greyscale index of intensity to create a map of MPOD. A foveal MPOD value is calculated at 
a point eccentricity [117, 161, 164] or within a certain area centred on the fovea [25, 154, 
161, 163]. As in FR, a correction should be made when using SLOs, to account for the argon 
laser lines not coinciding exactly with the maximum and minimum wavelengths of macular 
pigment absorption [26, 39, 141, 151, 153, 164]. 
 
Other equipment that has been used to assess MPOD using AF includes the fundus 
fluorometer/spectrophotometer (first described by Delori [156] and used specifically for 
macular pigment measurement by Delori et al. [56]) and a modified fundus camera [117, 
159]. The fundus fluorometer employs the comparison method. A number of different 
wavelengths are directed at a 3° retinal area and the fluorescence is collected from a 2° 
sampling field concentric within the 3° area [56]. The subject is asked to fixate centrally or at 
7° in order to obtain emission data from the fovea and parafovea. MPOD is then calculated 
using the foveal and parafoveal AF information at excitation wavelengths of 470 nm and 550 
nm. In contrast, the modified fundus camera employs the imaging method. The camera is 
coupled to a cooled CCD camera and takes pictures of a 15° retinal field using wavelengths 
of 470 and 545 nm. At this point the technique becomes very similar to that of SLO AF 
imaging, i.e. image alignment and analysis by a computer program, thus providing macular 
pigment density maps, including a measure of peak MPOD [117, 159]. 
 
Common to all forms of AF instrumentation is the need for bleaching of the visual pigments 
prior to measurement (see ‘assumptions’) and pupil dilation, although a non-mydriatic 
version has been described [153]. 
 
One-wavelength versus two-wavelength AF 
 
The vast majority of AF-based macular pigment studies have used two wavelengths 
(corresponding to high and low macular pigment absorption) to derive MPOD. There have 
been a handful of studies, however, that have used only the high absorption wavelength [19, 
39, 129]. It is then presumed that any reduction in AF across the imaged area is due entirely 
to the presence of macular pigment [19]. Whilst some good correlations between MPOD 
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measured with one-wavelength AF and minimum motion photometry have been found [39, 
129], certain criticisms have been leveled at the one-wavelength method. Principally, the 
problem lies with the assumption that the fluorophores, i.e. lipofuscin, are distributed evenly 
across the imaging field. This is not the case [165] and, as a result, any attenuation in AF 
could be due to the presence of macular pigment but may also be a consequence of a lower 
level of lipofuscin in that area [19, 159, 162]. The use of a second, longer wavelength that is 
minimally absorbed by macular pigment eliminates this issue. Trieschmann et al. [162] 
compared the one and two-wavelength methods on 120 subjects. They concluded that one-
wavelength AF is acceptable as a screening method, particularly in view of its widespread 
availability in SLOs, whilst two-wavelength AF should always be used for precise MPOD 
assessment. The same conclusion was reached by Sharifzadeh et al. [153] using a CCD 
camera-based AF device. 
 
Assumptions 
 
Macular pigment assessment using AF assumes the following: 
 
1. There are no fluorophores anterior to the macular pigment. Delori et al. [56] did find 
evidence of such a fluorophore and noted that it would cause a small underestimation of 
MPOD. This underestimation is minimized by detecting AF at a longer wavelength – 710 nm 
[56]. 
 
2. Lipofuscin at the fovea has the same excitation spectrum as lipofuscin in the surrounding 
retina. It is unknown whether this is entirely correct but according to Delori and colleagues 
[56], any differences are not big enough to affect the measured macular pigment spectral 
curve, as determined by their technique. The total amount of lipofuscin is known to vary 
across the retina but this is accounted for as long as the two-wavelength method is being 
used. 
 
3. Any foveal-perifoveal differences in absorbers other than the macular pigment – retinal 
blood, photoreceptor pigments and RPE melanin – have a negligible effect on the measured 
MPOD. Delori et al. [56] investigated these assumptions in detail and found that retinal blood 
differences had virtually no effect and photoreceptor bleaching meant there was very little 
error in terms of photopigment differences. They did, however, find that RPE melanin slightly 
overestimated MPOD.  
 
 
 
30 
 
4. Negligible macular pigment at any peripheral reference site. This is particularly important 
when the comparison technique is adopted but should be a true assumption because an 
adequate eccentricity is more easily accomplished with objective than subjective MPOD 
techniques. 
 
Validity 
 
The only study to date that has investigated the validity of AF in terms of a spectral 
comparison with in vitro MPOD data is that by Delori et al. [56]. Excitation wavelengths of 
430, 470, 510 and 550 nm were used on 147 healthy-eyed subjects, plus 450, 490 and 530 
nm on two of these subjects. The resultant spectral profiles for seven subjects are shown in 
Figure 12, along with the equivalent spectral profiles using a FR technique. The curves are 
in very good agreement with the chosen in vitro macular pigment curve, attesting to the 
validity of the AF method of MPOD measurement, in healthy eyes at least. 
 
INSERT FIGURE 12 ABOUT HERE 
 
Spatial profiles (or maps) of MPOD are the norm for AF imaging. In terms of validity, Robson 
et al. [39] demonstrated the symmetrical nature of macular pigment distribution (Figure 13), 
in line with findings using HFP and FR. Also like HFP and FR, however, an array of inter-
individual macular pigment distributions have been found. Figure 14, for instance, shows two 
distinct MPOD spatial profiles from a study by Wolf-Schnurrbusch et al. [154]. The top image 
is the classic distribution of a central peak in macular pigment with a rapid decline as 
distance from the fovea increases. The bottom image has a central peak in macular pigment 
followed by a decline, and there is also a secondary peak (a ‘parafoveal ring’) before further 
decline. In this particular study, the average eccentricity of the parafoveal ring was 0.66° 
from the fovea, which is in line with several other studies [59, 116, 117]. Many researchers 
now propose that the total complement of macular pigment, rather than the peak amount, 
may better represent an individual’s risk for, or protection from, AMD (see review by 
Bernstein et al. [155]).  
 
INSERT FIGURES 13 AND 14 ABOUT HERE 
 
In several studies, AF has been compared with other techniques of MPOD assessment, 
including HFP, using the same set of subjects [39, 56, 60, 129, 141]. All have shown good 
correlations, albeit with some systematic differences. 
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Reliability  
 
As with FR, most tests of reliability concerning AF have been carried out within the same 
session and are perhaps, therefore, not as useful as inter-session reliability data. 
Nevertheless, the results are impressive, indicating similar, if not better, reliability than HFP 
and FR. Table 4 contains a list of AF studies that have provided information on reliability. 
 
INSERT TABLE 4 ABOUT HERE 
 
Advantages and disadvantages of AF 
 
Advantages include: 1) its objectivity; as an objective test, AF requires no subject 
participation other than a short period of reasonable fixation 2) quick measurement time 3) 
spatial plots of macular pigment distribution produced as standard in AF imaging 4) good 
test-retest reliability 5) applicability to many subject populations, including children. 
Disadvantages include: 1) the need for pupil dilation 2) equipment expense 3) a lack of 
commercially-available two-wavelength SLOs 4) the need for photopigment bleaching and 
therefore unpleasant light levels 5) difficulty obtaining clear images from eyes with lens 
opacities. 
 
Resonance Raman spectroscopy 
 
With the exception of electrophysiology methods, resonance Raman spectroscopy (RRS) is 
the most recently developed MPOD technique and, arguably, the most controversial. First 
described by Bernstein et al. in 1998 [166], RRS takes advantage of lutein and zeaxanthin’s 
ability to exhibit a phenomenon called Raman scattering [167]. Over the last ten years the 
use of RRS to measure MPOD has quickly gained momentum, with many papers published 
on its use [57, 111, 168-178]. 
 
Procedure 
 
When monochromatic light is directed at a molecule, some of the light is scattered. Most of 
the light is scattered elastically (Rayleigh scattering) but a small proportion is scattered 
inelastically (Raman scattering). When this inelastic back-scattering happens, there is a 
wavelength shift of the incident light, known as a Raman shift; the shift in wavelength is 
molecule-specific and therefore the back-scattered light can be collected and analyzed to 
identify the molecule in question. Usually the Raman signal is very weak and as such is not 
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easily identified. However, if the incident wavelength overlaps with the absorption spectrum 
of the molecule, a large resonance enhancement of the Raman scattered light occurs and 
the molecule can be recognized. Carotenoids, including lutein and zeaxanthin, are an 
excellent example of this. When excited by 488 nm argon laser light, they exhibit a 
resonance enhancement of up to five orders of magnitude [169], with three characteristic 
Raman spectral peaks [166, 167, 171], as shown in Figure 15. The strongest peak is at 1525 
cm-1 and this is the Raman line that is subsequently quantified in Raman counts (RCs). 
 
RRS is completely different from almost all other MPOD techniques in that it measures 
absolute levels of macular pigment in a 1 mm (3.5°) area, with no peripheral consideration at 
all. The researchers in this field claim that this is acceptable since the signal is derived 
directly from the pigment itself, rather than relying on light that must travel to deeper layers 
of the retina [111, 171] and that furthermore, the signal is only strong enough to register at 
carotenoid concentrations found in the macula, rather than in any other structures such as 
the cornea and lens [166]. 
 
INSERT FIGURE 15 ABOUT HERE 
 
Instrumentation 
 
The setup for RRS detection of MPOD is shown in Figure 16. It consists of a 488 nm argon 
laser that is directed at the fovea. The returning back-scattered light is filtered so that only 
Raman shifted light is sent to the Raman spectrograph (via a fibre optic bundle). The 
spectrograph is linked to a CCD camera, which is in turn linked to a computer that is 
programmed to subtract the background fluorescence and quantify the intensity of the 
Raman peaks, in particular the 1525 cm-1 line. Optical alignment of the instrument to the 
fovea is achieved in human subjects by use of a red LED and a small portion of the blue 
argon laser light. The red LED is visible to the observer as a polka-dot pattern and the laser 
light as a blue disc. By small head movements along a head rest, the subject lines up the 
two images, at which point the operator pushes a button to begin the whole procedure. The 
488 nm light is directed as a 0.5 mW, 1 mm spot onto the macula for 0.5 seconds [170, 171, 
173]. Later studies using RRS have altered the settings slightly by using a 1mW, 1 mm spot 
directed at the macula for 0.25 seconds [57, 174, 175, 179]. Five measurements are taken 
at intervals of 30 – 180 secs (the time is dependent on afterimage fading) and the original 
protocol [171] dictated that the three highest recordings are used in the data analysis, to 
allow for subjects that blink or misalign.  
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Prior to measurement, pupil dilation to at least 6 mm is necessary [170, 171]; some later 
studies have found that dilation to at least 7 mm gives more reliable results [57, 174] – see 
discussion about pupil size in the ‘validity’ section. 
 
INSERT FIGURE 16 ABOUT HERE 
 
RESONANCE RAMAN IMAGING 
One limitation of RRS in its classic form is that it is limited to measuring MPOD in a 1 mm 
(3.5°) area centred on the fovea, rather than being able to produce a spatial profile of 
macular pigment across a larger retinal area. The technique has therefore been extended 
into an imaging mode covering a 3.5 mm area; initially using excised donor eyes [172], then 
more recently, following further modification, using living volunteers [175, 178]. 
 
Assumptions 
 
The assumptions associated with RRS are listed below. They are elaborated upon in the 
following section on validity. 
 
1. Accurate alignment and fixation by the subject, and no significant head movement during 
image capture. 
 
2. No significant effect on the Raman signal by differing levels of crystalline lens yellowing, 
i.e. absorption, within and across age groups. 
 
3. No significant effect on the Raman signal by inter-individual differences in the level of lens 
diffusion (scatter and aberration). 
 
Validity 
 
The validity of RRS has been a subject of fierce debate in the literature [e.g. 54, 180, 181-
186]. It is beyond the scope of this review to repeat the issues of contention verbatim; rather, 
the main points are summarized. 
 
The research group that developed RRS for measurement of MPOD have shown that it is 
very specific and sensitive to measurement of lutein and zeaxanthin [166, 170, 171]. 
However, unlike the other methods of MPOD measurement, RRS cannot generate spectral 
absorption curves of macular pigment to be compared with in vitro curves. Instead, the 
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investigators attest to the validity of RRS in several other ways. Firstly, the strength of the 
Raman signal from donor maculae has been compared with actual macular pigment levels 
as measured by HPLC (Figure 17) [166]. The results revealed a highly linear correlation (r = 
0.94, no p-value provided). Secondly, a model eye containing known amounts of lutein was 
measured with the Raman device (Figure 18) and the results again demonstrated a linear 
correlation (r = 0.99, no p-value provided) [171]. Thirdly, the Raman signals from six intact 
monkey eyes were determined then compared with their HPLC-measured macular pigment 
level (Figure 19) [171]. The correlation between the two was good but not perfect (r = 0.68, 
no p-value provided); the authors attributed this to differences in the detection area between 
the Raman (1 mm) and the HPLC (5 mm) method, and to difficulties with foveal alignment. 
Finally, Bernstein et al. [170] found a perfect linear correlation between Raman signals from 
lutein and zeaxanthin solutions placed in a model eye and their known concentrations 
(Figure 20A), up to about 0.35 density units (equivalent in this case to 1600 RCs). At higher 
concentrations, the Raman response became saturated and therefore non-linear (Figure 
20B), as a result of the 488 nm laser beam being unable to penetrate increasingly dense 
carotenoid concentrations [170]. Ermakov et al. [174] found a similar linear then non-linear 
response for various zeaxanthin concentrations, again using a model eye. 
 
INSERT FIGURES 17-20 ABOUT HERE 
 
Those questioning the validity of RRS as a method of MPOD measurement have made 
several criticisms of the above calibration procedures. The issues of contention include 
whether or not the model eye is a true representation of a real in vivo eye; whether or not the 
increasing underestimation of MPOD at higher concentrations is a problem in ordinary 
subject populations; and the credibility of using the monkey data as evidence of validity, 
given that the level of RCs was in general far higher than most human levels and well above 
the point at which the plateau occurs in the external calibration curve (see Figures 19 and 
20). 
 
Studies of MPOD using RRS have consistently shown a strong decline in macular pigment 
with increasing age (see, for example, Figure 21). Hammond et al. [54] argue that this is 
another area where the validity of RRS is questionable, since with all other MPOD 
techniques, there appears to be little or no age-related macular pigment decline [141]. The 
developers of RRS believe that the decrease is genuine [110, 111, 169-171, 173-175] and 
not just attributable to increasing lens absorption (yellowing) and diffusion (scatter and 
aberration) with age, as suggested by Hammond and Wooten [54, 182-184]. An independent 
study simulating incremental increases in lens yellowing and scatter found that the Raman 
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signal intensity was significantly attenuated as the density of the yellow and scatter filters 
increased [179]. The authors concluded that when using RRS to assess MPOD, the status 
of the lens needs to be taken into account. In other words, the large decline in MPOD with 
age reported in many RRS studies is unlikely to represent a true drop in macular pigment 
levels and therefore the validity of RRS in older subjects, at least, is uncertain. 
 
INSERT FIGURE 21 ABOUT HERE 
 
Another reason for the decrease in MPOD with age – as found by RRS – may be due in part 
to inadequate pupil dilation. Studies have shown that the Raman signal is weakened when 
pupil diameter is smaller than 7 mm [57, 171, 174]. This is because the entrance/exit pupil of 
the Raman instrument is also 7 mm and thus any pupil diameter less than this will result in a 
loss of signal [171, 174]. Neelam et al. [57] found that the significant age-related decline in 
RRS-derived MPOD of their subject population was reduced to a non-significant level when 
subjects with inadequate pupil dilation (< 7 mm) were excluded. It would therefore seem that 
an inability to sufficiently dilate the pupils of some older individuals might contribute to the 
decline in MPOD seen with RRS. Further to this, small head movements in subjects whose 
pupil diameter is at the 7 mm limit could also reduce the Raman signal, regardless of age 
[54, 176, 182-184, 186], although Bernstein and colleagues may contend that their 
procedure of taking the three highest RCs of five measurements allows for such head 
movements. 
 
Widely varying macular pigment spatial profiles have been observed using the RR imaging 
(RRI) device in living human subjects, including asymmetries and local depletions [178]. 
Although such distributions are not normally typical of other MPOD techniques, in comparing 
the integrated macular pigment densities of the entire imaged area with the densities 
measured over the same area with an AF method, the investigators found a very high 
correlation in 17 subjects (r = 0.89, no p-value provided). Furthermore, the integrated 
macular pigment levels of 11 donor maculae measured with the RRI instrument were 
compared with the levels as measured by HPLC. The correlation between the two was very 
strong (r = 0.92, p < 0.0001), although the influence of the ocular media was removed and 
therefore may have lead to an erroneously high agreement. Nevertheless, the validity of RRI 
looks promising. 
 
Indirect methods of assessing validity, mentioned previously, consist of comparisons with 
more established, validated techniques, and the ability to show rises in MPOD with 
increased lutein and/or zeaxanthin intake. The latter has apparently been proven, although 
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the study was only briefly described [110]. RRS-measured MPOD has been compared with 
HFP-measured MPOD in only two, detailed published papers [57, 176]. Neelam et al. [57], 
using Bland-Altman plots, demonstrated an agreement between the two techniques close to 
statistical significance. The correlation, as described by Pearson product-moment correlation 
coefficient, was r = 0.32 (derived by Hammond and Wooten [184]). Although statistically 
significant, this correlation only explains 10% of the variance in the two methods [184]. Hogg 
et al. [176] also found a weak, albeit statistically significant, correlation between RRS and 
HFP (r = 0.26, p = 0.012). They did not feel it was good enough for the two techniques to be 
interchangeable. Bernstein et al. [110] reported a better correlation (r = 0.467, p = 0.0024) in 
40 healthy subjects, but their study was not described in any detail. 
 
Reliability  
 
RRS appears to exhibit good within- and between-session reliability in the majority of studies 
(Table 5). The high variation in readings experienced in subjects from a study by Obana et 
al. [177], particularly in individuals with age-related maculopathy (ARM), is a notable 
exception. This is the only study that has provided any RRS reliability data for subjects with 
ocular disease and is an indication, perhaps, that more data is needed before evaluating 
information on MPOD in these populations. That said, 32 out of the 180 eyes with ARM had 
worse visual acuity than the recommended limit for RRS of 6/24 (20/80). This may have 
contributed to the variation. In view of the variation, Obana and colleagues chose to accept 
only the highest of the five Raman readings in all their subjects [177]. This means that 80% 
of the measurements were rejected, which seems a lot for a technique claiming to be 
validated. Nevertheless, many authorities have shown that MPOD measurements, as 
derived by RRS, do have good test-retest reliability (see Table 5). 
 
INSERT TABLE 5 ABOUT HERE  
 
Advantages and disadvantages of RRS 
 
Advantages include: 1) sensitivity and specificity for retinal carotenoids 2) rapid 
measurements requiring only momentary fixation from the subject 3) the possibility of quickly 
generated, detailed spatial distribution plots of macular pigment, using the RRI method 4) 
reasonable reliability 5) measurements possible in many individuals, including those with 
reduced acuity, up to 6/24 (20/80). Disadvantages include: 1) the need for pupil dilation 2) 
the reliance on subjects for accurate alignment, i.e. the lack of an objective alignment 
procedure 3) afterimages between measurements 3) questionable validity 4) attenuation of 
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the Raman signal with changes in the ocular media and inadequate pupil dilation 5) 
instrumentation that is highly specialized and expensive 6) RCs not being readily convertible 
to macular pigment density units, making direct comparisons with other techniques difficult.  
 
Electrophysiology – visual evoked potentials 
 
The first suggestion that visual evoked potentials (VEPs) could potentially be used to detect 
macular pigment was made over ten years ago, by Moreland et al. [37]. This was 
investigated further by Robson et al. [92] some time later. However, it is only very recently 
that this particular technique has looked like it could be a truly viable method for measuring 
MPOD. Using steady-state VEPs, Robson and Parry [41] measured MPOD across a range 
of eccentricities in three subjects. Blue-green gratings on a colour monitor were employed 
and these same gratings were also used to measure MPOD with HFP (see ‘recent 
developments’ in HFP section). The VEP and HFP results were compared with each other 
as well as with the equivalent MPOD as measured by minimum motion photometry. This 
required a correction factor on the part of the VEP and HFP results, to allow for the 
overlapping phosphor emissions of the blue and green stimuli. The correlation between all 
three techniques was excellent (r ≥ 0.94, p < 0.0005, in all cases), suggesting that steady-
state VEPs have potential as a valid, objective method for measuring macular pigment and 
its distribution. 
 
DISCUSSION 
 
There are currently two main psychophysical techniques for measuring MPOD in vivo, and 
three main objective techniques. All take advantage of the spectral absorption properties of 
macular pigment but in very diverse ways. This diversity may be useful for macular pigment 
research but it does present difficulties for those wishing to compare MPOD values between 
techniques. For instance, does the value represent the peak density of macular pigment, the 
density of macular pigment at a certain point within the fovea, or the total amount within the 
target area? 
 
If macular pigment measurement is to become commonplace in large populations, then 
equipment investors will have an important decision to make with regards to the method they 
choose to employ. Unfortunately, as each MPOD technique has its own benefits and 
limitations, there is no clear ideal choice, as highlighted by Beatty, van Kuijk and 
Chakravarthy [187]. Heterochromatic flicker photometry is probably the most affordable 
choice. It is also an established, valid and reliable method, particularly when protocols are 
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followed as per ‘customized’ HFP [50, 52]. There is, however, the problem that some 
individuals find this task very difficult and their results cannot necessarily be relied upon. A 
commercially available objective technique would therefore be desirable, possibly through 
adaptation of a scanning laser ophthalmoscope or fundus camera. The former is often used 
in a hospital setting and the latter is commonly found in optometric practice. A future 
objective technique could make use of FR or AF to assess MPOD, although AF may be 
preferred over FR because it is less influenced by light scatter and appears to have better 
reliability. Both have the facility to measure the spatial distribution of macular pigment and 
this seems to be an increasingly useful advantage [8, 39, 74, 108, 116]. Bhosale, Zhao and 
Bernstein [112] observed elevated lutein levels at the macula and at the peripheral retina in 
donors known to be using high dose lutein supplements. Therefore, if non-macula areas are 
not taken into account, the total complement of macular pigment may be underestimated, 
particularly with methods such as HFP, where the eccentric references are assumed to have 
virtually no macular pigment. The main issue associated with macular pigment screening 
using an objective technique is the need for pupil dilation, although several non-mydriatic 
devices have now been developed [58, 59, 153]. 
  
It is our view that the measurement of MPOD is best conducted using an objective technique 
based on FR or AF but we acknowledge that a commercial instrument capable of this is not 
currently available. The development of such an instrument will aid research in this area and 
provide a better understanding of the relationship between MPOD and AMD, as well as 
supporting MPOD screening in a clinical setting.
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Figure and table legends 
 
Figure 1. Schematic diagram of a Maxwellian view optical system, as used by Wooten et al. 
[46]. A1-A3 = apertures 1-3. BF = blocking filter (removes stray light). BS1 and BS2 = beam 
splitters 1 and 2. C = flicker vanes with a first surface mirror (produces alternation of the test 
and reference lights). HM1-HM3 = hot mirrors 1-3 (reduce heat transfer). IF1 and IF2 = 
interference filters 1 and 2. L1-L17 = lenses 1-17 (achromatic, planoconvex). M = 
monochromator (produces the test wavelength). M1-M4 = mirrors 1-4 (right angle, first 
surface). ND = neutral density filter (together with interference filters, produces the reference 
and background wavelengths). R = reticle. S = source light, in this case a xenon arc lamp. W 
= wedge (used to adjust the radiance of the test light). [Reprinted from Wooten et al. [46], 
with permission from the Association for Research in Vision and Ophthalmology.] 
 
Figure 2. Schematic diagram of a free view optical system, as used by Wooten et al. [46]. 
A1 and A2 = apertures 1 and 2. BS = beam splitter. D1 and D2 = optical diffusers (increase 
transmission efficiency). H = hole (1 inch circular viewing hole). L1 and L2 = lenses 1 and 2 
(achromatic, planoconvex). PC = photocell. S1 and S2 = source lights 1 and 2 (3 x 470 nm 
LEDs for S1, i.e. background field, and 2 x 458 nm plus 1 x 570 nm for S2, i.e. test field). 
[Reprinted from Wooten et al. [46], with permission from the Association for Research in 
Vision and Ophthalmology.] 
 
Figure 3. A detailed spatial profile of one subject’s macular pigment density, obtained using 
heterochromatic flicker photometry. Here, measurements have been taken along the 
horizontal (filled squares) and vertical (open circles) meridians of the retina, demonstrating a 
rapid and symmetrical decline in macular pigment with increasing eccentricity [Reprinted 
from Hammond et al. [44], with permission from the Optical Society of America.] 
 
Figure 4. The relative macular pigment spectral absorption profile of one subject (filled 
squares), as derived by heterochromatic flicker photometry. The continuous curve is an in 
vitro combination template as described in the text. Small deviations from the template at 
wavelengths below about 440 nm are typical. The reason for this is not clear and several 
theories have been proposed [see, for example, 54, 66, 71]. However, above 440 nm, the in 
vivo and in vitro methods are in very close agreement, so measurements of peak macular 
pigment optical density should remain accurate. [Reprinted from Wooten and Hammond 
[71], with permission from the American Academy of Optometry.] 
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Figure 5. A high correlation (r = 0.91, p < 0.00001) between macular pigment optical density 
measured with a centrally positioned 1° test stimulus and a 12′ test stimulus positioned 0.5° 
from the central fovea lends support to the edge hypothesis of heterochromatic flicker 
photometry. [Reprinted from Hammond et al. [44], with permission from the Optical Society 
of America.] 
 
Figure 6. Left panel: Macular pigment distribution in the central 1.5°, as determined by Bone 
et al. [68], using heterochromatic flicker photometry. The horizontal line is the average 
macular pigment optical density (MPOD) for 10 subjects, calculated using a centrally 
positioned 1.5° circular test stimulus (grey area = ± 1 standard deviation). The filled circles 
depict the average MPOD at various eccentricities (bars = ± 1 standard deviation), 
determined using a number of annular stimuli with central fixation marks (right panel). 
Whereas Hammond et al. [44] used a very small stimulus placed at the required retinal 
eccentricity, Bone and colleagues have used annular stimuli. This is an alternative method of 
knowingly measuring MPOD at a retinal eccentricity equivalent to the stimuli radii. The 
intersection point at 0.38° is the position at which MPOD appears to be measured when 
using a 1.5° test stimulus, i.e. 51% of the stimulus radius. Right panel: The four annular 
stimuli and two circular stimuli (1.17° circular stimulus not used in this graph). ID = inner 
diameter, OD = outer diameter. [Reprinted from Bone et al. [68], with permission from 
Elsevier.] 
 
Figure 7. Test configuration used in minimum motion photometry (left panel), with the 
associated stimuli dimensions given in the table (right panel). [Reprinted from Robson et al. 
[129], with permission from Pion Limited.] 
 
Figure 8. Apparent motion photometry. Left panel: Apparent movement to the right when the 
red bars are brighter than the blue, and vice-versa. Right panel: The test configuration for a 
parafoveal target [130]. 
 
Figure 9. Schematic diagram of the Foveal Reflection Analyzer 1, from Zagers et al. [146]. 
In (a): F = spectral filters. Lamp = 30W halogen lamp. L1-L11 = lenses 1-11. Lf = front lens. 
Li = insertable lens. Mh = mirror with central hole. Mi = insertable mirror. P = pupil plane. R = 
retinal plane. P’ and R’ = planes conjugate to P and R. V = video camera. In (b): The dilated 
pupil with entrance and exit pupil shown to scale (left panel). The illuminated field and the 
concentric sampled field, with fixation cross hairs (right panel). [Reprinted from Zagers et al. 
[146], with permission from the Optical Society of America.] 
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Figure 10. Schematic diagram of the Macular Pigment Reflectometer, from van de Kraats et 
al. [58]. L1-L8 = lenses 1-8. M = mirror. [Reprinted from van de Kraats et al. [58], with 
permission from SPIE.] 
 
Figure 11. Spatial profiles of macular pigment density in three age groups, obtained by 
fundus reflectometry: (a) young (24.8 ± 2.6 years), (b) mid-age (40.2 ± 8.3) and (c) old (67.5 
± 7.1). [Reprinted from Chen et al. [108], with permission from Informa Healthcare.] 
 
Figure 12. Left panel: Log ratio autofluorescence (AF) plotted against wavelength for seven 
subjects (symbols) along with the scaled macular pigment spectra (curves). The age of each 
subject is given to the left of each curve and the derived macular pigment optical density 
(with r2 values of the fits) is given to the right. Right panel: The equivalent fundus 
reflectometry (‘RE’) results. [Reprinted from Delori et al. [56], with permission from the 
Optical Society of America.] 
 
Figure 13. Autofluorescence images (first and third columns) and macular pigment spatial 
profiles (second and fourth columns) for 8 subjects (A-H). Open circles indicate the vertical 
meridian and filled circles the horizontal meridian. The arrows indicate disruptions due to 
prominent blood vessels. [Reprinted from Robson et al. [39], with permission from Elsevier.] 
 
Figure 14. Two example macular pigment spatial profiles with their corresponding 
autofluorescence images: (a) classic profile – central peak in macular pigment followed by a 
rapid decline, and (b) parafoveal ring profile – central peak in macular pigment, plus a 
secondary peak, before further decline. [Reprinted from Wolf-Schnurrbusch et al. [154], with 
permission from the Association for Research in Vision and Ophthalmology.] 
 
Figure 15. In vivo Raman spectra of a healthy subject, showing the characteristic peaks of 
macular pigment. Top trace = before subtraction of the background ocular fluorescence. 
Bottom trace = after subtraction. [Reprinted from Gellermann et al. [171], with permission 
from the Optical Society of America.] 
 
Figure 16. Schematic diagram of a resonance Raman spectroscopy macular pigment 
detector. Ar+ laser = air-cooled argon laser. BS = dichroic beam splitter. F = filter. LED = light 
emitting diode. L1-4 = lenses 1-4. M = Mirror. NF = holographic rejection notch filter. TB = 
trigger button. VHTF = volume holographic transmission grating. [Reprinted from Gellermann 
et al. [171], with permission from the Optical Society of America.] 
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Figure 17. Macular pigment measurements in seven human donor maculae, measured by 
high-performance liquid chromatography and resonance Raman spectroscopy. [Reprinted 
from Bernstein et al. [166], with permission from the Association for Research in Vision and 
Ophthalmology.] 
 
Figure 18. Macular pigment measurements by resonance Raman spectroscopy of four 
known lutein concentrations placed in a model eye. [Reprinted from Gellermann et al. [171], 
with permission from the Optical Society of America.] 
 
Figure 19. Macular pigment measurements in six monkey eyes, measured by high-
performance liquid chromatography and resonance Raman spectroscopy. [Reprinted from 
Gellermann et al. [171], with permission from the Optical Society of America.] 
 
Figure 20. Macular pigment measurements by resonance Raman spectroscopy of known 
lutein and zeaxanthin concentrations placed in a model eye: A = linear response range (filled 
circles are lutein, open circles are zeaxanthin). B = linear and non-linear response range. 
[Reprinted from Bernstein et al. [170], with permission from Elsevier.] 
 
Figure 21. The decline in macular pigment optical density with age, as measured by 
resonance Raman spectroscopy. [Reprinted from Bernstein et al. [170], with permission from 
Elsevier.] 
 
Table 1. A summary of the main differences between Maxwellian and free view optical 
systems. 
 
Table 2. A list of all heterochromatic flicker photometry (HFP) studies to date that have given 
statistical data on test-retest reliability. 
a Snodderly et al. [50] also calculated the equivalent values for the left eye, which were r = 
0.86, 22% test-retest difference and a coefficient of repeatability of 0.21.  
ARM = age-related maculopathy, the general term for degeneration of the macular region of 
the retina, which is normally separated into the two categories of early and late ARM, with 
the latter also being called age-related macular degeneration [188]. 
MPOD = macular pigment optical density.  
RE = right eye.  
RPE = retinal pigment epithelium. 
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Table 3. A list of all fundus reflectometry (FR) studies to date that have given statistical data 
on reliability. 
ARM = age-related maculopathy. 
FRA = Foveal Reflection Analyzer, a purpose-built reflectometer. 
MPR = Macular Pigment Reflectometer, a purpose-built reflectometer. 
SLO = scanning laser ophthalmoscope. 
 
Table 4. A list of all autofluorescence (AF) studies to date that have given statistical data on 
reliability. 
AMD = age-related macular degeneration. 
MPOD = macular pigment optical density. 
 
Table 5. A list of all resonance Raman spectroscopy (RRS) studies to date that have given 
statistical data on reliability. 
ARM = age-related maculopathy, the general term for degeneration of the macular region of 
the retina, which is normally separated into the two categories of early and late ARM, with 
the latter also being called age-related macular degeneration (AMD) [188]. 
MPOD = macular pigment optical density
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ABSTRACT 
 
Background: Macular pigment has been the focus of much attention in recent years, as a 
potential modifiable risk factor for age-related macular degeneration. This interest has been 
heightened by the ability to measure macular pigment optical density (MPOD) in vivo. 
Method: A systematic literature search was undertaken to identify all available papers that 
have used in vivo MPOD techniques. The papers were reviewed and all relevant information 
was incorporated into this article. Results: Measurement of MPOD is achievable with a wide 
range of techniques, which are typically categorized into one of two groups: psychophysical 
(requiring a response from the subject) or objective (requiring minimal input from the 
subject). The psychophysical methods include heterochromatic flicker photometry and 
minimum motion photometry. The objective methods include fundus reflectometry, fundus 
autofluorescence, resonance Raman spectroscopy and visual evoked potentials. Even 
within the individual techniques, there is often much variation in how data is obtained and 
processed. Conclusion: This review comprehensively details the procedure, instrumentation, 
assumptions, validity and reliability of each MPOD measurement technique currently 
available, along with their respective advantages and disadvantages. This leads us to 
conclude that development of a commercial instrument, based on fundus reflectometry or 
fundus autofluorescence, would be beneficial to macular pigment research and would 
support MPOD screening in a clinical setting. 
 
Keywords: fundus autofluorescence; fundus reflectometry; heterochromatic flicker 
photometry; macular pigment; macular pigment optical density; motion photometry; Raman 
spectroscopy.
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INTRODUCTION 
 
Macular pigment is the collective name for three carotenoids, lutein, zeaxanthin and meso-
zeaxanthin, which are found at higher concentrations in the retina than anywhere else in the 
body, and to the exclusion of all other carotenoids [1]. They are only accessible to the body 
by dietary intake of foodstuffs or supplements containing them [2, 3], with high levels being 
found in certain fruits and vegetables, such as kiwi fruit, corn and spinach, as well as egg 
yolks [4]. 
 
Analysis of donor maculae is possibly the most unequivocal approach for assessing the 
distribution of macular pigment in the retina, and pioneering work by Snodderly and 
colleagues in the 1980s achieved this [5, 6]. Using primate monkeys and the technique of 
microdensitometry, it was confirmed, as expected, that macular pigment reaches its peak in 
the centre of the retina. There was then a sharp decline to negligible levels at approximately 
1 mm (4°) from the central fovea. In 1988, Bone et al., using high-performance liquid 
chromatography (HPLC), investigated the spatial distribution of macular pigment in human 
donors; in this case, it was found to reach negligible levels at 7° eccentricity [7]. Within the 
retinal layers, macular pigment is primarily located in the photoreceptor axons and to a 
lesser extent in the inner plexiform layer [6, 8].  
 
The macular carotenoids have an absorption spectrum of 400 – 540 nm, peaking at 
approximately 460 nm [9]. This spectral peak, along with the spatial distribution and retinal 
layer localization of macular pigment contribute to its proposed function as a blue light filter. 
Short-wavelength (blue) light is more damaging to the retina than longer-wavelength light 
[10] so by attenuating the amount of blue light reaching the photoreceptors, macular pigment 
may protect the macula from this photo-damage; the higher the density of macular pigment 
(macular pigment optical density, or MPOD), the greater the amount of blue light filtering that 
will occur [11, 12]. A second proposed function of macular pigment is that it protects the 
macula against oxidative stress by acting as an antioxidant [e.g. 13]. These blue light filter 
and antioxidant functions have led to the school of thought that having a high MPOD could 
help to protect against the eye disease age-related macular degeneration (AMD), the most 
prevalent cause of severe visual impairment in Western society [14-16]. As a result, there 
have been a multitude of studies investigating possible links between MPOD and AMD, 
using a variety of measurement techniques. Some of these studies have supported an 
MPOD-AMD association [e.g. 17, 18, 19] and some have not [e.g. 20, 21]. This inconsistent 
evidence is not too surprising, given the apparent multifactorial nature of AMD. What’s more, 
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it is highly likely that an individual’s MPOD is equally multifactorial, but as one of the few 
potentially modifiable risk factors for AMD, its continued investigation is extremely important. 
 
Macular pigment optical density may be measured in vitro or in vivo. In vitro measurement 
involves the techniques of HPLC [e.g. 22, 23] or microdensitometry [e.g. 24]. However, they 
can only be performed on excised retinas and so are clearly not suitable for widespread use. 
This review therefore details the most common techniques currently used to measure MPOD 
in vivo. These in vivo techniques are noninvasive and are normally categorized under one of 
two headings: psychophysical (requiring a response from the subject) or objective (requiring 
minimal input from the subject). Together they have established that MPOD varies widely 
between individuals, from virtually no macular pigment to greater than 1 log unit optical 
density, with average levels ranging from 0.16 [25] to 0.50 [26], depending on the method 
and/or the study population. 
  
METHOD 
 
A systematic literature search was conducted using ISI Web of Knowledge and PubMed. 
Key words and their combinations used for the search included ‘macular pigment’, ‘macular 
pigment optical density’, ‘lutein’, ‘zeaxanthin’, ‘heterochromatic flicker photometry’, ‘motion 
photometry’, reflectometry’, ‘autofluorescence’, ‘Raman’, ‘electrophysiology’, and ‘macular 
degeneration’. Further searches were undertaken for key researchers in the field such as 
Beatty, Berendschot, Bernstein, Bone, Delori, Gellermann, Hammond, Landrum, Moreland, 
Nolan, Robson, Snodderly, Stringham, Trieschmann, van de Kraats, and Wenzel. Further 
papers were obtained from the references of the retrieved articles. All the articles were 
reviewed and relevant information was incorporated into the manuscript. 
 
RESULTS OF REVIEW 
 
Psychophysical techniques 
 
Psychophysical techniques of measuring macular pigment optical density (MPOD) include 
the following: 
 
Threshold spectral sensitivity [e.g. 27, 28-31]. 
Colour matching [e.g. 32, 33-35]. 
Dichroism-based measurements [e.g. 9, 36]. 
Minimum motion photometry and apparent motion photometry [e.g. 37, 38-41]. 
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Heterochromatic flicker photometry [e.g. 42, 43-53]. 
 
The first three of the psychophysical methods have now been largely superseded by 
heterochromatic flicker photometry (HFP) and, to some extent, minimum motion photometry. 
This is in part due to their increased level of difficulty and/or the longer time needed to 
perform them [54]. This review will therefore focus on the latter two methods. For information 
regarding the threshold sensitivity, colour matching and dichroism techniques, the reader is 
directed to the referenced studies, along with a validity review by Hammond et al. [54]. 
  
Heterochromatic flicker photometry 
 
Developed by Ives in the early 1900s [55], HFP has so far been the most commonly used of 
all the techniques for measuring MPOD. As such, it is often used as a standard against 
which other techniques are validated [e.g. 56, 57-60], although at present there is no true 
‘gold-standard’ in vivo measure of MPOD. 
 
The use of HFP to measure macular pigment levels was first described over 30 years ago by 
Werner and Wooten [61] but the technique wasn’t elaborated on until 1987, in a key paper 
by Werner, Donnelly and Kliegl [42]. Since then, HFP has been developed and used by 
numerous research groups investigating macular pigment. Key papers incorporating detailed 
descriptions and variations of the technique include Hammond and Fuld [43], Hammond et 
al. [44], Landrum et al. [45], Wooten et al. [46], Beatty et al. [47], Mellerio et al. [48], Bone 
and Landrum [49], Snodderly et al. [50], Tang et al. [62], Iannaccone et al. [51], Stringham et 
al. [52], and van der Veen et al. [53]. All other studies using HFP to measure MPOD tend to 
use the instruments originally designed or developed by these investigators. 
 
Procedure 
 
In conjunction with many of the MPOD techniques, HFP exploits the spectral absorption 
properties and retinal location of macular pigment. Essentially, HFP determines MPOD by 
presenting a light stimulus of two alternating wavelengths at the fovea and at a parafoveal 
area. The wavelengths are chosen such that one is a short wavelength blue light that is 
maximally absorbed by macular pigment and the other is a longer wavelength green to 
yellow light that is not absorbed by macular pigment [6]. If the colours are alternated at an 
appropriate frequency and the luminance of the two colours is not perceived to be equal by 
the subject, the stimulus will appear as a flickering light; the perceived colour of this light will 
be an amalgamation of the two source colours [47, 49, 50, 63]. Typically, the radiance (often 
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also termed intensity) of the blue light is adjusted by the subject until the observed flicker is 
minimized [e.g. 44, 45, 46, 48, 50, 52, 62]. This occurs when there is an equiluminance 
match between the blue and green lights [63, 64]. The procedure is then repeated at a 
parafoveal locus where macular pigment is negligible [65]. Since more blue light will be 
absorbed by macular pigment at the fovea than the parafovea, a greater radiance of blue 
light will be required at the fovea to appreciate minimal flicker. The log ratio of the radiance 
of blue light needed at the fovea compared with that needed at the parafovea gives a 
measure of peak MPOD (Formula 1), although whether this is truly the peak value is subject 
to discussion (see ‘the edge hypothesis of heterochromatic flicker photometry’). 
 
MPOD = log (Rfs / R
p
s
) − log (Rfγ / R
p
γ
) 
 
Formula 1. Example calculation for macular pigment optical density, from Stringham et al. 
[52]. Rfs = radiance of a peak macular pigment absorption wavelength, e.g. 460 nm, 
measured at a foveal location. Rps = radiance of a peak macular pigment absorption 
wavelength, measured at a parafoveal location, e.g. 7°. Rf γ = radiance of a negligible 
macular pigment absorption wavelength, e.g. 570 nm, measured at a foveal location. Rp γ = 
radiance of a negligible macular pigment absorption wavelength, measured at a parafoveal 
location. 
 
Instrumentation 
 
Several variations on MPOD measurement by HFP have been developed since its first use 
in the 1970s. Traditionally, Maxwellian view devices have been used [e.g. 42, 43, 45]. These 
are complex optical systems that are not easily portable and which require the use of a 
dental bite bar. The bite bar keeps the subject’s head stable so that their eye is correctly 
aligned with the incoming light beam [46, 65]. Given the complexity of these devices, 
operators need a significant amount of training [46]. As a result, several research groups 
have simplified the optics and allowed the use of a free view, or Newtonian view, setup [e.g. 
46, 47, 48, 62]. This negates the need for a bite bar, making the procedure more 
comfortable for the subject. Free view optical systems are also cheaper, easier to operate, 
and more portable (if not completely portable) than their Maxwellian counterparts [46, 47, 
62]. Wooten et al. [46] demonstrated a strong correlation for mean and individual MPOD 
calculated between their free view system and an established Maxwellian view system (r = 
0.95, no p-value provided). This showed that using the free viewing technique does not 
affect the accuracy of the derived result. Figures 1 and 2 depict a typical Maxwellian view 
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optical system and free view optical system, respectively, whilst Table 1 summarizes their 
differences. It should be noted that slight variations in these differences do occur. For 
instance, the instrument developed by Beatty and co-workers [47] uses both a quartz 
halogen and light-emitting diode (LED) light source. 
 
INSERT FIGURES 1 AND 2 ABOUT HERE 
INSERT TABLE 1 ABOUT HERE (AFTER FIGURES 1 AND 2) 
 
TEST FIELDS 
The test fields are viewed at a near working distance, e.g. 33 cm [48]. Most devices use a 
central stimulus that corresponds to a visual angle of 1° as standard, although there are 
exceptions; Landrum’s 1.5° [45] and Werner’s 0.70° [66], for instance. Moreover, many 
studies have used smaller test stimuli such as 12′ or 30′ when mapping the spatial profile of 
macular pigment [42, 44, 49, 50, 52, 60, 64, 67-79].  
 
The wavelength chosen for the blue light has varied between researchers from 458 nm [e.g. 
11, 46, 52, 75, 80, 81] to 476 nm [17], and from 530 nm [e.g. 43, 82-85] to 575 nm [62] for 
the green light. Where the blue wavelength does not coincide exactly with the peak of 
macular pigment absorption, this should be accounted for in the final calculation of MPOD. 
This is of greater importance in the objective techniques where wavelengths are often further 
from the peak than those used in HFP. MPOD should also be adjusted according to the 
bandwidth of the light source; the narrower the bandwidth, the more accurately the 
measurement reflects MPOD at the particular wavelength [54]. For the HFP device first 
described by Wooten et al. [46], the LED with peak energy at 458 nm has a half-bandwidth 
of 20 nm. As a result, MPOD must be increased by a 15% constant to correct for this [20, 
50, 54, 77]. 
  
The peripheral reference measurement is usually made using the same test stimulus as 
used for the central measure, but the subject’s gaze is directed to an eccentric fixation point. 
An exception to this is the Maculometer (developed by Mellerio et al. [48]) which instead 
turns the central 1° field into a fixation point and presents an annular test field at 5.5° from 
fixation. The subject therefore fixates centrally throughout the procedure. The authors 
reported that many subjects found this easier than maintaining an eccentric fixation. The 
parafoveal location used in different HFP apparatus varies from 4° from the central fovea 
[e.g. 11, 43, 46, 62, 71, 80, 81, 86] to 10° [72, 76] or 12° [66]. Similarly, the location of the 
peripheral point on the retina varies from temporal, nasal or superior retina, depending on 
instrument type. 
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FLICKER RATES 
The rate at which the blue and green lights are alternated is a difficult decision for 
researchers to make, since flicker sensitivity can vary between observers [65]. Ideally the 
flicker rate should allow for a suitable amount of null or minimal flicker to be achieved when 
adjusting the radiance of the test stimulus. If the flicker frequency is too low for an individual, 
they will have difficulty obtaining a point of null flicker. Conversely, if the flicker frequency is 
too high for an individual, they will have a wide range of null flicker, leading to variation in 
measurements [50, 52, 63, 75]. There is also the need for rod and short-wavelength cone 
suppression to consider (see ‘assumptions’). Until recently, most investigators have used set 
flicker frequencies that have varied from 11 Hz [e.g. 11, 57, 80, 81, 87, 88] to 30 Hz [e.g. 49, 
68, 89, 90] in the fovea and from 6 Hz [e.g. 11, 46, 57, 80, 81, 87, 88] to 25 Hz [e.g. 17, 47, 
91] in the parafovea. 
 
BACKGROUND FIELDS 
Like test fields, the backgrounds upon which they are presented can also vary in size and 
wavelength between equipment. Sizes have ranged from 4° in diameter [e.g. 43, 82] to 30° 
[53]. The colour of the background is invariably a blue wavelength or white. The purpose of 
these colours is discussed in the ‘assumptions’ section. 
 
RECENT DEVELOPMENTS 
In 2001, Moreland et al. described a novel method of measuring MPOD by HFP. They used 
the blue and green phosphor emissions of a colour computer monitor as stimuli for flicker 
minimization. Although perceptually distinct as blue and green, the broadband emission 
spectra of the phosphors resulted in a 50% underestimation of MPOD. This was correctable 
with a model that incorporated these emission spectra and therefore allowed a way of 
calibrating the monitor. Bone and Landrum [49] questioned whether the retinal illuminance 
provided by the instrument was high enough to avoid rod intrusion. Apart from further use by 
Robson et al. [92] and Robson and Parry [41] this method of MPOD determination does not 
appear to have been widely used. 
 
Snodderly et al. [50] paved the way for a new customized approach to HFP when they 
established a standardized protocol for measuring MPOD. The device used was a modified 
version of the one described by Wooten and colleagues in 1999, and included the addition of 
optimizing the flicker frequency for each individual. This was achieved by working out each 
subject’s critical flicker frequency at the fovea and parafovea, then using an algorithm to 
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determine the appropriate flicker rate to use when measuring MPOD. This procedure has 
since been adopted in other MPOD research [e.g. 51, 52, 64, 71, 72, 75, 76, 78, 79, 86, 93]. 
  
A new HFP technique called the macular assessment profile (MAP) test has been described 
by Rodriguez-Carmona et al. [94] and Kvansakul et al. [95]. The principle appears similar to 
the method detailed by Moreland et al. [38] and described above, in so far as the broadband 
phosphors of a visual display are employed and again require a correction model for this. 
The authors state that the test is a ‘rapid and convenient’ way of measuring a subject’s 
macular pigment profile up to 8° from the fovea, taking advantage of the ability of visual 
displays to produce stimuli of different sizes at randomized locations [94]. Although the test 
is said to have been validated, there does not appear to be any formally published data on 
this. 
 
A further development for customized HFP was briefly described by Engles et al. [93] and 
elaborated upon by Nolan et al. [75] and Stringham et al. [52]. This involves the inverse-
yoking of the radiances of the blue and green stimuli so that the overall luminance of the test 
field remains constant, i.e. when the radiance of the blue stimulus is increased, the radiance 
of the green stimulus is proportionately decreased. As a result, potential distractions by 
changes in perceived brightness for the subject are avoided. 
 
An entirely different approach to measurement of MPOD by HFP has been adopted in a new 
commercially available device which is described in detail by van der Veen et al. [53]. 
Instead of the subject responding to minimal or no flicker, they respond to the appearance of 
flicker as the alternation rate is decreased at 6 Hz per sec from a starting level of 60 Hz. This 
is above the critical flicker fusion frequency for the test conditions and therefore subjects do 
not perceive any flicker initially. Rather than the radiance of one wavelength being adjusted 
by the observer, a sequence of blue-green ratios is used. These are inverse-yoked to ensure 
that overall luminance stays the same. With similarities to Snodderly et al. [50], the 
instrument determines each observer’s sensitivity to flicker prior to the main part of the test. 
The technique also offers the possibility of estimating MPOD from a central measure alone, 
the peripheral measure being estimated from the age of the subject and their expected level 
of lens yellowing. A comparison between central and peripheral derived MPOD and 
estimated (central only) MPOD in 5616 eyes revealed a very close correlation (r = 0.92, no 
p-value provided) [96]. 
 
Most recently, a further development on customized HFP and inverse yoking has been 
described by Connolly et al. [78] and Nolan et al. [97]. Whilst sticking with the traditional 
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method of HFP MPOD determination, i.e. the radiance of blue light being 
increased/decreased until the point of minimal flicker, it takes on a more automated 
approach, as per the device of van der Veen et al. [53]. The instrument’s electronics 
increase/decrease the amount of blue in the stimulus at a set rate. This removes any inter-
individual variability in the speed at which the blue-green ratio is adjusted, therefore 
improving the accuracy of the MPOD value. 
 
Assumptions 
 
The HFP measurement of MPOD relies on several assumptions. Many of these assumptions 
are largely accepted because of the close relationship between HFP-derived macular 
pigment spectral absorption curves and spectral curves derived in vitro. Nevertheless, some 
of the main assumptions are described: 
 
1. Absorption or scattering properties of the ocular media being accounted for through use of 
a parafoveal locus [47, 49, 56, 98]. Essentially, this means that the amount of yellowing in 
the media (e.g. the crystalline lens) would influence the measured MPOD value but the 
reference measure outside of the fovea cancels this effect [96]. This is demonstrated by 
Formula 2, below. Evidence that this assumption is correct comes from real and simulated 
data. For instance, Ciulla et al. [81] measured MPOD in 24 patients before and after cataract 
surgery. No significant difference in MPOD pre or post surgery was found, indicating that 
varying degrees of crystalline lens absorption does not affect macular pigment measurement 
when the HFP method is used. Wooten et al. [46] simulated clear and dense lenses by 
incrementally altering the background field radiance of their free view device. No significant 
differences in MPOD were found. Most recently, Makridaki et al. [96] demonstrated on a new 
HFP instrument [53] that lens yellowing, whether simulated or real, had no effect on the 
measured MPOD. 
 
B fov x Tlens x TMP = B ref x Tlens  (i) 
 
TMP = B ref / B fov    (ii) 
 
MPOD = log 1/TMP = log (B fov / B ref) (iii) 
 
Formula 2: Macular pigment optical density derivation, from Snodderly and Hammond [65]. 
In addition to the transmission of blue light through the macular pigment (TMP), the 
transmission through the lens (Tlens) is taken into account. B fov and B ref are the radiances 
 
 
10 
 
of blue light needed to minimize flicker at the fovea and reference point, respectively. Since 
Tlens is assumed to be the same at both the fovea and reference, it is removed from equation 
(i). The final equation (iii) is a simplified version of Formula 1. 
 
2. Accurate subject fixation and response. This is partly checked through assessment of 
instrument reliability. Werner et al. [42] also checked fixation accuracy on four of their 
subjects (age range 15 to 71) with an additional test; all subjects were able to accurately 
fixate to within ±1.00° of the foveal and parafoveal stimuli, or better, providing further 
evidence for this particular assumption. 
 
3. Equal spectral sensitivity and distribution of photoreceptors across the retina, such that 
the difference ratio between the foveal and parafoveal locations is dependent solely on the 
macular pigment [12, 42, 65]. This assumption is not correct but is accounted for with the 
design of HFP instrumentation. Rods and short-wavelength sensitive cones (S-cones) are 
absent at the fovea, whilst being abundant in the peripheral retina and parafovea, 
respectively [99, 100]. Conversely, medium-wavelength cones (M-cones) and long-
wavelength cones (L-cones) are present in much higher concentration in the fovea than 
elsewhere [101]. However, unlike rods and S-cones, the ratio of M to L cones has been 
shown to remain fairly constant, at least in the central retina [102-104] and, as a result, 
should not affect the measured MPOD. It is therefore generally accepted that removing the 
rod and S-cone contributions is of greater importance. To do this, investigators have 
designed their HFP apparatus accordingly. The background field is often blue to suppress 
the S-cone population [e.g. 42, 43, 44, 46, 48, 50-52, 62, 105] or bright white to provide 
photopic conditions and hence suppress the rod population [e.g. 45, 49, 53]. The flicker 
frequency is chosen so that it is high enough to further exclude rods and S-cones. This is 
achieved because the flicker rate is above the critical flicker fusion frequency (the alternation 
rate at which a flickering light is no longer resolvable by the visual system and thus appears 
steady to an observer) of rods and S-cones, but is still lower than the critical flicker fusion 
frequency of M- and L-cones [65, 106, 107]. 
 
4. The peripheral reference locus having a negligible level of macular pigment. Some studies 
have questioned this assumption [39, 94, 108-112], particularly when eccentricities as little 
as 4° from the fovea have been used [11, 20, 43, 46, 62, 71, 80, 81, 86-88, 113]. HFP 
spatial distribution plots of macular pigment (see ‘validity and reliability’) have gone some 
way to disproving any concerns, such that for most individuals, the assumption holds. 
 
Validity and reliability 
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The validity and reliability of a technique are two important but quite different issues. 
Reliability, as described by Gallaher et al. [114], refers to the ‘ascertainment of the 
reproducibility of a given measurement on the same subject at two distinct points in time’. 
Although this is a very important aspect of any instrument, it does not automatically imply 
that the instrument is valid. This was well illustrated by Snodderly et al. [50], where it was 
pointed out that one observer had a repeatable negative value of MPOD. The measure was 
therefore reliable but was nevertheless of questionable validity. For in vivo measurement of 
MPOD, validity is demonstrated by showing a matching comparison with the known spectral 
and spatial properties of macular pigment in vitro. Some studies have done this indirectly by 
comparing the measurements from a new device with those of an older, more established 
device [46, 56-59]. 
 
VALIDITY 
As mentioned above, the validity of MPOD measurement by HFP can be assessed in two 
main ways [52, 71]. Either by deriving the spatial profile of macular pigment across the fovea 
[e.g. 42, 44, 50, 52, 53, 67, 70, 71, 75] and comparing that to in vitro knowledge of macular 
pigment distribution [e.g. 5, 7, 24, 115], or by deriving the spectral absorption profile of 
macular pigment [17, 42, 43, 47, 49, 52, 71] and comparing that to the shape of a known in 
vitro absorption curve of macular pigment. The latter method is considered to be more 
robust than the former, since spatial profile can vary between individuals [44, 50, 59, 64, 71, 
75, 78, 116, 117].  
 
Spatial profiles of MPOD are achieved by altering the size and/or the eccentric position of 
the test stimulus, thus producing a curve that can be used to describe the change in MPOD 
with increasing eccentricity from the central fovea. An example is shown in Figure 3. 
 
INSERT FIGURE 3 ABOUT HERE 
 
Spectral absorption profiles of MPOD are obtained by systematically altering the wavelength 
of the test stimulus. The procedure is the same as that used to determine peak MPOD, 
except that a number of light wavelengths must be alternated with the reference stimulus 
until minimum flicker is accomplished, instead of the blue light alone. The extra 
measurements increase the duration of the test but permit a curve of spectral absorption to 
be plotted, see Figure 4. The in vivo HFP-generated curve is simultaneously compared with 
the shape of an in vitro spectral curve of lutein and zeaxanthin. The choice of which in vitro 
curve to use is not an easy one, since the ideal comparison of in situ spectral data from 
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human retinas does not currently exist [54]. Consequently, different researchers have used 
different data. These include: Wyszecki and Stiles’ composite data curve1 [118], used by 
Werner et al. [42], Hammond and Fuld [43], Beatty et al. [47], and Beatty et al. [17]; 
Snodderly and colleagues’ microspectrophotometry-derived data from primate monkeys [6], 
used by Hammond and Fuld [43]; and spectral measures of lutein and zeaxanthin dissolved 
in olive oil [24] or incorporated in liposomes [9]. These last two in vitro spectrums have more 
recently been used in combination when assessing validity [52, 54, 71].  
 
The outcomes of these validity tests have shown a good correlation with in vitro MPOD 
distribution and absorption [e.g. 71] and therefore attest to the validity of HFP as a 
measurement method for MPOD. 
 
INSERT FIGURE 4 ABOUT HERE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1The data from Wyszecki and Stiles [118] is actually a weighted composite curve of six 
psychophysical methods that had been used up to that time, rather than in vitro data.
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RELIABILITY 
Numerous researchers, through test-retest checks, have assessed the reliability of HFP 
measurement of macular pigment. The statistical descriptors used to evaluate reliability vary 
between studies. Table 2 is a summary of all available information on HFP test-retest 
reliability indicators. It shows that for most subjects, HFP provides repeatable measures of 
MPOD and is therefore a reliable technique. Interestingly, the two most recent evaluations of 
HFP appear to give the weakest indication of its reliability [119, 120]. These studies were 
independent of each other but used the same HFP device, one of the first that has been 
designed for use in a clinical setting rather than a research setting. The results suggest that 
further developments may be required for this particular HFP instrument in order to verify its 
suitability to accurately assess MPOD. 
 
INSERT TABLE 2 ABOUT HERE 
 
The edge hypothesis of heterochromatic flicker photometry 
 
As mentioned previously, most instruments use a stimulus size of 1° to measure MPOD. 
One might reasonably assume that this measures the total amount of macular pigment 
across the whole 1° area or the peak level of macular pigment. However, many investigators 
disagree with both these assumptions and instead believe that the level of calculated MPOD 
is mediated by the edge of the stimulus [e.g. 11, 42, 44, 48, 50, 52, 121], so that for a 1° 
stimulus, the recorded MPOD corresponds to the macular pigment level at 0.5° from the 
centre of the fovea. Werner et al. [42] were the first to suggest this theory and it gained 
momentum when Hammond et al. [44] found a very high correlation (r = 0.91, p < 0.00001) 
between MPOD measured with a 1° test stimulus and a point test stimulus of 12′ placed at 
0.5° (see Figure 5). Their data also indicated that MPOD at 0.5° (as measured with a 1° 
stimulus) is an estimated 69% of the true peak MPOD. For example, an MPOD value of 0.4 
measured with a 1° test would indicate a peak macular pigment density of 0.58. The ‘edge 
hypothesis’ has been questioned, however, most notably by Bone et al. [68]. In contrast to 
Hammond et al. [44], they found that the measured MPOD corresponds to the level of 
macular pigment at approximately 50% of the stimulus radius (Figure 6). Further evaluation 
indicated that this equated closely to the average amount of macular pigment over the whole 
stimulus area [68]. Nevertheless, in spite of this conflicting evidence, most researchers have 
continued to assume the edge hypothesis in their HFP work [e.g. 60, 63, 64, 73-75, 78, 122] 
and this would appear to be a reasonable decision, with further evidence for it coming most 
recently from van der Veen et al.[121]. 
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INSERT FIGURES 5 AND 6 ABOUT HERE 
 
Advantages and disadvantages of HFP 
 
Advantages include: 1) no pupil dilation required 2) inexpensive equipment relative to 
objective techniques 3) independence from absorption and scattering properties of the 
ocular media 4) good test-retest reliability on many subject populations 5) proven validity. 
Disadvantages include: 1) some subjects finding HFP difficult to carry out, especially the 
peripheral task, which is subject to Troxler’s effect – a perceptual fading of peripheral stimuli 
[123]; Troxler’s effect also becomes more distracting the more eccentric the peripheral target 
is, making the use of eccentricities certain to have no macular pigment difficult to record 
accurately 2) a long testing time if complete spectral and/or spatial distribution is required 3) 
unsuitability for some individuals, such as young children, people with learning difficulties or 
people with insufficient visual acuity or visual fields. 
 
Motion photometry 
 
The minimum motion paradigm was initially described by Stumpf [124], although this went 
largely unnoticed until its translation into English by Todorović in 1996 [40, 125]. With 
parallels to HFP, it refers to the perceived reduction in motion of a moving square or sine 
wave grating as equiluminance of the colours involved is reached. The concept was taken 
up for use in photometry by both Moreland [126, 127] and Anstis and Cavanagh [128], but in 
subtly different ways. This then led to the use of minimum motion photometry for in vivo 
measurement of macular pigment [e.g. 33, 37]. 
 
Procedure 
 
Many of the principles described for HFP also apply for motion photometry measurement of 
MPOD, i.e. a wavelength of light at the peak of macular pigment absorption is compared 
with a wavelength of light not absorbed by macular pigment, at central and parafoveal 
locations. Moving square wave gratings are used, with the bars being alternately illuminated 
by the two light wavelengths. The radiance of the longer wavelength stimulus is adjusted 
until the motion appears to slow down or change direction, depending on the method being 
employed [126-128]. The slowing down of the grating is minimum motion photometry, 
whereas the reversal of grating movement is known as apparent motion photometry [40]. As 
with HFP, different radiances of the test wavelength will be required for equiluminance at the 
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foveal and parafoveal positions, on account of the higher levels of macular pigment at the 
fovea. A log ratio of these radiances provides a measure of MPOD [37-41, 92, 129]. 
  
Instrumentation 
 
The motion photometry technique for measurement of MPOD has not been as widely used 
as HFP. Apart from the fundamental differences between classic minimum motion 
photometry and apparent motion photometry (explained below), there is little variation in the 
instrumentation that has been adopted. 
 
MINIMUM MOTION PHOTOMETRY 
Minimum motion photometry for MPOD, as described and used by Moreland, Robson and 
colleagues [e.g. 37, 38-41, 92, 129], employs a Moreland anomaloscope (traditionally used 
for colour vision assessment) that is adapted to produce a moving square wave grating with 
a spatial frequency of 0.38 cycles per degree. A rotating spiral mirror generates the grating 
which, when viewed through a circular or annular stop, appears to move horizontally across 
the visual field. The bars of the grating are alternately illuminated with two narrow-band 
interference filters from a single tungsten-halogen lamp. The interference filters typically 
provide wavelengths of 460 nm (blue – maximal absorption by macular pigment) and 580 
nm (yellow – negligible absorption by macular pigment). Luminance matched filters of 450 
nm are added to the grating bars to create a background pedestal that saturates S-cones 
(see ‘assumptions’). The grating moves at a constant velocity of 14 Hz; this also rules out 
any rod or S-cone contribution. 
 
Unlike HFP, it is the norm with motion photometry for the spatial profile of macular pigment 
to be plotted, rather than peak MPOD alone. Consequently, the test fields comprise up to 
two central, circular stops of 0.8-0.9 (visual angle) and 2.2, and 11 annular stops placed 
eccentrically from 0.8-7.5 in the superior visual field. The setup is illustrated in Figure 7. 
The minimum motion technique described here uses a Maxwellian view system but does not 
require a bite bar; rather, an adjustable chin rest (vertically and horizontally) is used for pupil 
centration [40]. 
 
INSERT FIGURE 7 ABOUT HERE 
  
APPARENT MOTION PHOTOMETRY 
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Apparent motion photometry, based on the phenomenon detailed by Anstis and Cavanagh 
[128], has been developed into a commercially available device for MPOD assessment by 
West and Mellerio [130]. However, there do not appear to be any peer-reviewed studies on 
the instrument. The instrumentation details given below are therefore based on information 
from the Cambridge Research Systems’ (CRS) website 
(http://www.crsltd.com/catalog/metropsis/MP.html).  
 
Instead of a Moreland anomaloscope, a cathode ray tube (CRT) monitor is used. Four 
square wave gratings on a blue background are presented sequentially, 90 degrees out of 
phase with each other. The first and third gratings are made up of blue and red bars, 
produced by the blue and red phosphors of the CRT; blue for maximal macular pigment and 
red for negligible macular pigment absorption. The second and fourth gratings are 
achromatic, being composed of light and dark grey bars, i.e. luminance gratings. The 
apparent motion paradigm dictates that when the luminance of the red bars is greater than 
the blue, the red bars appear to jump rightwards to the light grey bars in the luminance 
grating, and when the luminance of the blue bars is greater than the red, the blue bars 
appear to jump leftwards to the light grey bars in the luminance grating (Figure 8, left). The 
subject therefore sees movement in one of two directions. The setup of West and Mellerio’s 
device results in these directions being up or down (Figure 8, right). The red luminance is 
adjustable, and at the point of red-blue equiluminance, the direction of motion becomes 
‘ambiguous’. A two-alternative forced choice procedure is used to determine equiluminance 
(and subsequent MPOD) at central and eccentric locations. The system crosses over the 
threshold several times and can provide the standard deviation of each MPOD 
measurement. The grating alternation frequency must be optimized, usually between 8 and 
20 Hz, for each subject for reliable results. 
 
INSERT FIGURE 8 ABOUT HERE 
  
Like minimum motion, the apparent motion photometer for MPOD routinely plots the spatial 
distribution of macular pigment. Two central vertical strips (0.3° x 1.25°) are located at 0° 
and 1°, whilst six 45° annular test fields are located from 2°-7° from fixation. A shorter three-
location test is also available.  
 
With a CRT monitor comes the problem of spectral overlap of the red, green and blue 
phosphors, similar to the problems of the colour monitor for HFP discussed in HFP ‘recent 
developments’ [38, 41, 92]. The apparent motion photometer overcomes this with the use of 
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an optical filter that blocks light between 460 and 640 nm, thus avoiding a significant 
underestimate of MPOD. 
 
Assumptions 
 
The same assumptions apply to minimum motion photometry as for HFP, namely absorption 
or scattering properties of the ocular media being accounted for through use of a parafoveal 
locus; accurate subject fixation and response; equal spectral sensitivity and distribution of L- 
and M-cones across the retina; and the peripheral reference locus having a negligible level 
of macular pigment.  
 
The apparent motion device offers an interesting solution to accurate fixation by using a 
video gaze tracking system that inhibits stimulus presentation whenever fixation is not 
maintained to a sufficient level (within  0.5° of target). This offers an improvement over 
unmonitored free view techniques whilst avoiding the need for a Maxwellian view system. 
With respect to L- and M-cone distribution, Robson et al. [129] used a 460/550 nm 
combination as well as the customary 460/580 nm to see if there was any variation in MPOD 
measurements. The correlation was extremely strong (slope = 1.00, r = 0.99), indicating that 
even if the distribution does vary with eccentricity, the effect is likely to be very small [129]. 
Like HFP, motion photometry also uses a blue background and a suitable temporal 
frequency to ensure rod and S-cone suppression. The assumption of the peripheral 
reference eccentricity having negligible macular pigment should hold for most individuals 
because spatial distribution is always plotted out as far as 7 or 8 degrees with motion 
photometry. 
 
Validity 
 
We could find no evidence of motion photometry being used to derive spectral profiles of 
macular pigment. As a result, it is difficult to know the true validity of the technique, although 
average MPOD values and spatial profiles are in line with HFP, and consistent correlations 
with the autofluorescence method of macular pigment measurement [39, 129] and two HFP 
devices [38, 48] have been found. Nevertheless, questions regarding the validity of motion 
photometry for measurement of macular pigment have been raised [54]. 
 
Reliability 
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The reliability of minimum and apparent motion photometry has not been as vigorously 
assessed as it has been with HFP. The average of five readings is taken at each location 
[37, 39, 41, 92, 129] and repeated measurements have been incorporated in averaged 
results [39]. However, there does not appear to be any published statistical data on test-
retest reliability. 
 
The non-edge hypothesis of motion photometry 
 
It was explained earlier that most researchers using HFP assume an edge hypothesis with 
MPOD. In minimum motion photometry, data analysis has led to the support of a non-edge 
hypothesis [34, 39, 40]. To reiterate, this would mean that when a circular, foveal stimulus is 
used, the measured MPOD would not represent the amount of macular pigment at the 
stimulus radius. In the case of motion photometry, researchers believe that the measured 
MPOD actually represents the amount of macular pigment at approximately 70% of the 
stimulus radius [34, 40]. Subsequently, the ‘peak’ MPOD value using the smaller 0.8-0.9° 
central stimulus has been plotted at 0.3° eccentricity from the fovea [e.g. 39, 41, 129]. 
 
Advantages and disadvantages of motion photometry 
 
As a psychophysical technique, motion photometry has much in common with HFP in terms 
of pros and cons. There is no need for pupil dilation, any interference from the ocular media 
is accounted for and it is a relatively straightforward test for subjects to partake in. On the 
down side, Troxler’s effect remains a problem for some individuals, and good 
comprehension of the task is required, so it is not suitable for everyone. No information is 
provided in any motion photometry studies regarding the level of visual acuity of subjects; 
therefore it is unknown whether reliable MPOD measurements are achievable on subjects 
with lower than normal acuity. 
 
Objective techniques 
 
The objective techniques for measuring MPOD are: 
 
Fundus reflectometry 
Fundus autofluorescence 
Resonance Raman spectroscopy 
Electrophysiology using visual evoked potentials 
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Fundus reflectometry 
 
Quantitative measurement of light reflected from the fundus is known as fundus 
reflectometry (FR), and the researchers Brindley and Willmer [131] were the first to adopt 
this technique. Their aim was to estimate MPOD in vivo by comparing light reflected at the 
macula with light reflected from a peripheral area of retina. Since then, FR has gone on to 
become the most widely used of the objective methods for MPOD measurement, although 
many improvements and variations have been developed along the way. 
 
Procedure 
 
When light enters the eye it has many structures to pass through, including the cornea, the 
crystalline lens, the retina and the choroid. Some of these structures (and their components) 
will reflect a small part of the light, whilst others will absorb part of it. Through measurement 
of reflected light from the retina and choroid, FR is able to assess several ocular features, 
including macular pigment [109]. A thorough history of FR is provided by Berendschot, 
DeLint and van Norren [132]; this review will be limited to the use of FR in measuring 
MPOD. 
 
Although there are several variations on the reflectometry procedure, there are two methods 
that predominate. The first is a comparison technique, similar to that used in HFP. Light 
reflected from the fovea is compared with light reflected from an eccentric retinal area, using 
two wavelengths (one absorbed by macular pigment and one not) or using a spectrum of 
wavelengths. Since macular pigment absorbs rather than reflects certain wavelengths there 
will be a difference in the observed reflectances at the fovea and periphery, owing to the 
assumed lack of macular pigment at the eccentric site. Researchers who have used this 
method include Brindley and Willmer [131], van Norren and Tiemeijer [133], Delori and 
Pflibsen [134], Elsner et al. [135], Berendschot et al. [136], Delori et al. [56], Bour et al. [137], 
Wüstemeyer et al. [98], and Cardinault et al. [138]. 
 
The second core technique is known as a spectral analysis [109]. As the name suggests, 
this involves the analysis of a spectrum of reflected light from a spot of light on the retina. To 
achieve this, a detailed optical model of the pathways of light in the eye is required. A 
number of optical models of increasing complexity have been proposed over the years, from 
van Norren and Tiemeijer [133] through to van de Kraats and van Norren [139]. Probably the 
most familiar optical model is that derived by van de Kraats, Berendschot and van Norren 
[140], which has been used to work out MPOD in several studies [e.g. 58, 136, 141-144]. In 
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essence, the density of macular pigment is determined using its known spectral 
characteristics and by taking into account the amount of light reflected at the internal limiting 
membrane, the photoreceptor discs and the sclera [58, 136, 140, 141, 143]. The densities of 
the lens, melanin and blood are likewise calculated. 
 
Even with these two quite separate forms of FR, there is often an overlap between the two, 
as demonstrated in the following section. 
 
Instrumentation 
 
Many instruments have been used for FR and it is beyond the scope of this review to explain 
them all. Consequently, only the more recent fundus reflectometers will be described in any 
detail. However, common to most methods of FR is the need for pupil dilation, a bleaching of 
the visual pigments prior to measurement, and some form of head stabilization, either with a 
bite bar or with a chin rest and temple pads.  
 
Equipment for reflectometry can be broadly categorised into modified fundus cameras, 
purpose-built reflectometers and modified scanning laser ophthalmoscopes. 
 
FUNDUS CAMERAS 
Many investigators have used modified fundus cameras to measure MPOD, including van 
Norren and Tiemeijer [133], Delori and Pflibsen [134], Chen, Chang and Wu [108], Bour et 
al. [137], Chang et al. [145], Neuringer et al. [3], and Bone, Brener and Gibert [59]. Of these, 
some have used the comparison technique, some spectral analysis and others a mixture of 
the two. Chen et al. [108], for example, used an optical model as per the spectral analysis 
technique but only two wavelengths (460 nm and 560 nm) rather than a full spectrum of 
wavelengths. In brief, their setup, like several others, consisted of a fundus camera 
connected to a cooled CCD (charge-coupled device). The filter normally used to take red-
free photographs was replaced with narrow band interference filters of 460 and 560 nm, i.e. 
maximal and minimal macular pigment absorption. Following pupil dilation, the subjects were 
instructed to fixate a dim red dot with the eye not being tested whilst the measured eye was 
slowly light adapted in order to bleach nearly all the photoreceptor pigments [56, 108, 146]. 
Two fundus pictures, one taken at each of the two wavelengths, were manually aligned 
using retinal landmarks. Using a chosen optical model, MPOD at each pixel point in the 
retina was calculated. In this way, Chen et al. were also able to plot the spatial distribution of 
macular pigment across the central retina. 
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Recently, Bone et al. [59] described a modified fundus camera that does not require pupil 
dilation or bleaching of the photoreceptor pigments. 
 
PURPOSE-BUILT REFLECTOMETERS 
The most recent ‘purpose-built reflectometers’ are the Foveal Reflection Analyzer (FRA), 
originally developed by Zagers et al. [146] and the Macular Pigment Reflectometer (MPR), 
originally developed by van de Kraats et al. [117]. 
  
The diagrammatic setup of the FRA is shown in Figure 9. After dilation, subjects fixate a 
central cross hair (Figure 9b). In the original instrument (FRA 1), light from a halogen lamp is 
directed into the eye as a Maxwellian view system with an entrance pupil of 0.8 x 1.2 mm. 
This illuminates a 2.8° spot on the central fovea, of which the middle 1.9° is used for 
analysis. A video observation channel of the pupil and retina helps alignment as well as 
allowing monitoring of subject fixation. An imaging spectrograph collects the reflected light 
from the 1.9° area and focuses it onto a cooled CCD camera. The spectrograph has a slit 
that creates a 0.8 x 12 mm exit pupil above the smaller entrance pupil, and its spectral range 
is 420 to 790 nm, thus allowing a spectral analysis of the reflected light using one of the 
optical models referred to earlier. The FRA 1 has been used to investigate MPOD in studies 
by Zagers and van Norren [147] and Berendschot and van Norren [141]. Berendschot and 
van Norren [141] also used a newer version of the device, the FRA 2, which has a number of 
differences from the first version, including being smaller, which makes it desktop 
mountable. Kanis et al. [143, 148] and van de Kraats and van Norren [139] have also used 
the FRA 2 in their studies. 
 
INSERT FIGURE 9 ABOUT HERE 
 
The diagrammatic setup of the MPR is shown in Figure 10. Like the FRA, the MPR, as 
described by van de Kraats et al. [58], involves a 30W halogen lamp directed into the pupil, 
a separated exit pupil and a spectrometer, i.e. spectrograph. The spectrometer has a 
spectral range of 400 to 800 nm. The subject is asked to fixate the centre of a 1° incoming 
light beam. This incoming illumination forms a 1° spot on the central fovea; the reflected light 
is also collected over the same 1° area and analyzed using an optical model. The MPR is 
the first reflectometry device that has a proven ability to measure MPOD through an 
undilated pupil, provided the pupil is 3 mm or larger; van de Kraats et al. [58] found no 
significant difference between their MPOD measurements for dilated and undilated pupils in 
20 subjects. A further development of the MPR, recently reported by van de Kraats et al. 
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[139], is the means to measure the individual optical densities of lutein and zeaxanthin, the 
components of macular pigment. 
 
INSERT FIGURE 10 ABOUT HERE 
 
SCANNING LASER OPHTHALMOSCOPES 
Elsner et al. [149] were the first to use a scanning laser ophthalmoscope (SLO) for the 
purpose of measuring MPOD. Since then it has become a popular FR method for measuring 
macular pigment [e.g. 25, 98, 116, 136, 141, 150]. Some SLOs have been custom-built for 
MPOD measurement and as such are not accessible to most clinicians [135, 136]. However, 
Wüstemeyer et al. [98] modified a commercially available SLO, allowing reflectance images 
to be recorded with an argon laser at wavelengths 488 nm and 514 nm, with a fast switch 
between the two. They used the comparison technique, with an eccentric reference point of 
14° from the fovea. MPOD in a 2° central fovea test field was calculated as follows (Formula 
3): 
 
MPOD = Cλ * [ log (Ref514,foveal / Ref488,foveal) – log (Ref514,parafoveal / Ref488,parafoveal) ] 
 
Formula 3. Calculation of macular pigment optical density, from Wüstemeyer et al. [98]. Cλ = 
constant, dependent on the absorption coefficients of macular pigment. Ref514 and Ref488 = 
reflectances measured at 514 and 488 nm. 
 
Using a foveal and parafoveal comparison is not common to all SLOs when measuring 
MPOD. Berendschot and van Norren [116, 141], for instance, used the same two 
wavelengths as Wüstemeyer et al. [98] but did not use any specific eccentric reference point 
and therefore produced density maps of the sum of both the lens and macular pigment. 
 
One of the main advantages of using a SLO over other FR techniques is its confocal optics, 
which help minimize stray light scatter, the biggest hindrance in FR. This will be elaborated 
on in the ‘assumptions’ section. 
 
TEST FIELD VARIATIONS 
The size of the detection field chosen to measure peak MPOD varies not only between the 
three categories of reflectometer but also within the categories, from 0.5° [116, 141] to 2° 
[25, 56, 98, 138] and 2.5° [133]. Likewise, when two wavelengths corresponding to high and 
low macular pigment absorption are used, as is often the case for modified fundus cameras, 
the chosen wavelengths differ slightly between equipment, as they do in HFP devices. In 
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SLOs, the two wavelengths are always 488 and 514 nm because these are the two most 
appropriate argon laser lines. The deviation of these laser lines from the true maximum and 
minimum of macular pigment absorption (460 and >530 nm, respectively [54]) requires that a 
correction is made to account for this in the final MPOD estimation [116, 136, 141, 151], 
although it is not clear whether all research groups actually do this. For the comparison 
technique when a peripheral reference point is used, the chosen eccentricity has ranged 
from as little as 4° from the central fovea [137] up to 14° [98, 136]. 
 
Assumptions 
 
The assumptions for FR are not as openly explained in the literature as for HFP. 
Nonetheless, several of the more commonly noted assumptions are highlighted below: 
 
1. Homogeneity of fundus tissues. The spectral characteristics, absorption, reflection and 
scattering properties of the various retinal tissues (e.g. melanin) are assumed to be 
homogenous across the areas being assessed. Gellermann and Bernstein [111], among 
others, point out that this is a simplification. However, most researchers [e.g. 58] do not 
consider this to be a problem, and with good reason it would seem. For instance, the effect 
of irregular RPE melanin distribution on measured MPOD was investigated by Delori et al. 
[56]. They concluded that it had no strong effect on MPOD as measured with their 
reflectometry technique. 
 
2. Bleaching of photoreceptor pigments. It has been established that 93-99% of cone 
photopigment and 59-85% of rod photopigment is bleached as a result of the level of 
illumination used prior to measurement, depending on the particular reflectometry method 
used [56, 58, 108, 137]. Bleaching is important to avoid light absorption by the pigments and 
their subsequent interference with MPOD. It is assumed that any remaining unbleached 
photopigment, particularly rhodopsin (the pigment in rods), has a minimal effect. This has 
been investigated by Chen et al. [108], Delori et al. [56] and Bour et al. [137] and proven to 
be the case. 
 
3. Light scatter accounted for. If reflectance from pre-retinal and intra-retinal structures are 
not controlled for, the measured MPOD can be artificially low [56, 109, 141]. This is because 
the reflectance method works on the principle that all the incident light is reflected after 
passing through the macular pigment. If some light is reflected before it reaches the macular 
pigment, e.g. by the crystalline lens, then this will be collected as reflected light but it won’t 
actually have been affected by macular pigment absorption, thus leading to an erroneously 
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low MPOD [25]. Most reflectometry devices do aim to eliminate this problem, although it 
would appear that some are more successful than others, judging by the lower than 
‘average’ MPOD estimates found in some studies [e.g. 25, 56, 98, 137]. Methods used to 
allow this assumption to hold as far as possible include separating the entrance and exit 
pupils, using confocal optics as found in SLOs, and the incorporation of stray light into 
optical models. In addition, for the comparison technique of FR, the use of a peripheral 
reference should account for crystalline lens scatter [56].  
 
4. Negligible macular pigment at a peripheral reference site. If the comparison method is 
used, the same rules apply as per HFP; provided the peripheral locus is eccentric enough to 
exclude any macular pigment contribution, the assumption will hold. Choosing a point far 
enough away from the fovea is easier with FR, since there is little participation required by 
the subject. Delori et al. [56] commented that the use of a peripheral reference in FR is 
enough to reduce the influence of the ocular media on the MPOD measurement. Hammond 
et al. [54], however, argue that regardless of this, as an objective technique FR will suffer 
from a loss of signal as a result of increased lens scatter and density in some subjects. 
 
5. MPOD measured over the entire stimulus area. Whereas with the psychophysical 
methods there is some disagreement regarding which part of the macular pigment 
distribution is actually being measured with the test stimulus, with FR there is a general 
consensus that the MPOD is the mean amount over the chosen detection field [56, 98, 136, 
141]. However, this assumption has not been verified [54].  
 
Validity 
 
Like HFP, the validity of FR for measurement of MPOD can be assessed by plotting spectral 
and spatial profiles of macular pigment and comparing these with in vitro data. Van de 
Kraats et al. [58] argue that any technique demonstrating an increase in MPOD following 
increased lutein intake is also an indication of its validity. Several reflectometry studies have 
shown such an increase [3, 136, 152]. 
 
Spectral profiles of macular pigment have not been generated to the extent that they have in 
HFP studies. In fact, there appears to be only one study that has comprehensively 
investigated this aspect of validity. Delori et al. [56], used the comparison technique and 
measured reflectance at wavelengths of 430, 450, 470, 490, 520 and 550 nm. Their results 
from 147 subjects accurately matched the spectral curve of macular pigment in vitro, albeit 
with some small systematic deviations such as lower values at 430 nm (see Figure 12). The 
 
 
25 
 
investigators point out, however, that the deviations altered depending on which in vitro 
curve they chose for comparison, highlighting the point that the true macular pigment 
absorption spectrum is not known with enough certainty to assume that the reflectometry 
deviations are an inaccuracy. It is also interesting to note that lower values at the short 
wavelength end of the spectrum are also a common finding in HFP spectral profiles (see 
Figure 4), perhaps lending further support to there being a genuine difference between the in 
vivo and in vitro macular pigment spectral profile. 
 
The plotting of ‘macular pigment maps’ to assess macular pigment spatial profiles has 
become reasonably commonplace in FR studies [e.g. 59, 108, 116, 135, 136, 137]. For 
SLOs, this generally involves a digital subtraction of the images obtained at two wavelengths 
(maximal and minimal macular pigment absorption). Chen et al. [108], used a modified 
fundus camera (the method is described above) and obtained spatial distributions for 54 
subjects of various ages. These distributions, divided into three age groups, are shown in 
Figure 11. The decline in macular pigment from the fovea is rapid and symmetrical, very 
similar to the decline in macular pigment expected from in vitro knowledge and also from 
HFP-derived plots of MPOD (see Figure 3). 
 
INSERT FIGURE 11 ABOUT HERE 
 
Chen et al. [108] looked at the half width of macular pigment distribution (HWMPD) for each 
of the age groups, and found a significant increase (i.e. widening) with age. With further 
analyses they also noted that ‘shoulders’ of varying type were present in the MPOD profile of 
all subjects. Small irregularities in the otherwise undisturbed decline of macular pigment with 
eccentricity have been reported in other studies [5, 44, 59, 64, 71, 75, 115-117, 153, 154], 
both in vivo and in vitro, and are the subject of much ongoing discussion [e.g. 155]. 
 
Recently, the MPR [58] has been used to investigate MPOD distribution, or more 
specifically, to plot the individual distributions of lutein and zeaxanthin [152]. Rather than 
macular pigment maps, reflection spectra were taken at a variety of eccentricities up to 8° 
from the fovea, in a similar manner to HFP. 
 
An indirect way of demonstrating validity is to compare results with those of a technique with 
established validity, i.e. HFP. This has been done in several FR studies with fairly good 
results [56, 58, 59, 141]. 
 
Reliability 
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With so many different instruments being used to measure MPOD by FR, there ought to be 
an abundance of reliability data available. However, few studies have assessed the inter-
session reliability of their devices, although more have assessed within-session reliability. 
This is perhaps because, unlike HFP, the actual measurement time in FR is short and does 
not demand too much effort from the subject; hence it’s more convenient to take repeat 
measurements within the same session. That said, Zagers et al. [146] believed the variability 
in their intra-session MPOD results was the result of fixation errors, with the less 
experienced subjects showing greater variability. Nonetheless, as Snodderly and colleagues 
point out, inter-session reliability is really more valuable than intra-session reliability [50]. 
Since results generally show higher variability between sessions, this is a more robust test 
for an instrument. Table 3 outlines the reliability indicators provided in FR studies regarding 
instrument reliability. It shows that for the studies with published data on reliability, the 
results are good and comparable with HFP. 
 
INSERT TABLE 3 ABOUT HERE 
 
Advantages and disadvantages of FR 
 
Advantages include: 1) as an objective method it requires minimal effort from the subject 2) 
quick measurement time 3) density maps of macular pigment distribution can be plotted 
quickly 4) reliability appears to be good in several instruments 5) suitability for many subject 
populations including children. Disadvantages include: 1) pupil dilation normally required 2) 
the need for precise alignment before measurements 3) unpleasant light levels because of 
the requirement for photopigment bleaching 4) the need to control for light scatter, which can 
include considerable modeling 5) costly and complicated instruments, although attempts are 
being made to produce less expensive reflectometers using commonly available equipment 
[59, 98, 137].  
 
Fundus autofluorescence 
 
One of the newer ways for measuring MPOD in vivo relies on the intrinsic fluorescence, or 
autofluorescence (AF), of lipofuscin in the retinal pigment epithelium (RPE). Lipofuscin in the 
RPE is a waste product of photoreceptor outer segment phagocytosis and it accumulates 
with age [156-158]. When excited with light wavelengths of 400 to 590 nm, lipofuscin 
fluoresces, emitting light in the wavelength range 520 – 800 nm [159]. 
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Delori [156] was the first to develop a technique for fundus AF with the primary aim of 
measuring lipofuscin. Further studies by Delori et al. [157] and von Rückmann et al. [158] 
provided evidence for lipofuscin being the main fluorophore in AF. It was their observations 
of a decrease in AF at the macula that lead to the use of AF as a means for measuring 
MPOD. For an in-depth look at fundus AF and its application, see Schmitz-Valckenberg et 
al. [160]. The current review will concentrate on the use of AF in macular pigment 
measurement. 
 
Procedure 
 
To recall, the absorption spectrum of macular pigment is in the range 400 – 540 nm [6] and 
the absorption spectrum of lipofuscin is in the range 400 – 590 nm [159]. Since macular 
pigment is located anterior to lipofuscin, incoming light directed at the fovea will be absorbed 
by the macular pigment before it reaches the lipofuscin, provided the wavelength of the light 
is within the absorption range of macular pigment. As a result, there will be an attenuation of 
lipofuscin fluorescence at the macula; the more macular pigment present, the higher the 
level of attenuation. By comparing the emitted AF at the fovea and parafovea of two 
excitation wavelengths, one that is well absorbed by macular pigment and one that is not, 
MPOD can be calculated [56].  
 
Two AF procedures exist for measurement of macular pigment. The first is a comparison 
method as used in HFP and some forms of FR. The emitted fluorescence is collected from a 
foveal and parafoveal sampling area, and then compared to give a measure of MPOD [e.g. 
56]. The second and more common procedure is an imaging method whereby up to 32 
images [39, 129] are taken in succession with one or two wavelengths. The images are 
aligned (manually or using dedicated software) and averaged, then a greyscale index of 
intensity is used to generate density maps of macular pigment, which includes a measure of 
peak MPOD. Key studies using the AF imaging technique include those of Wüstemeyer et 
al. [25], Berendschot and van Norren [141], Delori et al. [117], Liew et al. [161], Trieschmann 
et al. [162] and Wolf-Schnurrbusch et al. [154]. 
 
Instrumentation 
 
By far the most commonly used instrument for AF acquisition of MPOD is the confocal SLO, 
purpose-built [e.g. 116, 141] or a modified version of a commercially available SLO [e.g. 25, 
161, 163]. All SLOs use the imaging method of fundus AF. The subject fixes a target whilst 
multiple AF fundus images, usually taken over a 20° field, are obtained at wavelengths of 
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488 nm and 514 nm. A barrier filter above or close to the threshold of MP absorption (e.g. 
530 nm) is used to ensure that the emitted AF is only collected outside the absorption range 
of macular pigment, thereby avoiding any further absorption and allowing a single-pass 
measurement rather than a double-pass as used in reflectometry. All the AF images are 
aligned and averaged for each wavelength. A computer program (see Trieschmann et al. 
[162] for details) digitally subtracts the averaged images at the two wavelengths and uses a 
greyscale index of intensity to create a map of MPOD. A foveal MPOD value is calculated at 
a point eccentricity [117, 161, 164] or within a certain area centred on the fovea [25, 154, 
161, 163]. As in FR, a correction should be made when using SLOs, to account for the argon 
laser lines not coinciding exactly with the maximum and minimum wavelengths of macular 
pigment absorption [26, 39, 141, 151, 153, 164]. 
 
Other equipment that has been used to assess MPOD using AF includes the fundus 
fluorometer/spectrophotometer (first described by Delori [156] and used specifically for 
macular pigment measurement by Delori et al. [56]) and a modified fundus camera [117, 
159]. The fundus fluorometer employs the comparison method. A number of different 
wavelengths are directed at a 3° retinal area and the fluorescence is collected from a 2° 
sampling field concentric within the 3° area [56]. The subject is asked to fixate centrally or at 
7° in order to obtain emission data from the fovea and parafovea. MPOD is then calculated 
using the foveal and parafoveal AF information at excitation wavelengths of 470 nm and 550 
nm. In contrast, the modified fundus camera employs the imaging method. The camera is 
coupled to a cooled CCD camera and takes pictures of a 15° retinal field using wavelengths 
of 470 and 545 nm. At this point the technique becomes very similar to that of SLO AF 
imaging, i.e. image alignment and analysis by a computer program, thus providing macular 
pigment density maps, including a measure of peak MPOD [117, 159]. 
 
Common to all forms of AF instrumentation is the need for bleaching of the visual pigments 
prior to measurement (see ‘assumptions’) and pupil dilation, although a non-mydriatic 
version has been described [153]. 
 
One-wavelength versus two-wavelength AF 
 
The vast majority of AF-based macular pigment studies have used two wavelengths 
(corresponding to high and low macular pigment absorption) to derive MPOD. There have 
been a handful of studies, however, that have used only the high absorption wavelength [19, 
39, 129]. It is then presumed that any reduction in AF across the imaged area is due entirely 
to the presence of macular pigment [19]. Whilst some good correlations between MPOD 
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measured with one-wavelength AF and minimum motion photometry have been found [39, 
129], certain criticisms have been leveled at the one-wavelength method. Principally, the 
problem lies with the assumption that the fluorophores, i.e. lipofuscin, are distributed evenly 
across the imaging field. This is not the case [165] and, as a result, any attenuation in AF 
could be due to the presence of macular pigment but may also be a consequence of a lower 
level of lipofuscin in that area [19, 159, 162]. The use of a second, longer wavelength that is 
minimally absorbed by macular pigment eliminates this issue. Trieschmann et al. [162] 
compared the one and two-wavelength methods on 120 subjects. They concluded that one-
wavelength AF is acceptable as a screening method, particularly in view of its widespread 
availability in SLOs, whilst two-wavelength AF should always be used for precise MPOD 
assessment. The same conclusion was reached by Sharifzadeh et al. [153] using a CCD 
camera-based AF device. 
 
Assumptions 
 
Macular pigment assessment using AF assumes the following: 
 
1. There are no fluorophores anterior to the macular pigment. Delori et al. [56] did find 
evidence of such a fluorophore and noted that it would cause a small underestimation of 
MPOD. This underestimation is minimized by detecting AF at a longer wavelength – 710 nm 
[56]. 
 
2. Lipofuscin at the fovea has the same excitation spectrum as lipofuscin in the surrounding 
retina. It is unknown whether this is entirely correct but according to Delori and colleagues 
[56], any differences are not big enough to affect the measured macular pigment spectral 
curve, as determined by their technique. The total amount of lipofuscin is known to vary 
across the retina but this is accounted for as long as the two-wavelength method is being 
used. 
 
3. Any foveal-perifoveal differences in absorbers other than the macular pigment – retinal 
blood, photoreceptor pigments and RPE melanin – have a negligible effect on the measured 
MPOD. Delori et al. [56] investigated these assumptions in detail and found that retinal blood 
differences had virtually no effect and photoreceptor bleaching meant there was very little 
error in terms of photopigment differences. They did, however, find that RPE melanin slightly 
overestimated MPOD.  
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4. Negligible macular pigment at any peripheral reference site. This is particularly important 
when the comparison technique is adopted but should be a true assumption because an 
adequate eccentricity is more easily accomplished with objective than subjective MPOD 
techniques. 
 
Validity 
 
The only study to date that has investigated the validity of AF in terms of a spectral 
comparison with in vitro MPOD data is that by Delori et al. [56]. Excitation wavelengths of 
430, 470, 510 and 550 nm were used on 147 healthy-eyed subjects, plus 450, 490 and 530 
nm on two of these subjects. The resultant spectral profiles for seven subjects are shown in 
Figure 12, along with the equivalent spectral profiles using a FR technique. The curves are 
in very good agreement with the chosen in vitro macular pigment curve, attesting to the 
validity of the AF method of MPOD measurement, in healthy eyes at least. 
 
INSERT FIGURE 12 ABOUT HERE 
 
Spatial profiles (or maps) of MPOD are the norm for AF imaging. In terms of validity, Robson 
et al. [39] demonstrated the symmetrical nature of macular pigment distribution (Figure 13), 
in line with findings using HFP and FR. Also like HFP and FR, however, an array of inter-
individual macular pigment distributions have been found. Figure 14, for instance, shows two 
distinct MPOD spatial profiles from a study by Wolf-Schnurrbusch et al. [154]. The top image 
is the classic distribution of a central peak in macular pigment with a rapid decline as 
distance from the fovea increases. The bottom image has a central peak in macular pigment 
followed by a decline, and there is also a secondary peak (a ‘parafoveal ring’) before further 
decline. In this particular study, the average eccentricity of the parafoveal ring was 0.66° 
from the fovea, which is in line with several other studies [59, 116, 117]. Many researchers 
now propose that the total complement of macular pigment, rather than the peak amount, 
may better represent an individual’s risk for, or protection from, AMD (see review by 
Bernstein et al. [155]).  
 
INSERT FIGURES 13 AND 14 ABOUT HERE 
 
In several studies, AF has been compared with other techniques of MPOD assessment, 
including HFP, using the same set of subjects [39, 56, 60, 129, 141]. All have shown good 
correlations, albeit with some systematic differences. 
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Reliability  
 
As with FR, most tests of reliability concerning AF have been carried out within the same 
session and are perhaps, therefore, not as useful as inter-session reliability data. 
Nevertheless, the results are impressive, indicating similar, if not better, reliability than HFP 
and FR. Table 4 contains a list of AF studies that have provided information on reliability. 
 
INSERT TABLE 4 ABOUT HERE 
 
Advantages and disadvantages of AF 
 
Advantages include: 1) its objectivity; as an objective test, AF requires no subject 
participation other than a short period of reasonable fixation 2) quick measurement time 3) 
spatial plots of macular pigment distribution produced as standard in AF imaging 4) good 
test-retest reliability 5) applicability to many subject populations, including children. 
Disadvantages include: 1) the need for pupil dilation 2) equipment expense 3) a lack of 
commercially-available two-wavelength SLOs 4) the need for photopigment bleaching and 
therefore unpleasant light levels 5) difficulty obtaining clear images from eyes with lens 
opacities. 
 
Resonance Raman spectroscopy 
 
With the exception of electrophysiology methods, resonance Raman spectroscopy (RRS) is 
the most recently developed MPOD technique and, arguably, the most controversial. First 
described by Bernstein et al. in 1998 [166], RRS takes advantage of lutein and zeaxanthin’s 
ability to exhibit a phenomenon called Raman scattering [167]. Over the last ten years the 
use of RRS to measure MPOD has quickly gained momentum, with many papers published 
on its use [57, 111, 168-178]. 
 
Procedure 
 
When monochromatic light is directed at a molecule, some of the light is scattered. Most of 
the light is scattered elastically (Rayleigh scattering) but a small proportion is scattered 
inelastically (Raman scattering). When this inelastic back-scattering happens, there is a 
wavelength shift of the incident light, known as a Raman shift; the shift in wavelength is 
molecule-specific and therefore the back-scattered light can be collected and analyzed to 
identify the molecule in question. Usually the Raman signal is very weak and as such is not 
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easily identified. However, if the incident wavelength overlaps with the absorption spectrum 
of the molecule, a large resonance enhancement of the Raman scattered light occurs and 
the molecule can be recognized. Carotenoids, including lutein and zeaxanthin, are an 
excellent example of this. When excited by 488 nm argon laser light, they exhibit a 
resonance enhancement of up to five orders of magnitude [169], with three characteristic 
Raman spectral peaks [166, 167, 171], as shown in Figure 15. The strongest peak is at 1525 
cm-1 and this is the Raman line that is subsequently quantified in Raman counts (RCs). 
 
RRS is completely different from almost all other MPOD techniques in that it measures 
absolute levels of macular pigment in a 1 mm (3.5°) area, with no peripheral consideration at 
all. The researchers in this field claim that this is acceptable since the signal is derived 
directly from the pigment itself, rather than relying on light that must travel to deeper layers 
of the retina [111, 171] and that furthermore, the signal is only strong enough to register at 
carotenoid concentrations found in the macula, rather than in any other structures such as 
the cornea and lens [166]. 
 
INSERT FIGURE 15 ABOUT HERE 
 
Instrumentation 
 
The setup for RRS detection of MPOD is shown in Figure 16. It consists of a 488 nm argon 
laser that is directed at the fovea. The returning back-scattered light is filtered so that only 
Raman shifted light is sent to the Raman spectrograph (via a fibre optic bundle). The 
spectrograph is linked to a CCD camera, which is in turn linked to a computer that is 
programmed to subtract the background fluorescence and quantify the intensity of the 
Raman peaks, in particular the 1525 cm-1 line. Optical alignment of the instrument to the 
fovea is achieved in human subjects by use of a red LED and a small portion of the blue 
argon laser light. The red LED is visible to the observer as a polka-dot pattern and the laser 
light as a blue disc. By small head movements along a head rest, the subject lines up the 
two images, at which point the operator pushes a button to begin the whole procedure. The 
488 nm light is directed as a 0.5 mW, 1 mm spot onto the macula for 0.5 seconds [170, 171, 
173]. Later studies using RRS have altered the settings slightly by using a 1mW, 1 mm spot 
directed at the macula for 0.25 seconds [57, 174, 175, 179]. Five measurements are taken 
at intervals of 30 – 180 secs (the time is dependent on afterimage fading) and the original 
protocol [171] dictated that the three highest recordings are used in the data analysis, to 
allow for subjects that blink or misalign.  
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Prior to measurement, pupil dilation to at least 6 mm is necessary [170, 171]; some later 
studies have found that dilation to at least 7 mm gives more reliable results [57, 174] – see 
discussion about pupil size in the ‘validity’ section. 
 
INSERT FIGURE 16 ABOUT HERE 
 
RESONANCE RAMAN IMAGING 
One limitation of RRS in its classic form is that it is limited to measuring MPOD in a 1 mm 
(3.5°) area centred on the fovea, rather than being able to produce a spatial profile of 
macular pigment across a larger retinal area. The technique has therefore been extended 
into an imaging mode covering a 3.5 mm area; initially using excised donor eyes [172], then 
more recently, following further modification, using living volunteers [175, 178]. 
 
Assumptions 
 
The assumptions associated with RRS are listed below. They are elaborated upon in the 
following section on validity. 
 
1. Accurate alignment and fixation by the subject, and no significant head movement during 
image capture. 
 
2. No significant effect on the Raman signal by differing levels of crystalline lens yellowing, 
i.e. absorption, within and across age groups. 
 
3. No significant effect on the Raman signal by inter-individual differences in the level of lens 
diffusion (scatter and aberration). 
 
Validity 
 
The validity of RRS has been a subject of fierce debate in the literature [e.g. 54, 180, 181-
186]. It is beyond the scope of this review to repeat the issues of contention verbatim; rather, 
the main points are summarized. 
 
The research group that developed RRS for measurement of MPOD have shown that it is 
very specific and sensitive to measurement of lutein and zeaxanthin [166, 170, 171]. 
However, unlike the other methods of MPOD measurement, RRS cannot generate spectral 
absorption curves of macular pigment to be compared with in vitro curves. Instead, the 
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investigators attest to the validity of RRS in several other ways. Firstly, the strength of the 
Raman signal from donor maculae has been compared with actual macular pigment levels 
as measured by HPLC (Figure 17) [166]. The results revealed a highly linear correlation (r = 
0.94, no p-value provided). Secondly, a model eye containing known amounts of lutein was 
measured with the Raman device (Figure 18) and the results again demonstrated a linear 
correlation (r = 0.99, no p-value provided) [171]. Thirdly, the Raman signals from six intact 
monkey eyes were determined then compared with their HPLC-measured macular pigment 
level (Figure 19) [171]. The correlation between the two was good but not perfect (r = 0.68, 
no p-value provided); the authors attributed this to differences in the detection area between 
the Raman (1 mm) and the HPLC (5 mm) method, and to difficulties with foveal alignment. 
Finally, Bernstein et al. [170] found a perfect linear correlation between Raman signals from 
lutein and zeaxanthin solutions placed in a model eye and their known concentrations 
(Figure 20A), up to about 0.35 density units (equivalent in this case to 1600 RCs). At higher 
concentrations, the Raman response became saturated and therefore non-linear (Figure 
20B), as a result of the 488 nm laser beam being unable to penetrate increasingly dense 
carotenoid concentrations [170]. Ermakov et al. [174] found a similar linear then non-linear 
response for various zeaxanthin concentrations, again using a model eye. 
 
INSERT FIGURES 17-20 ABOUT HERE 
 
Those questioning the validity of RRS as a method of MPOD measurement have made 
several criticisms of the above calibration procedures. The issues of contention include 
whether or not the model eye is a true representation of a real in vivo eye; whether or not the 
increasing underestimation of MPOD at higher concentrations is a problem in ordinary 
subject populations; and the credibility of using the monkey data as evidence of validity, 
given that the level of RCs was in general far higher than most human levels and well above 
the point at which the plateau occurs in the external calibration curve (see Figures 19 and 
20). 
 
Studies of MPOD using RRS have consistently shown a strong decline in macular pigment 
with increasing age (see, for example, Figure 21). Hammond et al. [54] argue that this is 
another area where the validity of RRS is questionable, since with all other MPOD 
techniques, there appears to be little or no age-related macular pigment decline [141]. The 
developers of RRS believe that the decrease is genuine [110, 111, 169-171, 173-175] and 
not just attributable to increasing lens absorption (yellowing) and diffusion (scatter and 
aberration) with age, as suggested by Hammond and Wooten [54, 182-184]. An independent 
study simulating incremental increases in lens yellowing and scatter found that the Raman 
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signal intensity was significantly attenuated as the density of the yellow and scatter filters 
increased [179]. The authors concluded that when using RRS to assess MPOD, the status 
of the lens needs to be taken into account. In other words, the large decline in MPOD with 
age reported in many RRS studies is unlikely to represent a true drop in macular pigment 
levels and therefore the validity of RRS in older subjects, at least, is uncertain. 
 
INSERT FIGURE 21 ABOUT HERE 
 
Another reason for the decrease in MPOD with age – as found by RRS – may be due in part 
to inadequate pupil dilation. Studies have shown that the Raman signal is weakened when 
pupil diameter is smaller than 7 mm [57, 171, 174]. This is because the entrance/exit pupil of 
the Raman instrument is also 7 mm and thus any pupil diameter less than this will result in a 
loss of signal [171, 174]. Neelam et al. [57] found that the significant age-related decline in 
RRS-derived MPOD of their subject population was reduced to a non-significant level when 
subjects with inadequate pupil dilation (< 7 mm) were excluded. It would therefore seem that 
an inability to sufficiently dilate the pupils of some older individuals might contribute to the 
decline in MPOD seen with RRS. Further to this, small head movements in subjects whose 
pupil diameter is at the 7 mm limit could also reduce the Raman signal, regardless of age 
[54, 176, 182-184, 186], although Bernstein and colleagues may contend that their 
procedure of taking the three highest RCs of five measurements allows for such head 
movements. 
 
Widely varying macular pigment spatial profiles have been observed using the RR imaging 
(RRI) device in living human subjects, including asymmetries and local depletions [178]. 
Although such distributions are not normally typical of other MPOD techniques, in comparing 
the integrated macular pigment densities of the entire imaged area with the densities 
measured over the same area with an AF method, the investigators found a very high 
correlation in 17 subjects (r = 0.89, no p-value provided). Furthermore, the integrated 
macular pigment levels of 11 donor maculae measured with the RRI instrument were 
compared with the levels as measured by HPLC. The correlation between the two was very 
strong (r = 0.92, p < 0.0001), although the influence of the ocular media was removed and 
therefore may have lead to an erroneously high agreement. Nevertheless, the validity of RRI 
looks promising. 
 
Indirect methods of assessing validity, mentioned previously, consist of comparisons with 
more established, validated techniques, and the ability to show rises in MPOD with 
increased lutein and/or zeaxanthin intake. The latter has apparently been proven, although 
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the study was only briefly described [110]. RRS-measured MPOD has been compared with 
HFP-measured MPOD in only two, detailed published papers [57, 176]. Neelam et al. [57], 
using Bland-Altman plots, demonstrated an agreement between the two techniques close to 
statistical significance. The correlation, as described by Pearson product-moment correlation 
coefficient, was r = 0.32 (derived by Hammond and Wooten [184]). Although statistically 
significant, this correlation only explains 10% of the variance in the two methods [184]. Hogg 
et al. [176] also found a weak, albeit statistically significant, correlation between RRS and 
HFP (r = 0.26, p = 0.012). They did not feel it was good enough for the two techniques to be 
interchangeable. Bernstein et al. [110] reported a better correlation (r = 0.467, p = 0.0024) in 
40 healthy subjects, but their study was not described in any detail. 
 
Reliability  
 
RRS appears to exhibit good within- and between-session reliability in the majority of studies 
(Table 5). The high variation in readings experienced in subjects from a study by Obana et 
al. [177], particularly in individuals with age-related maculopathy (ARM), is a notable 
exception. This is the only study that has provided any RRS reliability data for subjects with 
ocular disease and is an indication, perhaps, that more data is needed before evaluating 
information on MPOD in these populations. That said, 32 out of the 180 eyes with ARM had 
worse visual acuity than the recommended limit for RRS of 6/24 (20/80). This may have 
contributed to the variation. In view of the variation, Obana and colleagues chose to accept 
only the highest of the five Raman readings in all their subjects [177]. This means that 80% 
of the measurements were rejected, which seems a lot for a technique claiming to be 
validated. Nevertheless, many authorities have shown that MPOD measurements, as 
derived by RRS, do have good test-retest reliability (see Table 5). 
 
INSERT TABLE 5 ABOUT HERE  
 
Advantages and disadvantages of RRS 
 
Advantages include: 1) sensitivity and specificity for retinal carotenoids 2) rapid 
measurements requiring only momentary fixation from the subject 3) the possibility of quickly 
generated, detailed spatial distribution plots of macular pigment, using the RRI method 4) 
reasonable reliability 5) measurements possible in many individuals, including those with 
reduced acuity, up to 6/24 (20/80). Disadvantages include: 1) the need for pupil dilation 2) 
the reliance on subjects for accurate alignment, i.e. the lack of an objective alignment 
procedure 3) afterimages between measurements 3) questionable validity 4) attenuation of 
 
 
37 
 
the Raman signal with changes in the ocular media and inadequate pupil dilation 5) 
instrumentation that is highly specialized and expensive 6) RCs not being readily convertible 
to macular pigment density units, making direct comparisons with other techniques difficult.  
 
Electrophysiology – visual evoked potentials 
 
The first suggestion that visual evoked potentials (VEPs) could potentially be used to detect 
macular pigment was made over ten years ago, by Moreland et al. [37]. This was 
investigated further by Robson et al. [92] some time later. However, it is only very recently 
that this particular technique has looked like it could be a truly viable method for measuring 
MPOD. Using steady-state VEPs, Robson and Parry [41] measured MPOD across a range 
of eccentricities in three subjects. Blue-green gratings on a colour monitor were employed 
and these same gratings were also used to measure MPOD with HFP (see ‘recent 
developments’ in HFP section). The VEP and HFP results were compared with each other 
as well as with the equivalent MPOD as measured by minimum motion photometry. This 
required a correction factor on the part of the VEP and HFP results, to allow for the 
overlapping phosphor emissions of the blue and green stimuli. The correlation between all 
three techniques was excellent (r ≥ 0.94, p < 0.0005, in all cases), suggesting that steady-
state VEPs have potential as a valid, objective method for measuring macular pigment and 
its distribution. 
 
DISCUSSION 
 
There are currently two main psychophysical techniques for measuring MPOD in vivo, and 
three main objective techniques. All take advantage of the spectral absorption properties of 
macular pigment but in very diverse ways. This diversity may be useful for macular pigment 
research but it does present difficulties for those wishing to compare MPOD values between 
techniques. For instance, does the value represent the peak density of macular pigment, the 
density of macular pigment at a certain point within the fovea, or the total amount within the 
target area? 
 
If macular pigment measurement is to become commonplace in large populations, then 
equipment investors will have an important decision to make with regards to the method they 
choose to employ. Unfortunately, as each MPOD technique has its own benefits and 
limitations, there is no clear ideal choice, as highlighted by Beatty, van Kuijk and 
Chakravarthy [187]. Heterochromatic flicker photometry is probably the most affordable 
choice. It is also an established, valid and reliable method, particularly when protocols are 
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followed as per ‘customized’ HFP [50, 52]. There is, however, the problem that some 
individuals find this task very difficult and their results cannot necessarily be relied upon. A 
commercially available objective technique would therefore be desirable, possibly through 
adaptation of a scanning laser ophthalmoscope or fundus camera. The former is often used 
in a hospital setting and the latter is commonly found in optometric practice. A future 
objective technique could make use of FR or AF to assess MPOD, although AF may be 
preferred over FR because it is less influenced by light scatter and appears to have better 
reliability. Both have the facility to measure the spatial distribution of macular pigment and 
this seems to be an increasingly useful advantage [8, 39, 74, 108, 116]. Bhosale, Zhao and 
Bernstein [112] observed elevated lutein levels at the macula and at the peripheral retina in 
donors known to be using high dose lutein supplements. Therefore, if non-macula areas are 
not taken into account, the total complement of macular pigment may be underestimated, 
particularly with methods such as HFP, where the eccentric references are assumed to have 
virtually no macular pigment. The main issue associated with macular pigment screening 
using an objective technique is the need for pupil dilation, although several non-mydriatic 
devices have now been developed [58, 59, 153]. 
  
It is our view that the measurement of MPOD is best conducted using an objective technique 
based on FR or AF but we acknowledge that a commercial instrument capable of this is not 
currently available. The development of such an instrument will aid research in this area and 
provide a better understanding of the relationship between MPOD and AMD, as well as 
supporting MPOD screening in a clinical setting.
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Figure and table legends 
 
Figure 1. Schematic diagram of a Maxwellian view optical system, as used by Wooten et al. 
[46]. A1-A3 = apertures 1-3. BF = blocking filter (removes stray light). BS1 and BS2 = beam 
splitters 1 and 2. C = flicker vanes with a first surface mirror (produces alternation of the test 
and reference lights). HM1-HM3 = hot mirrors 1-3 (reduce heat transfer). IF1 and IF2 = 
interference filters 1 and 2. L1-L17 = lenses 1-17 (achromatic, planoconvex). M = 
monochromator (produces the test wavelength). M1-M4 = mirrors 1-4 (right angle, first 
surface). ND = neutral density filter (together with interference filters, produces the reference 
and background wavelengths). R = reticle. S = source light, in this case a xenon arc lamp. W 
= wedge (used to adjust the radiance of the test light). [Reprinted from Wooten et al. [46], 
with permission from the Association for Research in Vision and Ophthalmology.] 
 
Figure 2. Schematic diagram of a free view optical system, as used by Wooten et al. [46]. 
A1 and A2 = apertures 1 and 2. BS = beam splitter. D1 and D2 = optical diffusers (increase 
transmission efficiency). H = hole (1 inch circular viewing hole). L1 and L2 = lenses 1 and 2 
(achromatic, planoconvex). PC = photocell. S1 and S2 = source lights 1 and 2 (3 x 470 nm 
LEDs for S1, i.e. background field, and 2 x 458 nm plus 1 x 570 nm for S2, i.e. test field). 
[Reprinted from Wooten et al. [46], with permission from the Association for Research in 
Vision and Ophthalmology.] 
 
Figure 3. A detailed spatial profile of one subject’s macular pigment density, obtained using 
heterochromatic flicker photometry. Here, measurements have been taken along the 
horizontal (filled squares) and vertical (open circles) meridians of the retina, demonstrating a 
rapid and symmetrical decline in macular pigment with increasing eccentricity [Reprinted 
from Hammond et al. [44], with permission from the Optical Society of America.] 
 
Figure 4. The relative macular pigment spectral absorption profile of one subject (filled 
squares), as derived by heterochromatic flicker photometry. The continuous curve is an in 
vitro combination template as described in the text. Small deviations from the template at 
wavelengths below about 440 nm are typical. The reason for this is not clear and several 
theories have been proposed [see, for example, 54, 66, 71]. However, above 440 nm, the in 
vivo and in vitro methods are in very close agreement, so measurements of peak macular 
pigment optical density should remain accurate. [Reprinted from Wooten and Hammond 
[71], with permission from the American Academy of Optometry.] 
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Figure 5. A high correlation (r = 0.91, p < 0.00001) between macular pigment optical density 
measured with a centrally positioned 1° test stimulus and a 12′ test stimulus positioned 0.5° 
from the central fovea lends support to the edge hypothesis of heterochromatic flicker 
photometry. [Reprinted from Hammond et al. [44], with permission from the Optical Society 
of America.] 
 
Figure 6. Left panel: Macular pigment distribution in the central 1.5°, as determined by Bone 
et al. [68], using heterochromatic flicker photometry. The horizontal line is the average 
macular pigment optical density (MPOD) for 10 subjects, calculated using a centrally 
positioned 1.5° circular test stimulus (grey area = ± 1 standard deviation). The filled circles 
depict the average MPOD at various eccentricities (bars = ± 1 standard deviation), 
determined using a number of annular stimuli with central fixation marks (right panel). 
Whereas Hammond et al. [44] used a very small stimulus placed at the required retinal 
eccentricity, Bone and colleagues have used annular stimuli. This is an alternative method of 
knowingly measuring MPOD at a retinal eccentricity equivalent to the stimuli radii. The 
intersection point at 0.38° is the position at which MPOD appears to be measured when 
using a 1.5° test stimulus, i.e. 51% of the stimulus radius. Right panel: The four annular 
stimuli and two circular stimuli (1.17° circular stimulus not used in this graph). ID = inner 
diameter, OD = outer diameter. [Reprinted from Bone et al. [68], with permission from 
Elsevier.] 
 
Figure 7. Test configuration used in minimum motion photometry (left panel), with the 
associated stimuli dimensions given in the table (right panel). [Reprinted from Robson et al. 
[129], with permission from Pion Limited.] 
 
Figure 8. Apparent motion photometry. Left panel: Apparent movement to the right when the 
red bars are brighter than the blue, and vice-versa. Right panel: The test configuration for a 
parafoveal target [130]. 
 
Figure 9. Schematic diagram of the Foveal Reflection Analyzer 1, from Zagers et al. [146]. 
In (a): F = spectral filters. Lamp = 30W halogen lamp. L1-L11 = lenses 1-11. Lf = front lens. 
Li = insertable lens. Mh = mirror with central hole. Mi = insertable mirror. P = pupil plane. R = 
retinal plane. P’ and R’ = planes conjugate to P and R. V = video camera. In (b): The dilated 
pupil with entrance and exit pupil shown to scale (left panel). The illuminated field and the 
concentric sampled field, with fixation cross hairs (right panel). [Reprinted from Zagers et al. 
[146], with permission from the Optical Society of America.] 
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Figure 10. Schematic diagram of the Macular Pigment Reflectometer, from van de Kraats et 
al. [58]. L1-L8 = lenses 1-8. M = mirror. [Reprinted from van de Kraats et al. [58], with 
permission from SPIE.] 
 
Figure 11. Spatial profiles of macular pigment density in three age groups, obtained by 
fundus reflectometry: (a) young (24.8 ± 2.6 years), (b) mid-age (40.2 ± 8.3) and (c) old (67.5 
± 7.1). [Reprinted from Chen et al. [108], with permission from Informa Healthcare.] 
 
Figure 12. Left panel: Log ratio autofluorescence (AF) plotted against wavelength for seven 
subjects (symbols) along with the scaled macular pigment spectra (curves). The age of each 
subject is given to the left of each curve and the derived macular pigment optical density 
(with r2 values of the fits) is given to the right. Right panel: The equivalent fundus 
reflectometry (‘RE’) results. [Reprinted from Delori et al. [56], with permission from the 
Optical Society of America.] 
 
Figure 13. Autofluorescence images (first and third columns) and macular pigment spatial 
profiles (second and fourth columns) for 8 subjects (A-H). Open circles indicate the vertical 
meridian and filled circles the horizontal meridian. The arrows indicate disruptions due to 
prominent blood vessels. [Reprinted from Robson et al. [39], with permission from Elsevier.] 
 
Figure 14. Two example macular pigment spatial profiles with their corresponding 
autofluorescence images: (a) classic profile – central peak in macular pigment followed by a 
rapid decline, and (b) parafoveal ring profile – central peak in macular pigment, plus a 
secondary peak, before further decline. [Reprinted from Wolf-Schnurrbusch et al. [154], with 
permission from the Association for Research in Vision and Ophthalmology.] 
 
Figure 15. In vivo Raman spectra of a healthy subject, showing the characteristic peaks of 
macular pigment. Top trace = before subtraction of the background ocular fluorescence. 
Bottom trace = after subtraction. [Reprinted from Gellermann et al. [171], with permission 
from the Optical Society of America.] 
 
Figure 16. Schematic diagram of a resonance Raman spectroscopy macular pigment 
detector. Ar+ laser = air-cooled argon laser. BS = dichroic beam splitter. F = filter. LED = light 
emitting diode. L1-4 = lenses 1-4. M = Mirror. NF = holographic rejection notch filter. TB = 
trigger button. VHTF = volume holographic transmission grating. [Reprinted from Gellermann 
et al. [171], with permission from the Optical Society of America.] 
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Figure 17. Macular pigment measurements in seven human donor maculae, measured by 
high-performance liquid chromatography and resonance Raman spectroscopy. [Reprinted 
from Bernstein et al. [166], with permission from the Association for Research in Vision and 
Ophthalmology.] 
 
Figure 18. Macular pigment measurements by resonance Raman spectroscopy of four 
known lutein concentrations placed in a model eye. [Reprinted from Gellermann et al. [171], 
with permission from the Optical Society of America.] 
 
Figure 19. Macular pigment measurements in six monkey eyes, measured by high-
performance liquid chromatography and resonance Raman spectroscopy. [Reprinted from 
Gellermann et al. [171], with permission from the Optical Society of America.] 
 
Figure 20. Macular pigment measurements by resonance Raman spectroscopy of known 
lutein and zeaxanthin concentrations placed in a model eye: A = linear response range (filled 
circles are lutein, open circles are zeaxanthin). B = linear and non-linear response range. 
[Reprinted from Bernstein et al. [170], with permission from Elsevier.] 
 
Figure 21. The decline in macular pigment optical density with age, as measured by 
resonance Raman spectroscopy. [Reprinted from Bernstein et al. [170], with permission from 
Elsevier.] 
 
Table 1. A summary of the main differences between Maxwellian and free view optical 
systems. 
 
Table 2. A list of all heterochromatic flicker photometry (HFP) studies to date that have given 
statistical data on test-retest reliability. 
a Snodderly et al. [50] also calculated the equivalent values for the left eye, which were r = 
0.86, 22% test-retest difference and a coefficient of repeatability of 0.21.  
ARM = age-related maculopathy, the general term for degeneration of the macular region of 
the retina, which is normally separated into the two categories of early and late ARM, with 
the latter also being called age-related macular degeneration [188]. 
MPOD = macular pigment optical density.  
RE = right eye.  
RPE = retinal pigment epithelium. 
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Table 3. A list of all fundus reflectometry (FR) studies to date that have given statistical data 
on reliability. 
ARM = age-related maculopathy. 
FRA = Foveal Reflection Analyzer, a purpose-built reflectometer. 
MPR = Macular Pigment Reflectometer, a purpose-built reflectometer. 
SLO = scanning laser ophthalmoscope. 
 
Table 4. A list of all autofluorescence (AF) studies to date that have given statistical data on 
reliability. 
AMD = age-related macular degeneration. 
MPOD = macular pigment optical density. 
 
Table 5. A list of all resonance Raman spectroscopy (RRS) studies to date that have given 
statistical data on reliability. 
ARM = age-related maculopathy, the general term for degeneration of the macular region of 
the retina, which is normally separated into the two categories of early and late ARM, with 
the latter also being called age-related macular degeneration (AMD) [188]. 
MPOD = macular pigment optical density
 
 
44 
 
REFERENCES 
 
1. Bone RA, Landrum JT, Hime GW, Cains A, Zamor J (1993) Stereochemistry of the human 
macular carotenoids. Invest Ophthalmol Vis Sci 34: 2033-2040 
2. Malinow MR, Feeneyburns L, Peterson LH, Klein ML, Neuringer M (1980) Diet-related 
macular anomalies in monkeys. Invest Ophthalmol Vis Sci 19: 857-863 
3. Neuringer M, Sandstrom MM, Johnson EJ, Snodderly DM (2004) Nutritional manipulation 
of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular 
pigment in xanthophyll-free rhesus monkeys. Invest Ophthalmol Vis Sci 45: 3234-3243 
4. Sommerburg O, Keunen JEE, Bird AC, van Kuijk F (1998) Fruits and vegetables that are 
sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 82: 
907-910 
5. Snodderly DM, Auran JD, Delori FC (1984) The macular pigment .II. Spatial distribution in 
primate retinas. Invest Ophthalmol Vis Sci 25: 674-685 
6. Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment .I. 
Absorbance spectra, localization, and discrimination from other yellow pigments in primate 
retinas. Invest Ophthalmol Vis Sci 25: 660-673 
7. Bone RA, Landrum JT, Fernandez L, Tarsis SL (1988) Analysis of the macular pigment by 
HPLC - retinal distribution and age study. Invest Ophthalmol Vis Sci 29: 843-849 
8. Trieschmann M, van Kuijk F, Alexander R, Hermans P, Luthert P, Bird AC, Pauleikhoff D 
(2008) Macular pigment in the human retina: histological evaluation of localization and 
distribution. Eye 22: 132-137 
9. Bone RA, Landrum JT, Cains A (1992) Optical density spectra of the macular pigment in 
vivo and in vitro. Vision Res 32: 105-110 
10. Ham WT, Mueller HA, Sliney DH (1976) Retinal sensitivity to damage from short 
wavelength light. Nature 260: 153-155 
11. Hammond BR, Caruso-Avery M (2000) Macular pigment optical density in a 
southwestern sample. Invest Ophthalmol Vis Sci 41: 1492-1497 
12. Landrum JT, Bone RA (2001) Lutein, zeaxanthin, and the macular pigment. Arch 
Biochem Biophys 385: 28-40 
13. Khachik F, Bernstein PS, Garland DL (1997) Identification of lutein and zeaxanthin 
oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 38: 1802-1811 
14. Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, Nickerson RJ, 
Pool J, Colton TL, Ganley JP, Loewenstein JI, Dawber TR (1980) The Framingham Eye 
Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, 
diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 
adults, 1973-1975. Surv Ophthalmol 24: 335-610 
15. Klein R, Klein BEK, Linton KLP (1992) Prevalence of age-related maculopathy - the 
Beaver Dam Eye Study. Ophthalmology 99: 933-943 
16. Mitchell P, Smith W, Attebo K, Wang JJ (1995) Prevalence of age-related maculopathy 
in Australia - the Blue Mountains Eye Study. Ophthalmology 102: 1450-1460 
17. Beatty S, Murray IJ, Henson DB, Carden D, Koh HH, Boulton ME (2001) Macular 
pigment and risk for age-related macular degeneration in subjects from a Northern European 
population. Invest Ophthalmol Vis Sci 42: 439-446 
18. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE (2001) Macular 
pigment in donor eyes with and without AMD: A case-control study. Invest Ophthalmol Vis 
Sci 42: 235-240 
19. Trieschmann M, Spital G, Lommatzsch A, van Kuijk E, Fitzke F, Bird AC, Pauleikhoff D 
(2003) Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch 
Clin Exp Ophthalmol 241: 1006-1012 
20. Ciulla TA, Hammond BR (2004) Macular pigment density and aging, assessed in the 
normal elderly and those with cataracts and age-related macular degeneration. Am J 
Ophthalmol 138: 582-587 
 
 
45 
 
21. LaRowe TL, Mares JA, Snodderly DM, Klein ML, Wooten BR, Chappell R, Grp CMPS 
(2008) Macular pigment density and age-related maculopathy in the carotenoids in age-
related eye disease study - an ancillary study of the women's health initiative. 
Ophthalmology 115: 876-883 
22. Bone RA, Landrum JT, Tarsis SL (1985) Preliminary identification of the human macular 
pigment. Vision Res 25: 1531-1535 
23. Handelman GJ, Dratz EA, Reay CC, Vankuijk F (1988) Carotenoids in the human 
macula and whole retina. Invest Ophthalmol Vis Sci 29: 850-855 
24. Handelman GJ, Snodderly DM, Krinsky NI, Russett MD, Adler AJ (1991) Biological 
control of primate macular pigment - biochemical and densitometric studies. Invest 
Ophthalmol Vis Sci 32: 257-267 
25. Wüstemeyer H, Moessner A, Jahn C, Wolf S (2003) Macular pigment density in healthy 
subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefes Arch 
Clin Exp Ophthalmol 241: 647-651 
26. Trieschmann M, Beatty S, Nolan JM, Hense HW, Heimes B, Austermann U, Fobker M, 
Pauleikhoff D (2007) Changes in macular pigment optical density and serum concentrations 
of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. 
Exp Eye Res 84: 718-728 
27. Brown PK, Wald G (1963) Visual pigments in human and monkey retinas. Nature 200: 
37-43 
28. Bone RA, Sparrock JM (1971) Comparison of macular pigment densities in human eyes. 
Vision Res 11: 1057-1064 
29. Stabell U, Stabell B (1980) Variation in density of macular pigmentation and in short-
wave cone sensitivity with eccentricity. J Opt Soc Am 70: 706-711 
30. Pease PL, Adams AJ (1983) Macular pigment difference spectrum from sensitivity 
measures of a single cone mechanism. Am J Optom Physiol Opt 60: 667-672 
31. Pease PL, Adams AJ, Nuccio E (1987) Optical density of human macular pigment. 
Vision Res 27: 705-710 
32. Ruddock KH (1963) Evidence for macular pigmentation from colour matching data. 
Vision Res 61: 417-429 
33. Moreland JD, Bhatt P (1984) Retinal distribution of macular pigment. Doc Ophthalmol 
Proc Ser 39: 127-132 
34. Moreland JD, Alexander EC (1997) Effect of macular pigment on colour matching with 
field sizes in the 1° to 10° range. Doc Ophthalmol Proc Ser 59: 363-368 
35. Davies NP, Morland AB (2002) Color matching in diabetes: optical density of the 
crystalline lens and macular pigments. Invest Ophthalmol Vis Sci 43: 281-289 
36. Bone RA (1980) The role of the macular pigment in the detection of polarized light. 
Vision Res 20: 213-220 
37. Moreland JD, Robson AG, Soto-Leon N, Kulikowski JJ (1998) Macular pigment and the 
colour-specificity of visual evoked potentials. Vision Res 38: 3241-3245 
38. Moreland JD, Robson AG, Kulikowski JJ (2001) Macular pigment assessment using a 
colour monitor. Color Res Appl 26: S261-S263 
39. Robson AG, Moreland JD, Pauleikhoff D, Morrissey T, Holder GE, Fitzke FW, Bird AC, 
van Kuijk F (2003) Macular pigment density and distribution: comparison of fundus 
autofluorescence with minimum motion photometry. Vision Res 43: 1765-1775 
40. Moreland JD (2004) Macular pigment assessment by motion photometry. Arch Biochem 
Biophys 430: 143-148 
41. Robson AG, Parry NRA (2008) Measurement of macular pigment optical density and 
distribution using the steady-state visual evoked potential. Vis Neurosci 25: 575-583 
42. Werner JS, Donnelly SK, Kliegl R (1987) Aging and human macular pigment density. 
Appended with translations from the work of MaxSchultze and Ewald Hering. Vision Res 27: 
257-268 
43. Hammond BR, Fuld K (1992) Interocular differences in macular pigment density. Invest 
Ophthalmol Vis Sci 33: 350-355 
 
 
46 
 
44. Hammond BR, Wooten BR, Snodderly DM (1997) Individual variations in the spatial 
profile of human macular pigment. J Opt Soc Am A Opt Image Sci Vis 14: 1187-1196 
45. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE (1997) A one year 
study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res 
65: 57-62 
46. Wooten BR, Hammond BR, Land RI, Snodderly DM (1999) A practical method for 
measuring macular pigment optical density. Invest Ophthalmol Vis Sci 40: 2481-2489 
47. Beatty S, Koh HH, Carden D, Murray IJ (2000) Macular pigment optical density 
measurement: a novel compact instrument. Ophthalmic Physiol Opt 20: 105-111 
48. Mellerio J, Ahmadi-Lari S, van Kuijk F, Pauleikhoff D, Bird A, Marshall J (2002) A 
portable instrument for measuring macular pigment with central fixation. Curr Eye Res 25: 
37-47 
49. Bone RA, Landrum JT (2004) Heterochromatic flicker photometry. Arch Biochem 
Biophys 430: 137-142 
50. Snodderly DM, Mares JA, Wooten BR, Oxton L, Gruber M, Ficek T (2004) Macular 
pigment measurement by heterochromatic flicker photometry in older subjects: the 
carotenoids and age-related eye disease study. Invest Ophthalmol Vis Sci 45: 531-538 
51. Iannaccone A, Mura M, Gallaher KT, Johnson EJ, Todd WA, Kenyon E, Harris TL, Harris 
T, Satterfield S, Johnson KC, Kritchevsky SB, Study HA (2007) Macular pigment optical 
density in the elderly: findings in a large biracial midsouth population sample. Invest 
Ophthalmol Vis Sci 48: 1458-1465 
52. Stringham JM, Hammond BR, Nolan JM, Wooten BR, Mammen A, Smollon W, 
Snodderly DM (2008) The utility of using customized heterochromatic flicker photometry 
(cHFP) to measure macular pigment in patients with age-related macular degeneration. Exp 
Eye Res 87: 445-453 
53. van der Veen RL, Berendschot TT, Hendrikse F, Carden D, Makridaki M, Murray IJ 
(2009) A new desktop instrument for measuring macular pigment optical density based on a 
novel technique for setting flicker thresholds. Ophthalmic Physiol Opt 29: 127-137 
54. Hammond BR, Wooten BR, Smollon B (2005) Assessment of the validity of in vivo 
methods of measuring human macular pigment optical density. Optom Vis Sci 82: 387-404 
55. Viner C (2003) Measuring macular pigment levels: an in-practice procedure? Optician 
226: 24-26 
56. Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment 
density measured by autofluorescence spectrometry: comparison with reflectometry and 
heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis 18: 1212-1230 
57. Neelam K, O'Gorman N, Nolan J, O'Donovan O, Wong HB, Eong KGA, Beatty S (2005) 
Measurement of macular pigment: Raman spectroscopy versus heterochromatic flicker 
photometry. Invest Ophthalmol Vis Sci 46: 1023-1032 
58. van de Kraats J, Berendschot T, Valen S, van Norren D (2006) Fast assessment of the 
central macular pigment density with natural pupil using the macular pigment reflectometer. 
J Biomed Opt 11: 064031 
59. Bone RA, Brener B, Gibert JC (2007) Macular pigment, photopigments, and melanin: 
distributions in young subjects determined by four-wavelength reflectometry. Vision Res 47: 
3259-3268 
60. Canovas R, Lima VC, Garcia P, Morini C, Prata TS, Rosen RB (2010) Comparison 
between macular pigment optical density measurements using two-wavelength 
autofluorescence and heterochromatic flicker photometry techniques. Invest Ophthalmol Vis 
Sci 51: 3152-3156 
61. Werner JS, Wooten BR (1979) Opponent chromatic response functions for an average 
observer. Percept Psychophys 25: 371-374 
62. Tang CY, Yip HS, Poon MY, Yau WL, Yap MKH (2004) Macular pigment optical density 
in young Chinese adults. Ophthalmic Physiol Opt 24: 586-593 
63. Loane E, Stack J, Beatty S, Nolan JM (2007) Measurement of macular pigment optical 
density using two different heterochromatic flicker photometers. Curr Eye Res 32: 555-564 
 
 
47 
 
64. Kirby ML, Galea M, Loane E, Stack J, Beatty S, Nolan JM (2009) Foveal anatomic 
associations with the secondary peak and the slope of the macular pigment spatial profile. 
Invest Ophthalmol Vis Sci 50: 1383-1391 
65. Snodderly DM, Hammond BR (1999) In vivo psychophysical assessment of nutritional 
and environmental influences on human ocular tissues: lens and macular pigment. In: Taylor 
A (eds) Nutritional and Environmental Influences on the Eye. CRC Press, Boca Raton, FL, 
pp 251-273 
66. Werner JS, Bieber ML, Schefrin BE (2000) Senescence of foveal and parafoveal cone 
sensitivities and their relations to macular pigment density. J Opt Soc Am A Opt Image Sci 
Vis 17: 1918-1932 
67. Hammond BR, Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly 
DM (1997) Dietary modification of human macular pigment density. Invest Ophthalmol Vis 
Sci 38: 1795-1801 
68. Bone RA, Landrum JT, Gibert JC (2004) Macular pigment and the edge hypothesis of 
flicker photometry. Vision Res 44: 3045-3051 
69. Burke JD, Curran-Celentano J, Wenzel AJ (2005) Diet and serum carotenoid 
concentrations affect macular pigment optical density in adults 45 years and older. J Nutr 
135: 1208-1214 
70. Lam RF, Rao SK, Fan DSP, Lau FTC, Lam DSC (2005) Macular pigment optical density 
in a Chinese sample. Curr Eye Res 30: 799-805 
71. Wooten BR, Hammond BR (2005) Spectral absorbance and spatial distribution of 
macular pigment using heterochromatic flicker photometry. Optom Vis Sci 82: 378-386 
72. Stringham JM, Hammond BR (2007) The glare hypothesis of macular pigment function. 
Optom Vis Sci 84: 859-864 
73. Wenzel AJ, Sheehan JP, Burke JD, Lefsrud MG, Curran-Celentano J (2007) Dietary 
intake and serum concentrations of lutein and zeaxanthin, but not macular pigment optical 
density, are related in spouses. Nutr Res 27: 462-469 
74. Wenzel AJ, Sheehan JP, Gerweck C, Stringham JM, Fuld K, Curran-Celentano J (2007) 
Macular pigment optical density at four retinal loci during 120 days of lutein supplementation. 
Ophthalmic Physiol Opt 27: 329-335 
75. Nolan JM, Stringham JM, Beatty S, Snodderly DM (2008) Spatial profile of macular 
pigment and its relationship to foveal architecture. Invest Ophthalmol Vis Sci 49: 2134-2142 
76. Stringham JM, Hammond BR (2008) Macular pigment and visual performance under 
glare conditions. Optom Vis Sci 85: 82-88 
77. Stringham JM, Hammond BR, Wooten BR, Snodderly DM (2006) Compensation for light 
loss resulting from filtering by macular pigment: relation to the S-cone pathway. Optom Vis 
Sci 83: 887-894 
78. Connolly EE, Beatty S, Thurnham DI, Loughman J, Howard AN, Stack J, Nolan JM 
(2010) Augmentation of macular pigment following supplementation with all three macular 
carotenoids: an exploratory study. Curr Eye Res 35: 335-351 
79. Loane E, McKay GJ, Nolan JM, Beatty S (2010) Apolipoprotein E genotype is associated 
with macular pigment optical density. Invest Ophthalmol Vis Sci 51: 2636-2643 
80. Ciulla TA, Curran-Celantano J, Cooper DA, Hammond BR, Danis RP, Pratt LM, Riccardi 
KA, Filloon TG (2001) Macular pigment optical density in a midwestern sample. 
Ophthalmology 108: 730-737 
81. Ciulla TA, Hammond BR, Yung CW, Pratt LM (2001) Macular pigment optical density 
before and after cataract extraction. Invest Ophthalmol Vis Sci 42: 1338-1341 
82. Hammond BR, Fuld K, Curran-Celentano J (1995) Macular pigment density in 
monozygotic twins. Invest Ophthalmol Vis Sci 36: 2531-2541 
83. Nolan JM, Stack J, Donovan OO, Loane E, Beatty S (2007) Risk factors for age-related 
maculopathy are associated with a relative lack of macular pigment. Exp Eye Res 84: 61-74 
84. Nolan JM, Stack J, O'Connell E, Beatty S (2007) The relationships between macular 
pigment optical density and its constituent carotenoids in diet and serum. Invest Ophthalmol 
Vis Sci 48: 571-582 
 
 
48 
 
85. Schalch W, Cohn W, Barker FM, Kopcke W, Mellerio J, Bird AC, Robson AG, Fitzke FF, 
van Kuijk FJGM (2007) Xanthophyll accumulation in the human retina during 
supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye 
Accumulation) study. Arch Biochem Biophys 458: 128-135 
86. Hammond BR, Wooten BR (2005) CFF thresholds: relation to macular pigment optical 
density. Ophthalmic Physiol Opt 25: 315-319 
87. Cooper DA, Curran-Celentano J, Ciulla TA, Hammond BR, Danis RB, Pratt LM, Riccardi 
KA, Filloon TG (2000) Olestra consumption is not associated with macular pigment optical 
density in a cross-sectional volunteer sample in Indianapolis. J Nutr 130: 642-647 
88. Curran-Celentano J, Hammond BR, Ciulla TA, Cooper DA, Pratt LM, Danis RB (2001) 
Relation between dietary intake, serum concentrations, and retinal concentrations of lutein 
and zeaxanthin in adults in a Midwest population. Am J Clin Nutr 74: 796-802 
89. Bone RA, Landrum JT, Guerra LH, Ruiz CA (2003) Lutein and zeaxanthin dietary 
supplements raise macular pigment density and serum concentrations of these carotenoids 
in humans. J Nutr 992-998 
90. Bone RA, Landrum JT, Cao Y, Howard AN, Alvarez-Calderon F (2007) Macular pigment 
response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Nutr Metab 4: 
12 
91. Koh HH, Murray IJ, Nolan D, Carden D, Feather J, Beatty S (2004) Plasma and macular 
response to lutein supplement in subjects with and without age-related maculopathy: a pilot 
study. Exp Eye Res 79: 21-27 
92. Robson AG, Holder GE, Moreland JD, Kulikowski JJ (2006) Chromatic VEP assessment 
of human macular pigment: comparison with minimum motion and minimum flicker profiles. 
Vis Neurosci 23: 275-283 
93. Engles M, Wooten B, Hammond B (2007) Macular pigment: a test of the acuity 
hypothesis. Invest Ophthalmol Vis Sci 48: 2922-2931 
94. Rodriguez-Carmona M, Kvansakul J, Harlow JA, Kopcke W, Schalch W, Barbur JL 
(2006) The effects of supplementation with lutein and/or zeaxanthin on human macular 
pigment density and colour vision. Ophthalmic Physiol Opt 26: 137-147 
95. Kvansakul J, Rodriguez-Carmona M, Edgar DF, Barker FM, Kopcke W, Schalch W, 
Barbur JL (2006) Supplementation with the carotenoids lutein or zeaxanthin improves 
human visual performance. Ophthalmic Physiol Opt 26: 362-371 
96. Makridaki M, Carden D, Murray IJ (2009) Macular pigment measurement in clinics: 
controlling the effect of the ageing media. Ophthalmic Physiol Opt 29: 338-344 
97. Nolan JM, Kenny R, O'Regan C, Cronin H, Loughman J, Connolly EE, Kearney P, Loane 
E, Beatty S (2010) Macular Pigment Optical Density in an Ageing Irish Population: The Irish 
Longitudinal Study on Ageing. Ophthalmic Res 44: 131-139 
98. Wüstemeyer H, Jahn C, Nestler A, Barth T, Wolf S (2002) A new instrument for the 
quantification of macular pigment density: first results in patients with AMD and healthy 
subjects. Graefes Arch Clin Exp Ophthalmol 240: 666-671 
99. Curcio CA, Allen KA, Sloan KR, Lerea CL, Hurley JB, Klock IB, Milam AH (1991) 
Distribution and morphology of human cone photoreceptors stained with anti-blue opsin. J 
Comp Neurol 312: 610-624 
100. Curcio CA, Sloan KR (1992) Packing geometry of human cone photoreceptors - 
variation with eccentricity and evidence for local anisotropy. Vis Neurosci 9: 169-180 
101. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE (1990) Human photoreceptor 
topography. J Comp Neurol 292: 497-523 
102. Cicerone CM, Nerger JL (1989) The relative numbers of long-wavelength-sensitive to 
middle-wavelength-sensitive cones in the human fovea centralis. Vision Res 29: 115-128 
103. Nerger JL, Cicerone CM (1992) The ratio of L-cones to M-cones in the human 
parafoveal retina. Vision Res 32: 879-888 
104. Knau H, Jagle H, Sharpe LT (2001) L/M cone ratios as a function of retinal eccentricity. 
Color Res Appl 26: S128-S132 
 
 
49 
 
105. Hammond BR, Wooten BR, Snodderly DM (1998) Preservation of visual sensitivity of 
older subjects: association with macular pigment density. Invest Ophthalmol Vis Sci 39: 397-
406 
106. Brindley GS, Du Croz JJ, Rushton WA (1966) The flicker fusion frequency of the blue-
sensitive mechanism of colour vision. J Physiol 183: 497-500 
107. Nolan J, O'Donovan O, Kavanagh H, Stack J, Harrison M, Muldoon A, Mellerio J, 
Beatty S (2004) Macular pigment and percentage of body fat. Invest Ophthalmol Vis Sci 45: 
3940-3950 
108. Chen SF, Chang Y, Wu JC (2001) The spatial distribution of macular pigment in 
humans. Curr Eye Res 23: 422-434 
109. Berendschot T, van Norren D (2004) Objective determination of the macular pigment 
optical density using fundus reflectance spectroscopy. Arch Biochem Biophys 430: 149-155 
110. Bernstein PS, Zhao DY, Sharifzadeh M, Ermakov IV, Gellermann W (2004) Resonance 
Raman measurement of macular carotenoids in the living human eye. Arch Biochem 
Biophys 430: 163-169 
111. Gellermann W, Bernstein PS (2004) Noninvasive detection of macular pigments in the 
human eye. J Biomed Opt 9: 75-85 
112. Bhosale P, Zhao DY, Bernstein PS (2007) HPLC measurement of ocular carotenoid 
levels in human donor eyes in the lutein supplementation era. Invest Ophthalmol Vis Sci 48: 
543-549 
113. Hammond BR, Ciulla TA, Snodderly DM (2002) Macular pigment density is reduced in 
obese subjects. Invest Ophthalmol Vis Sci 43: 47-50 
114. Gallaher KT, Mura M, Todd WA, Harris TL, Kenyon E, Harris T, Johnson KC, Satterfield 
S, Kritchevsky SB, Iannaccone A, Hlth ABCS (2007) Estimation of macular pigment optical 
density in the elderly: test-retest variability and effect of optical blur in pseudophakic 
subjects. Vision Res 47: 1253-1259 
115. Snodderly DM, Handelman GJ, Adler AJ (1991) Distribution of individual macular 
pigment carotenoids in central retina of macaque and squirrel-monkeys. Invest Ophthalmol 
Vis Sci 32: 268-279 
116. Berendschot T, van Norren D (2006) Macular pigment shows ringlike structures. Invest 
Ophthalmol Vis Sci 47: 709-714 
117. Delori FC, Goger DG, Keilhauer C, Salvetti P, Staurenghi G (2006) Bimodal spatial 
distribution of macular pigment: evidence of a gender relationship. J Opt Soc Am A Opt 
Image Sci Vis 23: 521-538 
118. Wyszecki G, Stiles WS (1982) The Eye. In: (eds) Color Science: Concepts and 
Methods, Quantitative Data and Formulae. Wiley-Interscience, New York, pp 112-114 
119. Bartlett H, Acton J, Eperjesi F (2010) Clinical evaluation of the MacuScope macular 
pigment densitometer. Br J Ophthalmol 94: 328-331 
120. Hagen S, Krebs I, Glittenberg C, Binder S (2010) Repeated measures of macular 
pigment optical density to test reproducibility of heterochromatic flicker photometry. Acta 
Ophthalmol 88: 207-211 
121. van der Veen RLP, Berendschot T, Makridaki M, Hendrikse F, Carden D, Murray IJ 
(2009) Correspondence between retinal reflectometry and a flicker-based technique in the 
measurement of macular pigment spatial profiles. J Biomed Opt 14: 064046 
122. Johnson EJ, Chung HY, Caldarella SM, Snodderly DM (2008) The influence of 
supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular 
pigmentation. Am J Clin Nutr 87: 1521-1529 
123. Troxler DIPV (1804) Über das Verschwinden gegebener Gegenstände innerhalb 
unseres Gesichtskreises. In: Himly J, Schmidt JA (eds) Ophthalmologische Bibliothek. Jena: 
Fromann, pp 1-53 
124. Stumpf P (1911) On the dependence of the visual sensation of movement and its 
negative aftereffect on the stimulation processes on the retina. Z Psychol 59: 321-330 
125. Todorović D (1996) A gem from the past: Pleikart Stumpf's (1911) anticipation of the 
aperture problem, Reichardt detectors, and perceived motion loss at equiluminance. 
Perception 25: 1235-1242 
 
 
50 
 
126. Moreland JD (1980) A modified Moreland anomaloscope using optokinetic nystagmus 
to define colour matches objectively. In: Verriest G (eds) Colour Vision Deficiencies V. 
Hilger, Bristol, pp 189-191 
127. Moreland JD (1982) Spectral sensitivity measurements by motion photometry. Doc 
Ophthalmol Proc Ser 33: 61-66 
128. Anstis SM, Cavanagh P (1983) A minimum motion technique for judging 
equiluminance. In: Mollon JD, Sharpe LT (eds) Colour Vision: Physiology and 
Psychophysics. Academic Press, London, pp 155-166 
129. Robson AG, Harding G, van Kuijk F, Pauleikhoff D, Holder GE, Bird AC, Fitzke FW, 
Moreland JD (2005) Comparison of fundus autofluorescence and minimum-motion 
measurements of macular pigment distribution profiles derived from identical retinal areas. 
Perception 34: 1029-1034 
130. West P, Mellerio J (2005) Measuring MPOD using a CRT display [online]. 
http://www.crsltd.com/research-topics/macular-pigment/index.html and 
http://www.crsltd.com/catalog/metropsis/MP.html. Accessed 1 May 2009 
131. Brindley GS, Willmer EN (1952) The reflexion of light from the macular and peripheral 
fundus oculi in man. J Physiol 116: 350-356 
132. Berendschot T, DeLint PJ, van Norren D (2003) Fundus reflectance - historical and 
present ideas. Prog Retin Eye Res 22: 171-200 
133. van Norren D, Tiemeijer LF (1986) Spectral reflectance of the human eye. Vision Res 
26: 313-320 
134. Delori FC, Pflibsen KP (1989) Spectral reflectance of the human ocular fundus. Appl 
Opt 28: 1061-1077 
135. Elsner AE, Burns SA, Beausencourt E, Weiter JJ (1998) Foveal cone photopigment 
distribution: small alterations associated with macular pigment distribution. Invest 
Ophthalmol Vis Sci 39: 2394-2404 
136. Berendschot T, Goldbohm RA, Klopping WAA, van de Kraats J, van Norel J, van 
Norren D (2000) Influence of lutein supplementation on macular pigment, assessed with two 
objective techniques. Invest Ophthalmol Vis Sci 41: 3322-3326 
137. Bour LJ, Koo L, Delori FC, Apkarian P, Fulton AB (2002) Fundus photography for 
measurement of macular pigment density distribution in children. Invest Ophthalmol Vis Sci 
43: 1450-1455 
138. Cardinault N, Gorrand JM, Tyssandier V, Grolier P, Rock E, Borel P (2003) Short-term 
supplementation with lutein affects biomarkers of lutein status similarly in young and elderly 
subjects. Exp Gerontol 38: 573-582 
139. van de Kraats J, van Norren D (2008) Directional and nondirectional spectral reflection 
from the human fovea. J Biomed Opt 13: 024010 
140. van de Kraats J, Berendschot T, van Norren D (1996) The pathways of light measured 
in fundus reflectometry. Vision Res 36: 2229-2247 
141. Berendschot T, van Norren D (2005) On the age dependency of the macular pigment 
optical density. Exp Eye Res 81: 602-609 
142. Kanis MJ, Berendschot T, van Norren D (2007) Influence of macular pigment and 
melanin on incident early AMD in a white population. Graefes Arch Clin Exp Ophthalmol 
245: 767-773 
143. Kanis MJ, Berendschot T, van Norren D (2007) Interocular agreement in melanin and 
macular pigment optical density. Exp Eye Res 84: 934-938 
144. Berendschot T, Willemse-Assink JJM, Bastiaanse M, de Jong P, van Norren D (2002) 
Macular pigment and melanin in age-related maculopathy in a general population. Invest 
Ophthalmol Vis Sci 43: 1928-1932 
145. Chang Y, Lee FL, Chen SJ, Chen SF (2002) Optical measurement of human retinal 
macular pigment and its spatial distribution with age. Med Phys 29: 2621-2628 
146. Zagers NPA, van de Kraats J, Berendschot T, van Norren D (2002) Simultaneous 
measurement of foveal spectral reflectance and cone-photoreceptor directionality. Appl Opt 
41: 4686-4696 
 
 
51 
 
147. Zagers NPA, van Norren D (2004) Absorption of the eye lens and macular pigment 
derived from the reflectance of cone photoreceptors. J Opt Soc Am A Opt Image Sci Vis 21: 
2257-2268 
148. Kanis MJ, Wisse RPL, Berendschot T, van de Kraats J, van Norren D (2008) Foveal 
cone-photoreceptor integrity in aging macula disorder. Invest Ophthalmol Vis Sci 49: 2077-
2081 
149. Elsner AE, Burns SA, Delori FC, Webb RH (1990) Quantitative reflectometry with the 
SLO. In: Naseman JE, Burk ROW (eds) Scanning Laser Ophthalmoscopy and Tomography. 
Quintessenz-Verlag, Munich, pp 109-121 
150. Seth R, Gouras P (2004) Assessing macular pigment from SLO images. Doc 
Ophthalmol 108: 197-202 
151. Helb HM, Issa PC, Van der Veen RLP, Berendschot T, Scholl HPN, Holz FG (2008) 
Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. Retina 28: 
808-816 
152. van de Kraats J, Kanis MJ, Genders SW, van Norren D (2008) Lutein and zeaxanthin 
measured separately in the living human retina with fundus reflectometry. Invest Ophthalmol 
Vis Sci 49: 5568-5573 
153. Sharifzadeh M, Bernstein PS, Gellermann W (2006) Nonmydriatic fluorescence-based 
quantitative imaging of human macular pigment distributions. J Opt Soc Am A Opt Image Sci 
Vis 23: 2373-2387 
154. Wolf-Schnurrbusch UEK, Roosli N, Weyermann E, Heldner MR, Hohne K, Wolf S 
(2007) Ethnic differences in macular pigment density and distribution. Invest Ophthalmol Vis 
Sci 48: 3783-3787 
155. Bernstein PS, Delori FC, Richer S, van Kuijk FJM, Wenzel AJ (2010) The value of 
measurement of macular carotenoid pigment optical densities and distributions in age-
related macular degeneration and other retinal disorders. Vision Res 50: 716-728 
156. Delori FC (1994) Spectrophotometer for noninvasive measurement of intrinsic 
fluorescence and reflectance of the ocular fundus. Appl Opt 33: 7439-7452 
157. Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ (1995) In vivo 
fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin 
characteristics. Invest Ophthalmol Vis Sci 36: 718-729 
158. von Ruckmann A, Fitzke FW, Bird AC (1995) Distribution of fundus autofluorescence 
with a scanning laser ophthalmoscope. Br J Ophthalmol 79: 407-412 
159. Delori FC (2004) Autofluorescence method to measure macular pigment optical 
densities fluorometry and autofluorescence imaging. Arch Biochem Biophys 430: 156-162 
160. Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF (2008) Fundus autofluorescence 
imaging - review and perspectives. Retina 28: 385-409 
161. Liew SHM, Gilbert CE, Spector TD, Mellerio J, Van Kuijk FJ, Beatty S, Fitzke F, 
Marshall J, Hammond CJ (2006) Central retinal thickness is positively correlated with 
macular pigment optical density. Exp Eye Res 82: 915-920 
162. Trieschmann M, Heimes B, Hense HW, Pauleikhoff D (2006) Macular pigment optical 
density measurement in autofluorescence imaging: comparison of one- and two-wavelength 
methods. Graefes Arch Clin Exp Ophthalmol 244: 1565-1574 
163. Jahn C, Wustemeyer H, Brinkmann C, Trautmann S, Mossner A, Wolf S (2005) 
Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol 
243: 222-227 
164. Liew SHM, Gilbert CE, Spector TD, Mellerio J, Marshall J, van Kuijk FJ, Beatty S, 
Fitzke F, Hammond CJ (2005) Heritability of macular pigment: a twin study. Invest 
Ophthalmol Vis Sci 46: 4430-4436 
165. Delori FC, Goger DG, Dorey CK (2001) Age-related accumulation and spatial 
distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci 42: 1855-1866 
166. Bernstein PS, Yoshida MD, Katz NB, McClane RW, Gellermann W (1998) Raman 
detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci 
39: 2003-2011 
 
 
52 
 
167. Koyama Y, Takatsuka I, Nakata M, Tasumi M (1988) Raman and infrared spectra of the 
all-trans, 7-cis, 9-cis, 13-cis and 15-cis isomers of beta carotene - key bands distinguishing 
stretched or terminal-bent configurations from central-bent configurations. J Raman 
Spectrosc 19: 37-49 
168. Ermakov IV, McClane RW, Gellermann W, Bernstein PS (2001) Resonant Raman 
detection of macular pigment levels in the living human retina. Opt Lett 26: 202-204 
169. Bernstein PS (2002) New insights into the role of the macular carotenoids in age-
related macular degeneration. Resonance Raman studies. Pure Appl Chem 74: 1419-1425 
170. Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W (2002) 
Resonance Raman measurement of macular carotenoids in normal subjects and in age-
related macular degeneration patients. Ophthalmology 109: 1780-1787 
171. Gellermann W, Ermakov IV, Ermakova MR, McClane RW, Zhao DY, Bernstein PS 
(2002) In vivo resonant Raman measurement of macular carotenoid pigments in the young 
and the aging human retina. J Opt Soc Am A Opt Image Sci Vis 19: 1172-1186 
172. Gellermann W, Ermakov IV, McClane RW, Bernstein PS (2002) Raman imaging of 
human macular pigments. Opt Lett 27: 833-835 
173. Zhao DY, Wintch SW, Ermakov IV, Gellermann W, Bernstein PS (2003) Resonance 
Raman measurement of macular carotenoids in retinal, choroidal, and macular dystrophies. 
Arch Ophthalmol 121: 967-972 
174. Ermakov I, Ermakova M, Gellermann W, Bernstein PS (2004) Macular pigment Raman 
detector for clinical applications. J Biomed Opt 9: 139-148 
175. Ermakov IV, Sharifzadeh M, Ermakova M, Gellermann W (2005) Resonance Raman 
detection of carotenoid antioxidants in living human tissue. J Biomed Opt 10: 064028 
176. Hogg RE, Anderson RS, Stevenson MR, Zlatkova MB, Chakravarthy U (2007) In vivo 
macular pigment measurements: a comparison of resonance Raman spectroscopy and 
heterochromatic flicker photometry. Br J Ophthalmol 91: 485-490 
177. Obana A, Hiramitsu T, Gohto Y, Ohira A, Mizuno S, Hirano T, Bernstein PS, Fujii H, 
Iseki K, Tanito M, Hotta Y (2008) Macular carotenoid levels of normal subjects and age-
related maculopathy patients in a Japanese population. Ophthalmology 115: 147-157 
178. Sharifzadeh M, Zhao DY, Bernstein PS, Gellermann W (2008) Resonance Raman 
imaging of macular pigment distributions in the human retina. J Opt Soc Am A Opt Image 
Sci Vis 25: 947-957 
179. Hogg RE, Zlatkova MB, Chakravarthy U, Anderson RS (2007) Investigation of the effect 
of simulated lens yellowing, transparency loss and refractive error on in vivo resonance 
Raman spectroscopy. Ophthalmic Physiol Opt 27: 225-231 
180. Bernstein PS, Gellermann W (2003) Author response: assessment of the Raman 
method of measuring human macular pigment [Letter] [online]. Investigative Ophthalmology 
& Visual Science. Available at: 
http://www.iovs.org/cgi/eletters?lookup=by_date&days=9999#74. Accessed 15 September 
2009 
181. Bernstein PS, Gellermann W (2003) Author response: assessment of the Raman 
method of measuring human macular pigment (II) [Letter] [online]. Investigative 
Ophthalmology & Visual Science. Available at: 
http://www.iovs.org/cgi/eletters?lookup=by_date&days=9999#74. Accessed 15 September 
2009 
182. Wooten BR, Hammond BR (2003) Assessment of the Raman method of measuring 
human macular pigment [Letter] [online]. Investigative Ophthalmology & Visual Science. 
Available at: http://www.iovs.org/cgi/eletters?lookup=by_date&days=9999#73. Accessed 15 
September 2009 
183. Wooten BR, Hammond BR (2003) Assessment of the Raman method of measuring 
human macular pigment (II) [Letter] [online]. Investigative Ophthalmology & Visual Science. 
Available at: http://www.iovs.org/cgi/eletters?lookup=by_date&days=9999#73. Accessed 15 
September 2009 
184. Hammond BR, Wooten BR (2005) Resonance Raman spectroscopic measurement of 
carotenoids in the skin and retina. J Biomed Opt 10: 054002 
 
 
53 
 
185. Gellermann W, Bernstein PS (2006) Assessment of the validity of in vivo methods of 
measuring human macular pigment optical density [Letter]. Optom Vis Sci 83: 254-255 
186. Hammond BR, Wooten BR, Smollon B (2006) Assessment of the validity of in vivo 
methods of measuring human macular pigment optical density - Authors' response [Letter]. 
Optom Vis Sci 83: 256-259 
187. Beatty S, van Kuijk F, Chakravarthy U (2008) Macular pigment and age-related macular 
degeneration: longitudinal data and better techniques of measurement are needed. Invest 
Ophthalmol Vis Sci 49: 843-845 
188. Bird AEC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, Dejong P, 
Klaver CCW, Klein BEK, Klein R, Mitchell P, Sarks JP, Sarks SH, Sourbane G, Taylor HR, 
Vingerling JR (1995) An international classification and grading system for age-related 
maculopathy and age-related macular degeneration. Surv Ophthalmol 39: 367-374 
 
 
  
Figure 1
 Figure 2
 Figure 3
  
Figure 4
 Figure 5
   
Figure 6
 Figure 7
   
Figure 8
 Figure 9
 Figure 10
  
Figure 11
 Figure 12
 Figure 13
 Figure 14
 Figure 15
 Figure 16
 Figure 17
 Figure 18
  
Figure 19
  
Figure 20
 Figure 21
Maxwellian view Free view 
Complex optical system. Simplified optical system.  
Test stimuli produced by a single light 
source, e.g. a quartz halogen lamp, an 
advantage being that deterioration of the 
equipment with age or voltage fluctuations 
alter both stimuli equally and therefore 
should not affect the results [49]. 
Test stimuli produced by light-emitting 
diodes (LEDs) with appropriate peak 
wavelengths. 
 
Light from the lamp is rendered into the 
appropriate monochromatic wavelengths 
using filters. 
LEDs have the advantage of producing near 
monochromatic light, i.e. no need for filters 
[48]. 
Test and reference lights alternated by a 
rotating chopper [e.g. 49] or mirror [e.g. 43-
46], with the radiance of the test light 
adjustable by a ‘highly linear, compensated, 
neutral density wedge’ [49]. 
 
Alternation of the test and reference lights is 
achieved by square wave current pulses 
[48]. The use of LEDs also permits the 
possibility of adjusting the test light radiance 
directly through voltage, thereby simplifying 
the use of the instrument and avoiding any 
need for rotating mirrors and neutral density 
wedges (see Wooten et al. [46]). 
Narrow beam light stimuli must enter the eye 
precisely in the centre of the pupil, which 
requires head stabilization with a dental bite 
bar [46, 65]. 
Wider beam light stimuli can enter the eye 
through the whole pupil so head stabilization 
with a bite bar is not necessary [46, 65]. 
Not easily portable. Portable. 
Expensive. Relatively inexpensive. 
Considerable training required to operate 
correctly. 
Simpler to operate than Maxwellian systems 
therefore less training required. 
 
 
 
Table 1
Study/Year 
Number of 
subjects 
Age range; eye health 
status; experience with HFP 
Reliability statistics 
Hammond and 
Fuld/1992 [43]  
10 19-42; normal; 7 novices. 5 sessions on different days. Intersession correlation 0.85 
(Cronbach’s ). Mean absolute difference between 1st and 2nd 
session 0.05 ± 0.03 (16% of mean MPOD, as cited in Delori et 
al. [56]; Y = 0.87X + 0.03, r = 0.94 (p<0.0005)). 
Hammond, Fuld and 
Curran-Celentano/1995 
[82]  
20 19-22; normal; all novices. 5 sessions on different days. Intersession correlation 0.68 
(Cronbach’s ). Mean absolute difference between 1st and 2nd 
session 0.10 ± 0.10 (33% of mean MPOD, as cited in Delori et 
al. [56]; Y = 0.56X + 0.12, r = 0.73 (p<0.0005)). 
Hammond, Wooten and 
Snodderly/1997 [44]  
32 21-63; normal; 29 novices. 2 sessions on different days. Mean absolute difference 
between sessions 0.08 ± 0.08; Y = 0.92X + 0.07, r = 0.91 (no 
p-value given). 
Hammond et al./1997 
[67]  
13 30-65; normal; not reported. 2 sessions. Mean absolute difference between sessions 0.08 ± 
0.07 (23% of mean MPOD, as cited in Delori et al. [56]; Y = 
0.83X + 0.03, r = 0.72 (no p-value given)). 
Hammond, Wooten and 
Snodderly/1998 [105]  
10 + 27 24-36 & 60-84; some older 
subjects with mild RPE 
changes and 2 with early 
cataract; not reported. 
2 sessions. Mean absolute difference between sessions 0.08 ± 
0.09; Y = 0.90X + 0.06, r = 0.91 (p<0.0000001). 
Wooten et al./1999 [46]  4 30 subjects in full study, 16-
60; not reported; not 
specifically reported. 
10 sessions over 2-4 weeks. Intersession correlation 0.89 
(Cronbach’s ). 
Hammond and Caruso-
Avery/2000 [11]  
8 217 subjects in full study, 
17-92; normal; all novices. 
10 sessions over 2-4 weeks. Intersession correlation 0.97 
(Cronbach’s ). Average range over sessions = 0.166 (best to 
worst 0.07 – 0.27). Mean absolute difference between 2 
sessions 0.04 ± 0.04 (18% of mean MPOD, as cited in Delori et 
al. [56]). 
Ciulla et al./2001 [81]  24 48-82; pre-post cataract; all 
novices. 
Mean absolute difference between 1st (pre cataract op) and 2nd 
(post cataract op) session 0.085 ± 0.08; Y = 0.53X + 0.07, r = 
0.58 (p<0.001). Excluding 2 outliers strengthens the 
relationship to Y = 0.69X + 0.03, r = 0.75 (p<0.0001). 
Mellerio et al./2002 [48]  3 124 subjects in full study, 
18-84; normal; not reported. 
4 sessions on successive days. Coefficients of variation = 
8.6%, 5.1% and 6.7% for subjects 1, 2 and 3 respectively. 
Table 2
Bernstein et al./2004 
[110]  
40 < 60; normal; not reported. 3 sessions over 1 month. Mean intersession variability 10.1%. 
Koh et al./2004 [91]  7 + 6 58-81; 7 early ARM, 6 
normal; not reported. 
2 sessions 1-4 weeks apart. Mean absolute difference between 
sessions 0.063 ± 0.054 (normal eyes), 0.037 ± 0.02 (ARM 
eyes) and 0.041 ± 0.027 (fellow eyes); Y = 0.95X + 0.019, r = 
0.88 (no p-value given). 
Nolan et al./2004 [107]  100 22-60; normal; not reported. 2 sessions at least 90 mins apart. Mean difference between 
sessions -0.01 ± 0.08. 
Snodderly et al./2004 
[50]   
48 50-79; 15 with self-reported 
eye disease; all novices. 
2 sessions on different days. Test-retest correlation at 0.5° RE 
was r = 0.90 (no p-value given); Y = 0.94X + 0.02. Mean 
absolute test-retest difference (as a percentage of mean 
density) = 17%. Coefficient of repeatability = 0.19.a 
Tang et al./2004 [62]  (i) 6 68 subjects in full study, 22-
23; normal; not reported. 
3 sessions, each separated by a week. Coefficient of variation 
= 8.0% and coefficient of repeatability = 0.12. 
Tang et al./2004 [62]  
(ii) 
1 45; normal; not reported. 5 sessions on consecutive days. Coefficient of variation = 
7.2%. 
Hammond and 
Wooten/2005 [86]  
8 20-30; normal; novices. 10 separate sessions over 2-4 weeks. Intersession correlation 
0.97 (Cronbach’s ). 
Lam et al./2005 [70]  9 Average age 31.2; normal; 
novices. 
2 sessions on different days. Test-retest correlation at 0.5° was 
r = 0.68 (no p-value given). 
Liew et al./2005 [164]  17 150 twin pairs in full study, 
18-50; normal; not reported. 
2 sessions on different days. Mean difference between 
sessions 0.10 ± 0.11. Mean coefficient of variation = 17.6% (± 
16.5%). 
Gallaher et al./2007 
[114] 
40 69-84; not specifically 
reported; not reported. 
2 sessions, 1 week to 20 months apart. Mean difference 
between sessions -0.01 ± 0.16. Test-retest correlation was r = 
0.734 (no p-value given). Mean coefficient of variation = 18.4%. 
Intraclass correlation = 0.96. 
Hogg et al./2007 [176]  11 21-50; normal; novices. 4 sessions over 2 weeks. Mean coefficient of variation between 
sessions = 11.5% at 0.5°. 
Johnson et al./2008 
[122]  
49 60-80; normal; not reported. 2 sessions 1-4 days apart. Test-retest correlation was r = 0.90 
(no p-value given). 
Kirby et al./2009 [64]  16 Not reported; normal; 
experienced. 
3 sessions on different days. Intraclass correlations ‘in the 
range’ 0.93-0.96 at 0.25°, 0.5° and 1° retinal eccentricity. 
Van der Veen et 
al./2009 [53]  
11 26 subjects in full study, 22-
64; normal; not reported. 
2 sessions on different days. Mean difference between 
sessions 0.0195 ± 0.047; Y = 1.2X - 0.05, r = 0.97 (p<0.001). 
Mean test-retest difference (as a percentage of mean density) 
= 11.7%. 
Bartlett et al./2010 [119]  38 19-46; normal; novices. 2 sessions 1 week apart. Test-retest coefficients of 
repeatability were 0.45 (operator 1) and 0.58 (operator 2). 
Hagen et al./2010 [120]  24 38.1 ± 10.6; normal; novices. 3 sessions over 11 ± 6.9 days. Coefficients of variation were 
36.1% and 23% for right and left eyes, respectively. 
 
Study/Year 
Number of 
subjects 
Age range; eye health status; 
inter or intra session reliability 
Reliability statistics 
Berendschot et al./2000 
[136]  
 
8 
 
18-50; normal; intra-session. 
 
2 measurements. Within subjects variation and coefficients of 
repeatability were 10% and 0.17 with a SLO, and 17% and 0.27 with 
a purpose-built reflectometer. 
Delori et al./2001 [56]  (i) 
 
9 
 
21-72; normal; both. 
 
2 sessions, 4 on different days & 5 on the same day. Mean absolute 
difference between 1st and 2nd session 0.039 ± 0.029. Mean absolute 
test-retest difference (as a percentage of mean density) = 22%. 
Delori et al./2001 [56]  (ii) 
 
22 
 
22-78; normal; inter-session. 
 
2 sessions, 10-24 months apart. Mean absolute difference between 
sessions 0.042 ± 0.042. Mean absolute test-retest difference = 19%. 
Berendschot et al./2002 
[144] 
17 
 
Average age 67.5; 6 ARM, 11 
normal; intra-session. 
2 sets of measurements. Coefficient of repeatability 0.11. Mean 
relative difference between measurements = 10%. 
Bour et al./2002 [137]  
 
‘6 eyes’ 
 
23 subjects in full study, 6-20; 
normal; intra-session. 
2 sets of measurements with a fundus camera. Correlation 
coefficient between measures was r = 0.77 (p<0.05). 
Wüstemeyer et al./2002 
[98]  
 
10 16-43; normal; intra-session. 
 
2 sessions with a SLO, no more than 30 mins apart. Mean within 
subjects coefficient of variation = 6.2%. As a percentage of mean 
density, as used by Delori et al. [56], mean test-retest difference = 
3.1%. 
Zagers et al./2002 [146]  
 
21 
 
18-27 (n=15) & 40-74 (n=6); 
normal; intra-session. 
25 measurements all in the same sitting with the FRA. Coefficient of 
repeatability 0.084. 
Berendschot and van 
Norren/2005 [141]  
 
53 
 
19-76; normal; intra-session. 
 
5 measurements (same sitting). Mean within subjects variation and 
coefficients of repeatability were 5.5% and 0.078 with the FRA 1, and 
7.0% and 0.09 with the FRA 2. 
van de Kraats et al./2006 
[58]   
 
10 
 
20 subjects in full study, 18-79; 
normal; both. 
 
2 sessions on different days with the MPR. Test-retest correlation 
was r = 0.94 (p<0.001). 5 spectra measured in each test condition 
(intra-session), gave a mean within subjects variation of ‘typically’ 
7%. 
Bone et al./2007 [59]  
 
22 
 
18-24; normal; inter-session. 
 
6-8 sessions at ~2 weekly intervals with a fundus camera. Standard 
deviation of the set of measurements was ‘typically’ ≤0.05. 
 
 
 
Table 3
Study/Year 
Number of 
subjects 
Age range; eye health status; 
inter or intra session reliability 
Reliability statistics 
Delori et al./2001 [56]  (i) 
 
9 
 
21-72; normal; both. 
 
AF comparison method: 2 sessions, 4 on different days & 5 on the 
same day. Mean absolute difference between 1st and 2nd session 
0.042 ± 0.019. Mean absolute test-retest difference (as a percentage 
of mean density) = 9.0%. 
Delori et al./2001 [56]  (ii) 
 
22 22-78; normal; inter-session. 
 
AF comparison method: 2 sessions, 10-24 months apart. Mean 
absolute difference between sessions 0.053 ± 0.048. Mean absolute 
test-retest difference = 11%. 
Delori/2004 [159] 38 24-77; normal; intra-session. AF imaging: Test-retest reproducibility 0.03 ± 0.03. 
Berendschot and van 
Norren/2005 [141]  
 
53 19-76; normal; intra-session. 
 
AF imaging: 10 single AF images at 488 nm and 514 nm (without 
averaging). Mean within subjects variation = 17% and coefficient of 
repeatability = 0.13. 
Liew et al./2005 [164]  8 150 twin pairs in full study, 18-
50; normal; inter-session. 
 
AF imaging: 2 sessions less than 1 month apart. Mean difference 
between sessions 0.02 ± 0.02 (range 0-0.05). Mean coefficient of 
variation = 3.3% (± 2.1%). 
Delori et al./2006 [117]  
 
37 20-70; normal; intra-session. 
 
AF imaging: Short break between first and second measurement. 
Mean absolute test-retest difference (as a percentage of mean 
density) = 6.4% (range 0-34%) for peak (0°) MPOD and 6.4% (range 
0-36%) for MPOD averaged over a 1° foveal-centred area. 
Sharifzadeh et al./2006 
[153]  
1 Age unreported; normal; inter-
session. 
AF imaging: 8 measurements over 4 weeks. Standard deviation of 
MPOD 2.4%. 
Trieschmann et al./2006 
[162]  
 
20 120 subjects in full study, 20-
86; 15 normal, 5 AMD; intra-
session. 
AF imaging: 5 repeats. 1- method at 0.5°: median coefficient of 
variation = 3.6% and reliability ratio = 0.97. 2- method at 0.5°: 
median coefficient of variation = 6.8% and reliability ratio = 0.94. 
 
Table 4
Study/Year 
Number of 
subjects 
Age range; eye health status; 
inter or intra session reliability 
Reliability statistics 
Bernstein et al./2002 
[170]  
2 26 and 37; normal; both. 
 
5 sessions over 2 weeks. Variability within and between sessions 
was ‘generally less than  10%’. 
Gellermann et al./2002 
[171]  
 
2 26 and 37; normal; both. 
 
5 sessions over 2 weeks. Standard deviation within sessions (5 
readings) was typically less than 15%. Reproducibility between 
sessions was ‘high’. 
Bernstein et al./2004 
[110]  
40 < 60; normal; inter-session. 3 sessions over 1 month. Mean intersession variability 6.4%. 
Ermakov et al./2004 [174]  
 
2 Age unreported; normal; both. 
 
Subject 1: 6 measurements with 3-4 minute intervals. Relative 
standard deviation = 5.3%. 
Subject 2: 5 sessions over 2 weeks. Relative standard deviation = 
5.1%. 
Neelam et al./2005 [57]  
 
20 120 subjects in full study, 20-
60; normal; both. 
 
2 sessions less than 2 weeks apart. Within-session mean coefficient 
of variation (using three highest readings) = 12.61% (± 9.46%) at 
session 1 and 8.42% (± 7.12%) at session 2. Bland-Altman plots for 
inter-session reproducibility showed that 95% of MPOD readings 
were within the 95% limits of agreement. 
Hogg et al./2007 [176]  
 
11 21-50; normal; inter-session. 
 
4 sessions over 2 weeks. Mean coefficient of variation between 
sessions = 13.5%. 
Obana et al./2008 [177]  
 
197 20-80 & 50-85; 100 normal, 97 
ARM/AMD; intra-session. 
Coefficient of variation of 5 readings was 1.0% - 69.4% in normal 
subjects and 0.9% - 145.4% in ARM subjects. 
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